1	Neurogenetics	NNS	O	neurogenetic	nsubj	2	SENT_1	[p1l52t81r253b114],
2	(	VBP	O	(	_	0	SENT_1	[p1l267t81r357b114],
3	2011	CD	DATE	2011	dobj	2	SENT_1	[p1l267t81r357b114],
4	)	CD	NUMBER	)	num	5	SENT_1	[p1l267t81r357b114],
5	l2	NN	O	l2	dep	3	SENT_1	[p1l374t82r502b107],
6	:79	CD	NUMBER	:79	num	7	SENT_1	[p1l374t82r502b107],
7	—	CD	NUMBER	—	dep	2	SENT_1	[p1l374t82r502b107],
8	82	CD	NUMBER	82	num	9	SENT_1	[p1l374t82r502b107],
9	DOI	NNP	O	DOI	dep	7	SENT_1	[p1l53t129r114b154],
10	10.1007	CD	NUMBER	10.1007	num	9	SENT_1	[p1l130t129r525b154],
11	/	:	O	/	punct	7	SENT_1	[p1l130t129r525b154],
12	s10048-010-0254-5	NN	O	s10048-010-0254-5	dep	7	SENT_1	[p1l130t129r525b154],
13	:	:	O	:	_	0	SENT_1	[p1l53t220r1044b251],
14	SP	NN	O	sp	nn	16	SENT_1	[p1l53t220r1044b251],
15	[	CD	NUMBER	[	num	16	SENT_1	[p1l53t220r1044b251],
16	OiMMUNICATI	NN	O	oimmunicatus	dep	12	SENT_1	[p1l53t220r1044b251],
17	(	CD	NUMBER	(	number	18	SENT_1	[p1l53t220r1044b251],
18	§	CD	NUMBER	§	num	19	SENT_1	[p1l53t220r1044b251],
19	NM	NN	O	nm	dep	16	SENT_1	[p1l53t220r1044b251],

1	OCT1	NN	O	oct1	nn	2	SENT_2	[p1l55t326r239b376],
2	polymorphism	NN	O	polymorphism	nsubjpass	4	SENT_2	[p1l270t326r714b391],
3	is	VBZ	O	be	auxpass	4	SENT_2	[p1l740t326r785b376],
4	associated	VBN	O	associate	_	0	SENT_2	[p1l814t326r1120b376],
5	with	IN	O	with	_	0	SENT_2	[p1l1146t326r1278b376],
6	response	NN	O	response	nn	9	SENT_2	[p1l1306t341r1569b391],
7	and	CC	O	and	_	0	SENT_2	[p1l56t409r167b458],
8	survival	NN	O	survival	nn	9	SENT_2	[p1l195t408r440b458],
9	time	NN	O	time	prep_with	4	SENT_2	[p1l465t408r597b458],
10	in	IN	O	in	_	0	SENT_2	[p1l623t408r680b457],
11	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	13	SENT_2	[p1l709t408r1257b458],
12	drug	NN	O	drug	nn	13	SENT_2	[p1l1286t409r1429b473],
13	users	NNS	O	user	prep_in	4	SENT_2	[p1l1457t423r1612b458],

1	Matthijs	NNP	PERSON	Matthijs	nn	3	SENT_3	[p1l53t548r202b586],
2	L.	NNP	PERSON	L.	nn	3	SENT_3	[p1l217t549r253b577],
3	Becker	NNP	PERSON	Becker	_	0	SENT_3	[p1l269t549r391b577],
4	-	:	O	-	_	0	SENT_3	[p1l404t561r412b570],
5	Loes	NNP	PERSON	Loes	nn	7	SENT_3	[p1l424t549r505b577],
6	E.	NNP	PERSON	E.	nn	7	SENT_3	[p1l521t549r557b577],
7	Visser	NNP	PERSON	Visser	dep	3	SENT_3	[p1l572t548r680b578],
8	Ron	NNP	PERSON	Ron	nn	12	SENT_3	[p1l692t561r701b570, p1l53t600r125b629],
9	H.	NNP	PERSON	H.	nn	12	SENT_3	[p1l141t600r181b629],
10	N.	NNP	PERSON	N.	nn	12	SENT_3	[p1l197t600r235b629],
11	van	NNP	PERSON	van	nn	12	SENT_3	[p1l250t608r313b629],
12	Schaik	NNP	PERSON	Schaik	dep	7	SENT_3	[p1l330t600r448b629],
13	-	:	O	-	_	0	SENT_3	[p1l460t613r468b622],
14	Albert	NNP	PERSON	Albert	nn	18	SENT_3	[p1l480t600r593b629],
15	Hofman	NNP	PERSON	Hofman	nn	18	SENT_3	[p1l608t600r750b629],
16	André	NNP	PERSON	André	nn	18	SENT_3	[p1l763t613r772b622, p1l53t651r164b680],
17	G.	NNP	PERSON	G.	nn	18	SENT_3	[p1l180t651r219b680],
18	Uitterlinden	NNP	PERSON	Uitterlinden	dep	7	SENT_3	[p1l235t651r448b680],
19	-	:	O	-	_	0	SENT_3	[p1l461t664r469b673],
20	Bruno	NNP	PERSON	Bruno	nn	22	SENT_3	[p1l481t652r592b680],
21	H.	NNP	PERSON	H.	nn	22	SENT_3	[p1l607t652r647b680],
22	Ch	NNP	PERSON	Ch	dep	18	SENT_3	[p1l664t651r724b680],
23	.	.	O	.	_	0	SENT_3	[p1l664t651r724b680],

1	Stricker	NNP	PERSON	Stricker	_	0	SENT_4	[p1l742t651r883b680],

1	Received	VBN	O	receive	_	0	SENT_5	[p1l53t755r190b781],
2	:	:	O	:	_	0	SENT_5	[p1l53t755r190b781],
3	3	CD	DATE	3	num	4	SENT_5	[p1l205t756r219b781],
4	May	NNP	DATE	May	dep	1	SENT_5	[p1l234t756r298b788],
5	2010	CD	DATE	2010	num	4	SENT_5	[p1l310t756r379b781],
6	/	:	O	/	punct	7	SENT_5	[p1l388t755r398b781],
7	Accepted	JJ	O	accepted	dep	4	SENT_5	[p1l402t755r541b788],
8	:	:	O	:	_	0	SENT_5	[p1l402t755r541b788],
9	19	CD	DATE	19	dep	7	SENT_5	[p1l559t756r589b781],
10	July	NNP	DATE	July	tmod	9	SENT_5	[p1l602t755r660b788],
11	2010	CD	DATE	2010	num	10	SENT_5	[p1l673t756r741b781],
12	/	:	O	/	punct	7	SENT_5	[p1l751t755r761b781],
13	Published	VBN	O	publish	partmod	4	SENT_5	[p1l765t755r903b781],
14	onlinez	NN	O	onlinez	nn	16	SENT_5	[p1l915t755r1009b781],
15	1	CD	DATE	1	num	16	SENT_5	[p1l1027t756r1037b780],
16	August	NNP	DATE	August	dobj	13	SENT_5	[p1l1053t756r1154b788],
17	2010	CD	DATE	2010	num	18	SENT_5	[p1l1166t756r1235b781],
18	©	CD	NUMBER	©	nsubj	24	SENT_5	[p1l55t794r85b824],
19	The	DT	O	the	det	21	SENT_5	[p1l100t797r153b822],
20	Author	NN	O	author	nn	21	SENT_5	[p1l166t797r300b829],
21	(	NN	O	(	dep	18	SENT_5	[p1l166t797r300b829],
22	s	VBZ	O	s	cop	24	SENT_5	[p1l166t797r300b829],
23	)	CD	NUMBER	)	num	24	SENT_5	[p1l166t797r300b829],
24	2010	CD	DATE	2010	rcmod	16	SENT_5	[p1l314t797r390b822],
25	.	.	O	.	_	0	SENT_5	[p1l314t797r390b822],

1	This	DT	O	this	det	2	SENT_6	[p1l405t797r465b822],
2	article	NN	O	article	nsubjpass	4	SENT_6	[p1l479t797r563b822],
3	is	VBZ	O	be	auxpass	4	SENT_6	[p1l577t797r598b822],
4	published	VBN	O	publish	_	0	SENT_6	[p1l610t797r747b829],
5	with	IN	O	with	_	0	SENT_6	[p1l759t797r820b822],
6	open	JJ	O	open	amod	7	SENT_6	[p1l833t805r900b829],
7	access	NN	O	access	prep_with	4	SENT_6	[p1l913t805r1000b822],
8	at	IN	O	at	_	0	SENT_6	[p1l1014t800r1038b822],
9	Springerlinlccom	NNP	LOCATION	Springerlinlccom	prep_at	4	SENT_6	[p1l1052t797r1293b829],

1	Abstract	JJ	O	abstract	amod	2	SENT_7	[p1l6t993r337b1055],
2	Substrates	NNS	O	substrate	nsubj	21	SENT_7	[p1l387t991r744b1055],
3	for	IN	O	for	_	0	SENT_7	[p1l782t991r884b1055],
4	the	DT	O	the	det	7	SENT_7	[p1l914t991r1020b1055],
5	Organic	NNP	O	Organic	nn	7	SENT_7	[p1l1057t991r1338b1073],
6	Cation	NNP	O	Cation	nn	7	SENT_7	[p1l1375t991r1609b1055],
7	Transporter	NNP	O	Transporter	prep_for	2	SENT_7	[p1l1644t994r2054b1073],
8	1	CD	NUMBER	1	num	7	SENT_7	[p1l2095t993r2148b1068],
9	,	,	O	,	_	0	SENT_7	[p1l2095t993r2148b1068],
10	encoded	VBN	O	encode	partmod	2	SENT_7	[p1l9t1102r304b1166],
11	by	IN	O	by	_	0	SENT_7	[p1l329t1102r419b1184],
12	the	DT	O	the	det	14	SENT_7	[p1l445t1102r551b1166],
13	SLC22AI	NN	O	slc22aus	nn	14	SENT_7	[p1l579t1103r915b1166],
14	gene	NN	O	gene	agent	10	SENT_7	[p1l950t1123r1134b1184],
15	,	,	O	,	_	0	SENT_7	[p1l950t1123r1134b1184],
16	are	VBP	O	be	cop	21	SENT_7	[p1l1167t1123r1269b1166],
17	metformin	NN	O	metformin	nn	21	SENT_7	[p1l1297t1102r1690b1179],
18	,	,	O	,	_	0	SENT_7	[p1l1297t1102r1690b1179],
19	amantadine	NN	O	amantadine	dep	21	SENT_7	[p1l1722t1102r2148b1179],
20	,	,	O	,	_	0	SENT_7	[p1l1722t1102r2148b1179],
21	pramipexole	NN	O	pramipexole	_	0	SENT_7	[p1l6t1213r469b1295],
22	,	,	O	,	_	0	SENT_7	[p1l6t1213r469b1295],
23	and	CC	O	and	_	0	SENT_7	[p1l509t1213r653b1290],
24	,	,	O	,	_	0	SENT_7	[p1l509t1213r653b1290],
25	possibly	RB	O	possibly	dep	21	SENT_7	[p1l689t1213r1000b1295],
26	,	,	O	,	_	0	SENT_7	[p1l689t1213r1000b1295],
27	levodopa	NN	O	levodopa	conj_and	21	SENT_7	[p1l1040t1213r1380b1294],
28	.	.	O	.	_	0	SENT_7	[p1l1040t1213r1380b1294],

1	Recently	RB	DATE	recently	advmod	4	SENT_8	[p1l1420t1213r1748b1295],
2	,	,	O	,	_	0	SENT_8	[p1l1420t1213r1748b1295],
3	we	PRP	O	we	nsubj	4	SENT_8	[p1l1785t1234r1887b1277],
4	identiﬁed	VBD	O	identiﬁed	_	0	SENT_8	[p1l1923t1213r2149b1277, p1l9t1324r144b1388],
5	that	IN	O	that	complm	13	SENT_8	[p1l179t1324r312b1388],
6	the	DT	O	the	det	7	SENT_8	[p1l347t1324r453b1388],
7	rs622342	NN	O	rs622342	nsubjpass	13	SENT_8	[p1l490t1326r819b1388],
8	A	DT	O	a	det	11	SENT_8	[p1l858t1326r922b1387],
9	>	JJR	O	>	amod	11	SENT_8	[p1l959t1335r1007b1378],
10	C	NN	O	c	nn	11	SENT_8	[p1l1045t1326r1099b1388],
11	polymorphism	NN	O	polymorphism	dep	7	SENT_8	[p1l1137t1324r1658b1406],
12	is	VBZ	O	be	auxpass	13	SENT_8	[p1l1695t1324r1749b1388],
13	associated	VBN	O	associate	ccomp	4	SENT_8	[p1l1790t1324r2152b1388],
14	with	IN	O	with	_	0	SENT_8	[p1l6t1435r164b1499],
15	the	DT	O	the	det	18	SENT_8	[p1l195t1435r301b1499],
16	HbAlc	NN	O	hbalc	nn	18	SENT_8	[p1l335t1435r589b1499],
17	lowering	NN	O	lowering	nn	18	SENT_8	[p1l625t1435r938b1517],
18	effect	NN	O	effect	prep_with	13	SENT_8	[p1l972t1435r1170b1499],
19	in	IN	O	in	_	0	SENT_8	[p1l1202t1435r1268b1498],
20	metformin	NN	O	metformin	nn	21	SENT_8	[p1l1299t1435r1673b1499],
21	users	NNS	O	user	prep_in	18	SENT_8	[p1l1703t1456r1903b1499],
22	.	.	O	.	_	0	SENT_8	[p1l1703t1456r1903b1499],

1	In	IN	O	in	_	0	SENT_9	[p1l1941t1438r2013b1498],
2	the	DT	O	the	det	4	SENT_9	[p1l2044t1435r2150b1499],
3	Rotterdam	NNP	LOCATION	Rotterdam	nn	4	SENT_9	[p1l7t1546r382b1610],
4	Study	NNP	O	Study	prep_in	7	SENT_9	[p1l432t1546r648b1628],
5	,	,	O	,	_	0	SENT_9	[p1l432t1546r648b1628],
6	we	PRP	O	we	nsubj	7	SENT_9	[p1l697t1567r799b1610],
7	associated	VBD	O	associate	_	0	SENT_9	[p1l848t1546r1211b1610],
8	this	DT	O	this	det	9	SENT_9	[p1l1256t1546r1381b1610],
9	polymorphism	NN	O	polymorphism	dobj	7	SENT_9	[p1l1427t1546r1949b1628],
10	with	IN	O	with	_	0	SENT_9	[p1l1994t1546r2151b1610],
11	higher	JJR	O	higher	amod	13	SENT_9	[p1l7t1657r235b1738],
12	prescribed	JJ	O	prescribed	amod	13	SENT_9	[p1l289t1657r660b1738],
13	doses	NNS	O	dose	prep_with	7	SENT_9	[p1l720t1657r913b1721],
14	of	IN	O	of	_	0	SENT_9	[p1l975t1657r1056b1721],
15	all	DT	O	all	det	17	SENT_9	[p1l1105t1657r1189b1720],
16	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	17	SENT_9	[p1l1250t1657r1874b1721],
17	drugs	NNS	O	drug	prep_of	13	SENT_9	[p1l1934t1657r2146b1738],
18	.	.	O	.	_	0	SENT_9	[p1l1934t1657r2146b1738],

1	Between	IN	O	between	_	0	SENT_10	[p1l7t1770r318b1832],
2	the	DT	O	the	det	6	SENT_10	[p1l354t1768r461b1832],
3	first	JJ	ORDINAL	first	amod	6	SENT_10	[p1l502t1768r641b1832],
4	and	CC	O	and	_	0	SENT_10	[p1l679t1768r805b1832],
5	ﬁfth	JJ	O	ﬁfth	amod	6	SENT_10	[p1l844t1768r992b1831],
6	prescriptions	NNS	O	prescription	pobj	1	SENT_10	[p1l1028t1768r1485b1849],
7	for	IN	O	for	_	0	SENT_10	[p1l1527t1768r1628b1832],
8	levodopa	NN	O	levodopa	prep_for	6	SENT_10	[p1l1665t1768r2008b1849],
9	,	,	O	,	_	0	SENT_10	[p1l1665t1768r2008b1849],
10	for	IN	O	for	prep	6	SENT_10	[p1l2052t1768r2153b1832],

1	M.	NNP	PERSON	M.	nn	7	SENT_11	[p1l7t2052r87b2104],
2	L.	NNP	PERSON	L.	nn	7	SENT_11	[p1l119t2052r178b2104],
3	Becker	NNP	PERSON	Becker	nn	7	SENT_11	[p1l209t2049r424b2104],
4	°	NNP	PERSON	°	nn	7	SENT_11	[p1l445t2069r457b2081],
5	L.	NNP	PERSON	L.	nn	7	SENT_11	[p1l482t2052r540b2104],
6	E.	NNP	PERSON	E.	nn	7	SENT_11	[p1l572t2052r631b2104],
7	Visser	NNP	PERSON	Visser	poss	9	SENT_11	[p1l661t2049r851b2104],
8	'	POS	O	'	_	0	SENT_11	[p1l872t2069r884b2081],
9	A.	NN	PERSON	a.	_	0	SENT_11	[p1l908t2051r976b2104],
10	Hofman	NNP	PERSON	Hofman	dep	9	SENT_11	[p1l1008t2050r1254b2104],
11	-	:	O	-	_	0	SENT_11	[p1l1278t2069r1289b2081],
12	A.	NN	PERSON	a.	dep	23	SENT_11	[p1l1313t2051r1381b2104],
13	G.	NNP	PERSON	G.	nn	14	SENT_11	[p1l1414t2051r1480b2104],
14	Uitterlinden	NNP	PERSON	Uitterlinden	dep	12	SENT_11	[p1l1511t2049r1875b2104],
15	°	NNP	O	°	nn	21	SENT_11	[p1l1898t2069r1910b2081],
16	B.	NNP	PERSON	B.	nn	21	SENT_11	[p1l7t2140r71b2192],
17	H.	NNP	PERSON	H.	nn	21	SENT_11	[p1l102t2140r170b2192],
18	C.	NNP	PERSON	C.	nn	21	SENT_11	[p1l203t2139r265b2192],
19	Stricker	NNP	PERSON	Stricker	nn	21	SENT_11	[p1l300t2138r535b2192],
20	(	NN	O	(	nn	21	SENT_11	[p1l554t2135r684b2207],
21	E	NN	O	e	dep	23	SENT_11	[p1l554t2135r684b2207],
22	)	CD	NUMBER	)	num	23	SENT_11	[p1l554t2135r684b2207],
23	Department	NNP	ORGANIZATION	Department	dep	40	SENT_11	[p1l7t2228r363b2295],
24	of	IN	ORGANIZATION	of	_	0	SENT_11	[p1l390t2225r459b2279],
25	Epidemiology	NNP	ORGANIZATION	Epidemiology	nn	28	SENT_11	[p1l477t2225r916b2295],
26	,	,	O	,	_	0	SENT_11	[p1l477t2225r916b2295],
27	Erasmus	NNP	ORGANIZATION	Erasmus	appos	28	SENT_11	[p1l946t2227r1202b2279],
28	MC	NNP	ORGANIZATION	MC	prep_of	23	SENT_11	[p1l1231t2226r1364b2291],
29	,	,	O	,	_	0	SENT_11	[p1l1231t2226r1364b2291],
30	P.O.	NNP	O	P.O.	nn	31	SENT_11	[p1l7t2316r128b2369],
31	Box	NNP	O	Box	appos	28	SENT_11	[p1l159t2317r285b2369],
32	2040	CD	DATE	2040	num	31	SENT_11	[p1l313t2316r479b2380],
33	,	,	O	,	_	0	SENT_11	[p1l313t2316r479b2380],
34	3000	CD	NUMBER	3000	num	31	SENT_11	[p1l511t2316r658b2369],
35	CA	NNP	O	CA	nn	36	SENT_11	[p1l688t2316r791b2369],
36	Rotterdam	NNP	LOCATION	Rotterdam	dep	31	SENT_11	[p1l817t2314r1150b2380],
37	,	,	O	,	_	0	SENT_11	[p1l817t2314r1150b2380],
38	The	DT	LOCATION	the	det	39	SENT_11	[p1l1182t2314r1296b2369],
39	Netherlands	NNP	LOCATION	Netherlands	nsubj	40	SENT_11	[p1l1322t2314r1685b2369],
40	e-mail	VB	O	e-mail	dep	9	SENT_11	[p1l9t2402r213b2457],
41	:	:	O	:	_	0	SENT_11	[p1l9t2402r213b2457],
42	b.stricker@erasmusmc.nl	NN	O	b.stricker@erasmusmc.nl	dep	9	SENT_11	[p1l244t2402r1012b2472],

1	M.	NNP	PERSON	M.	_	0	SENT_12	[p1l7t2583r87b2635],
2	L.	NNP	PERSON	L.	nn	3	SENT_12	[p1l119t2583r178b2635],
3	Becker	NNP	PERSON	Becker	dep	1	SENT_12	[p1l209t2581r424b2635],
4	-	:	O	-	_	0	SENT_12	[p1l445t2602r457b2614],
5	L.	NNP	PERSON	L.	nn	9	SENT_12	[p1l482t2583r540b2635],
6	E.	NNP	PERSON	E.	nn	9	SENT_12	[p1l572t2584r631b2635],
7	Visser	NNP	PERSON	Visser	nn	9	SENT_12	[p1l661t2581r851b2636],
8	Hospital	NNP	ORGANIZATION	Hospital	nn	9	SENT_12	[p1l7t2669r261b2739],
9	Pharmacy	NNP	ORGANIZATION	Pharmacy	dep	1	SENT_12	[p1l288t2669r600b2739],
10	,	,	O	,	_	0	SENT_12	[p1l288t2669r600b2739],
11	Erasmus	NNP	ORGANIZATION	Erasmus	nn	12	SENT_12	[p1l630t2672r887b2724],
12	MC	NNP	ORGANIZATION	MC	appos	9	SENT_12	[p1l915t2671r1048b2735],
13	,	,	O	,	_	0	SENT_12	[p1l915t2671r1048b2735],
14	Rotterdam	NNP	LOCATION	Rotterdam	appos	9	SENT_12	[p1l7t2759r340b2824],
15	,	,	O	,	_	0	SENT_12	[p1l7t2759r340b2824],
16	The	DT	LOCATION	the	det	17	SENT_12	[p1l371t2759r486b2813],
17	Netherlands	NNPS	LOCATION	Netherlands	appos	9	SENT_12	[p1l511t2759r874b2813],

1	R.	NNP	PERSON	R.	nn	3	SENT_13	[p1l7t2940r71b2992],
2	H.	NNP	PERSON	H.	nn	3	SENT_13	[p1l102t2940r170b2992],
3	N.	NNP	PERSON	N.	_	0	SENT_13	[p1l199t2940r269b2992],
4	Van	NNP	PERSON	Van	nn	6	SENT_13	[p1l300t2955r409b2992],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_13	[p1l439t2937r641b2992],
6	Department	NNP	ORGANIZATION	Department	dep	3	SENT_13	[p1l7t3028r362b3095],
7	of	IN	ORGANIZATION	of	_	0	SENT_13	[p1l390t3026r459b3080],
8	Clinical	JJ	ORGANIZATION	clinical	amod	9	SENT_13	[p1l478t3026r713b3080],
9	Chemistry	NNP	ORGANIZATION	Chemistry	prep_of	6	SENT_13	[p1l742t3026r1065b3095],
10	,	,	O	,	_	0	SENT_13	[p1l742t3026r1065b3095],
11	Erasmus	NNP	ORGANIZATION	Erasmus	nn	12	SENT_13	[p1l1095t3028r1351b3080],
12	MC	NNP	ORGANIZATION	MC	appos	9	SENT_13	[p1l1380t3027r1513b3091],
13	,	,	O	,	_	0	SENT_13	[p1l1380t3027r1513b3091],
14	Rotterdam	NNP	LOCATION	Rotterdam	appos	9	SENT_13	[p1l7t3115r340b3181],
15	,	,	O	,	_	0	SENT_13	[p1l7t3115r340b3181],
16	The	DT	LOCATION	the	det	17	SENT_13	[p1l371t3115r485b3169],
17	Netherlands	NNPS	LOCATION	Netherlands	appos	9	SENT_13	[p1l511t3115r874b3169],

1	R.	NNP	PERSON	R.	nn	4	SENT_14	[p1l7t3296r71b3348],
2	H.	NNP	PERSON	H.	nn	4	SENT_14	[p1l102t3296r170b3348],
3	N.	NNP	PERSON	N.	nn	4	SENT_14	[p1l199t3296r269b3348],
4	Van	NNP	PERSON	Van	_	0	SENT_14	[p1l300t3311r409b3348],
5	Schaik	NNP	PERSON	Schaik	nn	9	SENT_14	[p1l439t3294r641b3348],
6	STAR	NNP	O	STAR	nn	9	SENT_14	[p1l10t3383r195b3436],
7	Medical	NNP	O	Medical	nn	9	SENT_14	[p1l221t3382r466b3436],
8	Diagnostic	NNP	O	Diagnostic	nn	9	SENT_14	[p1l493t3382r817b3451],
9	Center	NNP	O	Center	dep	4	SENT_14	[p1l847t3383r1060b3447],
10	,	,	O	,	_	0	SENT_14	[p1l847t3383r1060b3447],
11	Rotterdam	NNP	LOCATION	Rotterdam	appos	9	SENT_14	[p1l7t3471r340b3537],
12	,	,	O	,	_	0	SENT_14	[p1l7t3471r340b3537],
13	The	DT	LOCATION	the	det	14	SENT_14	[p1l371t3471r485b3525],
14	Netherlands	NNPS	LOCATION	Netherlands	appos	9	SENT_14	[p1l511t3471r874b3525],

1	A.	NN	PERSON	a.	_	0	SENT_15	[p1l6t3651r75b3704],
2	Hofman	NNP	PERSON	Hofman	dep	1	SENT_15	[p1l106t3650r353b3704],
3	-	:	O	-	_	0	SENT_15	[p1l377t3670r388b3681],
4	A.	NN	PERSON	a.	dep	1	SENT_15	[p1l412t3651r480b3704],
5	G.	NNP	PERSON	G.	nn	6	SENT_15	[p1l513t3651r579b3704],
6	Uitterlinden	NNP	PERSON	Uitterlinden	poss	11	SENT_15	[p1l609t3650r973b3704],
7	'	POS	O	'	_	0	SENT_15	[p1l997t3670r1008b3681],
8	B.	NNP	PERSON	B.	nn	11	SENT_15	[p1l1033t3652r1097b3704],
9	H.	NNP	PERSON	H.	nn	11	SENT_15	[p1l1128t3652r1196b3704],
10	C.	NNP	PERSON	C.	nn	11	SENT_15	[p1l1229t3651r1291b3704],
11	Stricker	NNP	PERSON	Stricker	dep	4	SENT_15	[p1l1326t3650r1560b3704],

1	The	DT	O	the	det	3	SENT_16	[p2l8t24r122b78],
2	Netherlands	NNP	O	Netherlands	nn	3	SENT_16	[p2l148t24r511b78],
3	Consortium	NNP	O	Consortium	_	0	SENT_16	[p2l541t24r897b78],
4	on	IN	O	on	_	0	SENT_16	[p2l924t41r999b78],
5	Healthy	JJ	O	healthy	amod	6	SENT_16	[p2l1025t24r1262b93],
6	Aging	NN	O	aging	prep_on	3	SENT_16	[p2l1289t24r1493b93],
7	,	,	O	,	_	0	SENT_16	[p2l1289t24r1493b93],
8	Leiden/Rotterdam	NN	O	leiden/rotterdam	appos	6	SENT_16	[p2l7t113r570b179],
9	,	,	O	,	_	0	SENT_16	[p2l7t113r570b179],
10	The	DT	LOCATION	the	det	11	SENT_16	[p2l602t113r716b167],
11	Netherlands	NNPS	LOCATION	Netherlands	dep	3	SENT_16	[p2l742t113r1105b167],

1	A.	NN	PERSON	a.	_	0	SENT_17	[p2l6t293r75b346],
2	G.	NNP	PERSON	G.	nn	9	SENT_17	[p2l108t293r174b346],
3	Uitterlinden	NNP	PERSON	Uitterlinden	nn	9	SENT_17	[p2l205t292r568b346],
4	°	NNP	O	°	nn	9	SENT_17	[p2l591t312r603b324],
5	B.	NNP	PERSON	B.	nn	9	SENT_17	[p2l627t294r691b346],
6	H.	NNP	PERSON	H.	nn	9	SENT_17	[p2l723t294r790b346],
7	C.	NNP	PERSON	C.	nn	9	SENT_17	[p2l824t293r886b346],
8	Stricker	NNP	PERSON	Stricker	nn	9	SENT_17	[p2l921t292r1155b346],
9	Department	NNP	ORGANIZATION	Department	dep	1	SENT_17	[p2l7t382r363b449],
10	of	IN	ORGANIZATION	of	_	0	SENT_17	[p2l390t380r459b434],
11	Intemal	NNP	ORGANIZATION	Intemal	nn	12	SENT_17	[p2l477t380r708b434],
12	Medicine	NNP	ORGANIZATION	Medicine	prep_of	9	SENT_17	[p2l736t380r1035b446],
13	,	,	O	,	_	0	SENT_17	[p2l736t380r1035b446],
14	Erasmus	NNP	ORGANIZATION	Erasmus	nn	15	SENT_17	[p2l1066t382r1322b434],
15	MC	NNP	ORGANIZATION	MC	appos	12	SENT_17	[p2l1350t381r1483b446],
16	,	,	O	,	_	0	SENT_17	[p2l1350t381r1483b446],
17	Rotterdam	NNP	LOCATION	Rotterdam	appos	12	SENT_17	[p2l7t469r340b534],
18	,	,	O	,	_	0	SENT_17	[p2l7t469r340b534],
19	The	DT	LOCATION	the	det	20	SENT_17	[p2l371t469r486b523],
20	Netherlands	NNPS	LOCATION	Netherlands	appos	12	SENT_17	[p2l511t469r874b523],

1	B.	NNP	PERSON	B.	nn	7	SENT_18	[p2l7t650r71b702],
2	H.	NNP	PERSON	H.	nn	7	SENT_18	[p2l102t650r170b702],
3	C.	NNP	PERSON	C.	nn	7	SENT_18	[p2l203t649r265b702],
4	Stricker	NNP	PERSON	Stricker	nn	7	SENT_18	[p2l300t648r535b702],
5	Drug	NNP	O	Drug	nn	7	SENT_18	[p2l7t738r161b806],
6	Safety	NNP	O	Safety	nn	7	SENT_18	[p2l192t736r379b806],
7	Unit	NNP	O	Unit	nsubj	29	SENT_18	[p2l405t736r554b802],
8	,	,	O	,	_	0	SENT_18	[p2l405t736r554b802],
9	Inspectorate	NNP	ORGANIZATION	Inspectorate	appos	7	SENT_18	[p2l585t738r950b805],
10	for	IN	ORGANIZATION	for	_	0	SENT_18	[p2l979t736r1066b790],
11	Health	NNP	ORGANIZATION	Health	nn	12	SENT_18	[p2l1090t736r1290b790],
12	Care	NNP	ORGANIZATION	Care	prep_for	9	SENT_18	[p2l1318t737r1473b802],
13	,	,	O	,	_	0	SENT_18	[p2l1318t737r1473b802],
14	The	DT	O	the	det	15	SENT_18	[p2l8t824r122b878],
15	Hague	NNP	O	Hague	appos	12	SENT_18	[p2l150t826r362b893],
16	,	,	O	,	_	0	SENT_18	[p2l150t826r362b893],
17	The	DT	LOCATION	the	det	18	SENT_18	[p2l393t824r508b878],
18	Netherlands	NNP	LOCATION	Netherlands	appos	12	SENT_18	[p2l533t824r896b878],
19	each	DT	O	each	det	23	SENT_18	[p2l10t925r169b989],
20	minor	JJ	O	minor	amod	23	SENT_18	[p2l210t925r423b989],
21	rs622342	NN	O	rs622342	nn	23	SENT_18	[p2l461t927r789b989],
22	C	NN	O	c	nn	23	SENT_18	[p2l835t926r889b989],
23	allele	NN	O	allele	dep	18	SENT_18	[p2l935t925r1140b1002],
24	,	,	O	,	_	0	SENT_18	[p2l935t925r1140b1002],
25	the	DT	O	the	det	27	SENT_18	[p2l1185t925r1291b989],
26	prescribed	JJ	O	prescribed	amod	27	SENT_18	[p2l1331t925r1701b1007],
27	doses	NNS	O	dose	appos	12	SENT_18	[p2l1743t925r1936b989],
28	were	VBD	O	be	cop	29	SENT_18	[p2l1978t946r2148b989],
29	0.34	CD	NUMBER	0.34	_	0	SENT_18	[p2l10t1037r161b1100],
30	deﬁned	VBN	O	deﬁned	partmod	29	SENT_18	[p2l206t1036r469b1100],
31	daily	RB	SET	daily	advmod	36	SENT_18	[p2l512t1036r687b1118],
32	dose	NN	O	dose	npadvmod	33	SENT_18	[p2l729t1036r888b1100],
33	higher	JJR	O	higher	advmod	36	SENT_18	[p2l930t1036r1157b1118],
34	(	CD	PERCENT	(	number	35	SENT_18	[p2l1199t1036r1386b1117],
35	95	CD	PERCENT	95	num	36	SENT_18	[p2l1199t1036r1386b1117],
36	%	NN	PERCENT	%	dobj	30	SENT_18	[p2l1199t1036r1386b1117],
37	CI	NN	O	ci	dep	36	SENT_18	[p2l1430t1037r1515b1100],
38	0.064	CD	NUMBER	0.064	num	37	SENT_18	[p2l1558t1037r1775b1113],
39	,	,	O	,	_	0	SENT_18	[p2l1558t1037r1775b1113],
40	0.62	CD	NUMBER	0.62	appos	36	SENT_18	[p2l1822t1037r1995b1113],
41	;	:	O	;	_	0	SENT_18	[p2l1822t1037r1995b1113],
42	p	NN	O	p	dep	36	SENT_18	[p2l2030t1058r2141b1117],
43	=	JJ	O	=	amod	45	SENT_18	[p2l2030t1058r2141b1117],
44	0.017	CD	NUMBER	0.017	tmod	43	SENT_18	[p2l10t1147r254b1228],
45	)	NN	O	)	dep	42	SENT_18	[p2l10t1147r254b1228],
46	.	.	O	.	_	0	SENT_18	[p2l10t1147r254b1228],

1	The	DT	O	the	det	3	SENT_19	[p2l299t1147r433b1211],
2	mortality	NN	O	mortality	nn	3	SENT_19	[p2l470t1147r794b1229],
3	ratio	NN	O	ratio	nsubj	15	SENT_19	[p2l831t1147r990b1211],
4	after	IN	O	after	_	0	SENT_19	[p2l1031t1147r1190b1211],
5	start	NN	O	start	prep_after	3	SENT_19	[p2l1228t1156r1376b1211],
6	of	IN	O	of	_	0	SENT_19	[p2l1414t1147r1495b1211],
7	levodopa	NN	O	levodopa	nn	8	SENT_19	[p2l1523t1147r1849b1228],
8	therapy	NN	O	therapy	prep_of	5	SENT_19	[p2l1884t1147r2150b1229],
9	was	VBD	O	be	cop	15	SENT_19	[p2l7t1279r143b1322],
10	1.47	CD	NUMBER	1.47	num	11	SENT_19	[p2l185t1260r329b1322],
11	times	NNS	O	time	npadvmod	12	SENT_19	[p2l363t1258r551b1322],
12	higher	JJR	O	higher	advmod	15	SENT_19	[p2l584t1258r812b1340],
13	(	CD	PERCENT	(	number	14	SENT_19	[p2l844t1259r1031b1339],
14	95	CD	PERCENT	95	num	15	SENT_19	[p2l844t1259r1031b1339],
15	%	NN	PERCENT	%	_	0	SENT_19	[p2l844t1259r1031b1339],
16	CI	NN	O	ci	dep	15	SENT_19	[p2l1066t1260r1150b1322],
17	1.01	CD	NUMBER	1.01	num	16	SENT_19	[p2l1192t1260r1356b1336],
18	,	,	O	,	_	0	SENT_19	[p2l1192t1260r1356b1336],
19	2.13	CD	NUMBER	2.13	appos	15	SENT_19	[p2l1392t1260r1567b1336],
20	;	:	O	;	_	0	SENT_19	[p2l1392t1260r1567b1336],
21	p	NN	O	p	dep	15	SENT_19	[p2l1591t1259r1959b1340],
22	=	JJ	O	=	amod	24	SENT_19	[p2l1591t1259r1959b1340],
23	0.045	CD	NUMBER	0.045	tmod	22	SENT_19	[p2l1591t1259r1959b1340],
24	)	NN	O	)	dep	21	SENT_19	[p2l1591t1259r1959b1340],
25	.	.	O	.	_	0	SENT_19	[p2l1591t1259r1959b1340],

1	Keywords	NNPS	O	Keywords	nn	4	SENT_20	[p2l9t1485r391b1564],
2	Organic	NNP	O	Organic	nn	4	SENT_20	[p2l435t1482r715b1564],
3	Cation	NNP	O	Cation	nn	4	SENT_20	[p2l750t1482r984b1546],
4	Transporter	NNP	O	Transporter	_	0	SENT_20	[p2l1016t1485r1426b1564],
5	1	LS	NUMBER	1	dep	4	SENT_20	[p2l1465t1484r1489b1545],
6	-	:	O	-	_	0	SENT_20	[p2l1522t1482r2098b1546],
7	Anti-Parkinson	NNP	O	Anti-Parkinson	nn	8	SENT_20	[p2l1522t1482r2098b1546],
8	Agents	NNPS	O	Agents	dep	4	SENT_20	[p2l7t1594r257b1674],
9	-	:	O	-	_	0	SENT_20	[p2l282t1628r293b1638],
10	Pharrnacogenetics	SYM	O	pharrnacogenetics	dep	12	SENT_20	[p2l316t1593r959b1674],
11	-	:	O	-	_	0	SENT_20	[p2l984t1628r994b1639],
12	Pharrnacoepidemiology	NN	DATE	pharrnacoepidemiology	dep	8	SENT_20	[p2l1018t1593r1863b1674],

1	Introduction	NN	O	introduction	_	0	SENT_21	[p2l8t1836r488b1899],

1	Transporter	NN	O	transporter	nn	2	SENT_22	[p2l9t2061r419b2141],
2	proteins	NNS	O	protein	nsubj	3	SENT_22	[p2l457t2059r741b2140],
3	have	VBP	O	have	_	0	SENT_22	[p2l784t2059r950b2123],
4	a	DT	O	a	det	6	SENT_22	[p2l995t2080r1032b2122],
5	major	JJ	O	major	amod	6	SENT_22	[p2l1071t2059r1279b2141],
6	role	NN	O	role	dobj	3	SENT_22	[p2l1317t2059r1452b2123],
7	in	IN	O	in	_	0	SENT_22	[p2l1497t2059r1563b2122],
8	the	DT	O	the	det	9	SENT_22	[p2l1603t2059r1709b2123],
9	absorption	NN	O	absorption	prep_in	6	SENT_22	[p2l1754t2059r2146b2141],
10	,	,	O	,	_	0	SENT_22	[p2l1754t2059r2146b2141],
11	distribution	NN	O	distribution	prep_in	6	SENT_22	[p2l10t2170r435b2247],
12	,	,	O	,	_	0	SENT_22	[p2l10t2170r435b2247],
13	and	CC	O	and	_	0	SENT_22	[p2l491t2170r617b2234],
14	elimination	NN	O	elimination	prep_in	6	SENT_22	[p2l669t2170r1070b2234],
15	of	IN	O	of	_	0	SENT_22	[p2l1121t2170r1203b2234],
16	a	DT	O	a	det	18	SENT_22	[p2l1244t2191r1281b2234],
17	wide	JJ	O	wide	amod	18	SENT_22	[p2l1329t2170r1500b2234],
18	variety	NN	O	variety	prep_of	9	SENT_22	[p2l1551t2170r1796b2252],
19	of	IN	O	of	_	0	SENT_22	[p2l1847t2170r1929b2234],
20	compounds	NNS	O	compound	prep_of	18	SENT_22	[p2l1970t2191r2147b2234, p2l7t2281r282b2363],
21	.	.	O	.	_	0	SENT_22	[p2l1970t2191r2147b2234, p2l7t2281r282b2363],

1	Organic	NNP	MISC	Organic	nn	3	SENT_23	[p2l322t2281r602b2363],
2	cation	NN	O	cation	nn	3	SENT_23	[p2l638t2281r852b2345],
3	transporters	NNS	O	transporter	nsubj	4	SENT_23	[p2l884t2290r1299b2363],
4	(	VBP	O	(	dep	31	SENT_23	[p2l1335t2281r1566b2363],
5	OCT	NN	DATE	oct	nn	6	SENT_23	[p2l1335t2281r1566b2363],
6	)	NN	O	)	nsubjpass	8	SENT_23	[p2l1335t2281r1566b2363],
7	are	VBP	O	be	auxpass	8	SENT_23	[p2l1602t2302r1705b2345],
8	involved	VBN	O	involve	ccomp	4	SENT_23	[p2l1740t2281r2050b2345],
9	in	IN	O	in	_	0	SENT_23	[p2l2083t2281r2150b2344],
10	the	DT	O	the	det	11	SENT_23	[p2l8t2392r114b2456],
11	carriage	NN	O	carriage	prep_in	8	SENT_23	[p2l176t2392r459b2474],
12	of	IN	O	of	_	0	SENT_23	[p2l521t2392r603b2456],
13	both	CC	O	both	preconj	15	SENT_23	[p2l650t2392r810b2456],
14	endogenous	JJ	O	endogenous	amod	15	SENT_23	[p2l871t2392r1297b2474],
15	compounds	NNS	O	compound	prep_of	11	SENT_23	[p2l1360t2392r1792b2474],
16	,	,	O	,	_	0	SENT_23	[p2l1360t2392r1792b2474],
17	such	JJ	O	such	_	0	SENT_23	[p2l1857t2392r2018b2456],
18	as	IN	O	as	_	0	SENT_23	[p2l2079t2413r2148b2456],
19	dopamine	NN	O	dopamine	prep_such_as	15	SENT_23	[p2l10t2503r377b2584],
20	,	,	O	,	_	0	SENT_23	[p2l10t2503r377b2584],
21	and	CC	O	and	_	0	SENT_23	[p2l425t2503r552b2567],
22	drugs	NNS	O	drug	prep_such_as	15	SENT_23	[p2l595t2503r808b2584],
23	,	,	O	,	_	0	SENT_23	[p2l595t2503r808b2584],
24	such	JJ	O	such	_	0	SENT_23	[p2l858t2503r1017b2567],
25	as	IN	O	as	_	0	SENT_23	[p2l1062t2523r1130b2567],
26	metformin	NN	O	metformin	prep_such_as	19	SENT_23	[p2l1175t2503r1548b2567],
27	and	CC	O	and	_	0	SENT_23	[p2l1592t2503r1719b2567],
28	some	DT	O	some	det	30	SENT_23	[p2l1763t2523r1945b2567],
29	antiParkinsonian	JJ	O	antiparkinsonian	amod	30	SENT_23	[p2l1991t2503r2147b2566, p2l8t2614r493b2678],
30	drugs	NNS	O	drug	prep_of	11	SENT_23	[p2l556t2614r756b2695],
31	[	VBP	O	[	_	0	SENT_23	[p2l826t2615r1037b2694],
32	1	CD	NUMBER	1	num	33	SENT_23	[p2l826t2615r1037b2694],
33	—	CD	NUMBER	—	dobj	31	SENT_23	[p2l826t2615r1037b2694],
34	3	CD	NUMBER	3	num	35	SENT_23	[p2l826t2615r1037b2694],
35	]	NN	O	]	nsubj	31	SENT_23	[p2l826t2615r1037b2694],
36	.	.	O	.	_	0	SENT_23	[p2l826t2615r1037b2694],

1	The	DT	O	the	det	5	SENT_24	[p2l1106t2614r1244b2677],
2	three	CD	NUMBER	three	num	5	SENT_24	[p2l1306t2614r1488b2678],
3	most	RBS	O	most	advmod	4	SENT_24	[p2l1551t2622r1730b2678],
4	important	JJ	O	important	amod	5	SENT_24	[p2l1792t2614r2151b2695],
5	members	NNS	O	member	nsubj	13	SENT_24	[p2l8t2725r336b2789],
6	of	IN	O	of	_	0	SENT_24	[p2l400t2725r482b2789],
7	the	DT	O	the	det	9	SENT_24	[p2l531t2725r639b2789],
8	OCT	NN	DATE	oct	nn	9	SENT_24	[p2l702t2727r879b2790],
9	family	NN	O	family	prep_of	5	SENT_24	[p2l941t2725r1174b2807],
10	are	VBP	O	be	cop	13	SENT_24	[p2l1236t2746r1341b2789],
11	OCTl	NN	O	octl	nn	13	SENT_24	[p2l1404t2727r1647b2803],
12	,	,	O	,	_	0	SENT_24	[p2l1404t2727r1647b2803],
13	OCT2	NN	O	oct2	_	0	SENT_24	[p2l1713t2727r1955b2803],
14	,	,	O	,	_	0	SENT_24	[p2l1713t2727r1955b2803],
15	and	CC	O	and	_	0	SENT_24	[p2l2021t2725r2150b2789],
16	OCT3	NN	O	oct3	conj_and	13	SENT_24	[p2l10t2837r248b2914],
17	,	,	O	,	_	0	SENT_24	[p2l10t2837r248b2914],
18	encoded	VBN	O	encode	partmod	13	SENT_24	[p2l284t2836r579b2900],
19	by	IN	O	by	_	0	SENT_24	[p2l607t2836r696b2918],
20	the	DT	O	the	det	21	SENT_24	[p2l725t2836r831b2900],
21	SLC22AI	NN	O	slc22aus	agent	18	SENT_24	[p2l862t2837r1223b2913],
22	,	,	O	,	_	0	SENT_24	[p2l862t2837r1223b2913],
23	SLC22A2	NN	O	slc22a2	agent	18	SENT_24	[p2l1256t2837r1617b2913],
24	,	,	O	,	_	0	SENT_24	[p2l1256t2837r1617b2913],
25	and	CC	O	and	_	0	SENT_24	[p2l1653t2836r1778b2900],
26	SLC22/13	NN	O	slc22/13	nn	27	SENT_24	[p2l1807t2837r2146b2900],
27	genes	NNS	O	gene	agent	18	SENT_24	[p2l9t2967r228b3029],
28	,	,	O	,	_	0	SENT_24	[p2l9t2967r228b3029],
29	respectively	RB	O	respectively	advmod	18	SENT_24	[p2l270t2947r709b3029],
30	.	.	O	.	_	0	SENT_24	[p2l270t2947r709b3029],

1	Pramipexole	NNP	O	Pramipexole	nsubj	5	SENT_25	[p2l753t2947r1200b3028],
2	and	CC	O	and	_	0	SENT_25	[p2l1242t2947r1368b3011],
3	amantadine	NN	O	amantadine	conj_and	1	SENT_25	[p2l1408t2947r1812b3011],
4	are	VBP	O	be	cop	5	SENT_25	[p2l1855t2967r1958b3011],
5	substrates	NNS	O	substrate	_	0	SENT_25	[p2l2001t2947r2147b3011, p2l11t3067r229b3122],
6	for	IN	O	for	_	0	SENT_25	[p2l291t3058r393b3122],
7	OCTl	NN	O	octl	nn	10	SENT_25	[p2l449t3059r659b3122],
8	and	CC	O	and	_	0	SENT_25	[p2l729t3058r855b3122],
9	OCT2	NN	O	oct2	nn	10	SENT_25	[p2l913t3059r1130b3122],
10	[	NN	O	[	prep_for	5	SENT_25	[p2l1197t3059r1282b3138],
11	2	CD	NUMBER	2	dep	10	SENT_25	[p2l1197t3059r1282b3138],
12	,	,	O	,	_	0	SENT_25	[p2l1197t3059r1282b3138],
13	4-6	CD	NUMBER	4-6	num	14	SENT_25	[p2l1342t3059r1521b3138],
14	]	NN	O	]	appos	10	SENT_25	[p2l1342t3059r1521b3138],
15	.	.	O	.	_	0	SENT_25	[p2l1342t3059r1521b3138],

1	Levodopa	NN	O	levodopa	nsubj	4	SENT_26	[p2l1585t3058r1941b3139],
2	is	VBZ	O	be	cop	4	SENT_26	[p2l1999t3058r2053b3122],
3	a	DT	O	a	det	4	SENT_26	[p2l2114t3079r2151b3121],
4	substrate	NN	O	substrate	_	0	SENT_26	[p2l11t3169r319b3233],
5	for	IN	O	for	_	0	SENT_26	[p2l361t3169r463b3233],
6	OCT	NN	DATE	oct	prep_for	4	SENT_26	[p2l500t3171r687b3246],
7	,	,	O	,	_	0	SENT_26	[p2l500t3171r687b3246],
8	although	IN	O	although	mark	15	SENT_26	[p2l730t3169r1040b3251],
9	the	DT	O	the	det	10	SENT_26	[p2l1075t3169r1181b3233],
10	subtype	NN	O	subtype	nsubjpass	15	SENT_26	[p2l1223t3169r1495b3251],
11	has	VBZ	O	have	aux	15	SENT_26	[p2l1534t3169r1649b3233],
12	not	RB	O	not	neg	15	SENT_26	[p2l1688t3178r1802b3233],
13	yet	RB	O	yet	advmod	15	SENT_26	[p2l1837t3178r1946b3251],
14	been	VBN	O	be	auxpass	15	SENT_26	[p2l1981t3169r2150b3233],
15	identiﬁed	VBN	O	identiﬁed	advcl	4	SENT_26	[p2l9t3280r347b3344],
16	[	CD	NUMBER	[	num	17	SENT_26	[p2l384t3282r468b3361],
17	7	CD	NUMBER	7	dobj	15	SENT_26	[p2l384t3282r468b3361],
18	,	,	O	,	_	0	SENT_26	[p2l384t3282r468b3361],
19	8	CD	NUMBER	8	num	20	SENT_26	[p2l508t3282r593b3361],
20	]	NN	O	]	appos	17	SENT_26	[p2l508t3282r593b3361],
21	.	.	O	.	_	0	SENT_26	[p2l508t3282r593b3361],

1	Recently	RB	DATE	recently	advmod	4	SENT_27	[p2l111t3391r438b3473],
2	,	,	O	,	_	0	SENT_27	[p2l111t3391r438b3473],
3	we	PRP	O	we	nsubj	4	SENT_27	[p2l471t3412r573b3455],
4	identiﬁed	VBD	O	identiﬁed	_	0	SENT_27	[p2l605t3391r942b3455],
5	that	IN	O	that	complm	33	SENT_27	[p2l971t3391r1103b3455],
6	the	DT	O	the	det	9	SENT_27	[p2l1132t3391r1238b3455],
7	polymorphism	NN	O	polymorphism	nn	9	SENT_27	[p2l1268t3391r1788b3473],
8	rs622342	NN	O	rs622342	nn	9	SENT_27	[p2l1817t3393r2146b3455],
9	A	NN	O	a	nsubj	33	SENT_27	[p2l7t3503r71b3564],
10	>	JJR	O	>	amod	11	SENT_27	[p2l125t3513r173b3556],
11	C	NN	O	c	nsubjpass	22	SENT_27	[p2l230t3503r284b3566],
12	in	IN	O	in	_	0	SENT_27	[p2l343t3502r409b3564],
13	the	DT	O	the	det	15	SENT_27	[p2l462t3502r568b3566],
14	SLC22A1	NN	O	slc22a1	nn	15	SENT_27	[p2l623t3503r958b3566],
15	gene	NN	O	gene	prep_in	11	SENT_27	[p2l1021t3522r1205b3583],
16	,	,	O	,	_	0	SENT_27	[p2l1021t3522r1205b3583],
17	coding	VBG	O	code	partmod	22	SENT_27	[p2l1265t3502r1503b3583],
18	for	IN	O	for	_	0	SENT_27	[p2l1561t3502r1662b3566],
19	OCTl	NN	O	octl	prep_for	17	SENT_27	[p2l1716t3503r1955b3579],
20	,	,	O	,	_	0	SENT_27	[p2l1716t3503r1955b3579],
21	was	VBD	O	be	auxpass	22	SENT_27	[p2l2012t3522r2148b3566],
22	associated	VBN	O	associate	rcmod	9	SENT_27	[p2l10t3614r372b3678],
23	with	IN	O	with	_	0	SENT_27	[p2l408t3614r565b3678],
24	the	DT	O	the	det	25	SENT_27	[p2l602t3614r708b3678],
25	reduction	NN	O	reduction	prep_with	22	SENT_27	[p2l746t3614r1081b3678],
26	in	IN	O	in	_	0	SENT_27	[p2l1120t3614r1187b3677],
27	HbAlc	NN	O	hbalc	nn	28	SENT_27	[p2l1224t3614r1478b3678],
28	levels	NNS	O	level	prep_in	25	SENT_27	[p2l1519t3614r1720b3678],
29	in	IN	O	in	_	0	SENT_27	[p2l1761t3614r1828b3677],
30	incident	NN	O	incident	nn	32	SENT_27	[p2l1866t3614r2150b3678],
31	metformin	NN	O	metformin	nn	32	SENT_27	[p2l8t3725r381b3789],
32	users	NNS	O	user	prep_in	28	SENT_27	[p2l416t3746r596b3789],
33	[	VBP	O	[	ccomp	4	SENT_27	[p2l640t3727r752b3806],
34	9	CD	NUMBER	9	num	35	SENT_27	[p2l640t3727r752b3806],
35	]	NN	O	]	dobj	33	SENT_27	[p2l640t3727r752b3806],
36	.	.	O	.	_	0	SENT_27	[p2l640t3727r752b3806],

1	As	IN	O	as	mark	7	SENT_28	[p2l794t3727r890b3789],
2	this	DT	O	this	det	3	SENT_28	[p2l928t3725r1053b3789],
3	polymorphism	NN	O	polymorphism	nsubjpass	7	SENT_28	[p2l1090t3725r1611b3807],
4	might	MD	O	might	aux	7	SENT_28	[p2l1646t3725r1853b3807],
5	also	RB	O	also	advmod	7	SENT_28	[p2l1891t3725r2028b3789],
6	be	VB	O	be	auxpass	7	SENT_28	[p2l2066t3725r2148b3789],
7	involved	VBN	O	involve	advcl	18	SENT_28	[p3l9t22r320b86],
8	in	IN	O	in	_	0	SENT_28	[p3l351t22r418b85],
9	the	DT	O	the	det	11	SENT_28	[p3l448t22r554b86],
10	transportation	NN	O	transportation	nn	11	SENT_28	[p3l586t22r1077b104],
11	efficacy	NN	O	efficacy	prep_in	7	SENT_28	[p3l1110t22r1391b104],
12	of	IN	O	of	_	0	SENT_28	[p3l1423t22r1504b86],
13	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	14	SENT_28	[p3l1526t22r2150b86],
14	drugs	NNS	O	drug	prep_of	11	SENT_28	[p3l10t133r223b215],
15	,	,	O	,	_	0	SENT_28	[p3l10t133r223b215],
16	it	PRP	O	it	nsubj	18	SENT_28	[p3l273t133r319b196],
17	may	MD	O	may	aux	18	SENT_28	[p3l362t153r515b215],
18	affect	VB	O	affect	_	0	SENT_28	[p3l561t133r758b197],
19	the	DT	O	the	det	20	SENT_28	[p3l800t133r906b197],
20	response	NN	O	response	dobj	18	SENT_28	[p3l951t153r1260b215],
21	to	TO	O	to	_	0	SENT_28	[p3l1306t142r1371b197],
22	these	DT	O	these	det	23	SENT_28	[p3l1417t133r1597b197],
23	drugs	NNS	O	drug	prep_to	18	SENT_28	[p3l1645t133r1856b215],
24	.	.	O	.	_	0	SENT_28	[p3l1645t133r1856b215],

1	In	IN	O	in	_	0	SENT_29	[p3l1907t135r1978b196],
2	this	DT	O	this	det	5	SENT_29	[p3l2022t133r2147b197],
3	population-based	JJ	O	population-based	amod	5	SENT_29	[p3l7t244r620b326],
4	cohort	NN	O	cohort	nn	5	SENT_29	[p3l674t244r899b308],
5	study	NN	O	study	prep_in	8	SENT_29	[p3l953t244r1155b326],
6	,	,	O	,	_	0	SENT_29	[p3l953t244r1155b326],
7	we	PRP	O	we	nsubj	8	SENT_29	[p3l1210t265r1312b308],
8	studied	VBD	O	study	_	0	SENT_29	[p3l1368t244r1621b308],
9	whether	IN	O	whether	complm	18	SENT_29	[p3l1672t244r1959b308],
10	prescribed	VBN	O	prescribe	csubj	18	SENT_29	[p3l2007t265r2147b326, p3l11t355r285b419],
11	doses	NNS	O	dose	dobj	10	SENT_29	[p3l351t355r559b419],
12	of	IN	O	of	_	0	SENT_29	[p3l628t355r713b419],
13	levodopa	NN	O	levodopa	nn	17	SENT_29	[p3l769t355r1121b437],
14	and	CC	O	and	_	0	SENT_29	[p3l1186t355r1320b419],
15	co-prescribed	JJ	O	co-prescribed	nn	17	SENT_29	[p3l1386t355r1909b437],
16	antiParkinsonian	JJ	O	antiparkinsonian	amod	17	SENT_29	[p3l1976t355r2147b419, p3l8t466r472b530],
17	drugs	NNS	O	drug	prep_of	11	SENT_29	[p3l517t466r709b548],
18	differed	VBD	O	differ	ccomp	8	SENT_29	[p3l757t466r1033b530],
19	between	IN	O	between	_	0	SENT_29	[p3l1074t466r1371b530],
20	rs622342	NN	O	rs622342	nn	21	SENT_29	[p3l1413t468r1742b530],
21	genotypes	NNS	O	genotype	prep_between	18	SENT_29	[p3l1790t475r2147b548],
22	in	IN	O	in	_	0	SENT_29	[p3l9t577r76b639],
23	incident	NN	O	incident	nn	25	SENT_29	[p3l102t577r385b641],
24	levodopa	NN	O	levodopa	nn	25	SENT_29	[p3l410t577r736b658],
25	users	NNS	O	user	prep_in	18	SENT_29	[p3l757t597r957b641],
26	.	.	O	.	_	0	SENT_29	[p3l757t597r957b641],

1	We	PRP	O	we	nsubj	3	SENT_30	[p3l986t579r1100b641],
2	also	RB	O	also	advmod	3	SENT_30	[p3l1128t577r1264b641],
3	studied	VBD	O	study	_	0	SENT_30	[p3l1294t577r1547b641],
4	the	DT	O	the	det	5	SENT_30	[p3l1571t577r1676b641],
5	difference	NN	O	difference	dobj	3	SENT_30	[p3l1704t577r2056b641],
6	in	IN	O	in	_	0	SENT_30	[p3l2083t577r2150b640],
7	survival	NN	O	survival	nn	8	SENT_30	[p3l11t688r292b752],
8	time	NN	O	time	prep_in	3	SENT_30	[p3l323t688r478b751],
9	after	IN	O	after	_	0	SENT_30	[p3l512t688r672b752],
10	start	NN	O	start	prep_after	3	SENT_30	[p3l705t696r853b752],
11	of	IN	O	of	_	0	SENT_30	[p3l884t688r966b752],
12	levodopa	NN	O	levodopa	nn	13	SENT_30	[p3l988t688r1313b769],
13	therapy	NN	O	therapy	prep_of	10	SENT_30	[p3l1343t688r1619b769],
14	.	.	O	.	_	0	SENT_30	[p3l1343t688r1619b769],

1	Q	NNP	O	Q	nn	2	SENT_31	[p3l1809t931r1882b1021],
2	Springer	NNP	O	Springer	_	0	SENT_31	[p3l1908t954r2153b1024],

1	80	CD	NUMBER	80	num	2	SENT_32	[p3l54t1100r86b1124],
2	Neurogenetics	NNS	O	neurogenetic	nsubj	3	SENT_32	[p3l1656t1099r1858b1131],
3	(	VBP	O	(	_	0	SENT_32	[p3l1872t1099r1962b1131],
4	2011	CD	DATE	2011	num	5	SENT_32	[p3l1872t1099r1962b1131],
5	)	CD	NUMBER	)	dobj	3	SENT_32	[p3l1872t1099r1962b1131],
6	12:79	CD	NUMBER	12:79	num	7	SENT_32	[p3l1979t1099r2106b1124],
7	-82	CD	NUMBER	-82	dep	5	SENT_32	[p3l1979t1099r2106b1124],

1	Methods	NNS	O	method	_	0	SENT_33	[p3l7t1275r333b1336],

1	Data	NNS	O	datum	nsubjpass	6	SENT_34	[p3l7t1498r173b1559],
2	for	IN	O	for	_	0	SENT_34	[p3l207t1495r309b1559],
3	these	DT	O	these	det	4	SENT_34	[p3l339t1495r518b1559],
4	analyses	NNS	O	analysis	prep_for	1	SENT_34	[p3l555t1495r850b1577],
5	were	VBD	O	be	auxpass	6	SENT_34	[p3l885t1516r1054b1559],
6	obtained	VBN	O	obtain	ccomp	32	SENT_34	[p3l1090t1495r1394b1559],
7	from	IN	O	from	_	0	SENT_34	[p3l1428t1495r1597b1559],
8	the	DT	O	the	det	10	SENT_34	[p3l1629t1495r1735b1559],
9	Rotterdam	NNP	LOCATION	Rotterdam	nn	10	SENT_34	[p3l1770t1495r2142b1559],
10	Study	NNP	O	Study	prep_from	6	SENT_34	[p3l11t1606r227b1688],
11	,	,	O	,	_	0	SENT_34	[p3l11t1606r227b1688],
12	a	DT	O	a	det	16	SENT_34	[p3l256t1627r293b1670],
13	prospective	JJ	O	prospective	amod	16	SENT_34	[p3l314t1606r721b1688],
14	population-based	JJ	O	population-based	amod	16	SENT_34	[p3l745t1606r1358b1688],
15	cohort	NN	O	cohort	nn	16	SENT_34	[p3l1383t1606r1607b1670],
16	study	NN	O	study	nsubj	32	SENT_34	[p3l1633t1606r1822b1688],
17	of	IN	O	of	_	0	SENT_34	[p3l1848t1606r1929b1670],
18	7,983	CD	NUMBER	7,983	num	19	SENT_34	[p3l1944t1608r2135b1683],
19	Caucasians	NNPS	MISC	Caucasians	prep_of	16	SENT_34	[p3l9t1717r403b1781],
20	aged	JJ	O	aged	amod	19	SENT_34	[p3l448t1717r613b1798],
21	55	CD	DURATION	55	num	22	SENT_34	[p3l657t1719r737b1780],
22	years	NNS	NUMBER	year	tmod	20	SENT_34	[p3l783t1737r968b1798],
23	and	CC	O	and	_	0	SENT_34	[p3l1013t1717r1139b1781],
24	older	JJR	O	older	conj_and	20	SENT_34	[p3l1182t1717r1377b1794],
25	,	,	O	,	_	0	SENT_34	[p3l1182t1717r1377b1794],
26	who	WP	O	who	nsubjpass	28	SENT_34	[p3l1422t1717r1572b1781],
27	were	VBD	O	be	auxpass	28	SENT_34	[p3l1616t1737r1785b1781],
28	followed	VBN	O	follow	rcmod	19	SENT_34	[p3l1830t1717r2143b1781],
29	from	IN	O	from	_	0	SENT_34	[p3l9t1828r177b1892],
30	1990	CD	DATE	1990	num	31	SENT_34	[p3l218t1829r383b1892],
31	onwards	NNS	O	onward	prep_from	28	SENT_34	[p3l418t1828r714b1892],
32	[	VBP	O	[	_	0	SENT_34	[p3l753t1829r909b1908],
33	10	CD	NUMBER	10	number	34	SENT_34	[p3l753t1829r909b1908],
34	]	CD	NUMBER	]	dobj	32	SENT_34	[p3l753t1829r909b1908],
35	.	.	O	.	_	0	SENT_34	[p3l753t1829r909b1908],

1	All	DT	O	all	det	2	SENT_35	[p3l945t1828r1056b1890],
2	participants	NNS	O	participant	nsubj	7	SENT_35	[p3l1086t1828r1496b1909],
3	of	IN	O	of	_	0	SENT_35	[p3l1531t1828r1612b1892],
4	the	DT	O	the	det	6	SENT_35	[p3l1632t1828r1737b1892],
5	Rotterdam	NNP	LOCATION	Rotterdam	nn	6	SENT_35	[p3l1770t1828r2142b1892],
6	Study	NNP	O	Study	prep_of	2	SENT_35	[p3l11t1939r213b2020],
7	gave	VBD	O	give	_	0	SENT_35	[p3l244t1959r408b2020],
8	written	VBN	O	write	amod	10	SENT_35	[p3l438t1939r686b2003],
9	informed	VBN	O	inform	amod	10	SENT_35	[p3l717t1939r1040b2003],
10	consent	NN	O	consent	dobj	7	SENT_35	[p3l1070t1947r1355b2003],
11	.	.	O	.	_	0	SENT_35	[p3l1070t1947r1355b2003],

1	Ethical	JJ	O	ethical	amod	2	SENT_36	[p3l1390t1939r1638b2003],
2	approval	NN	O	approval	nsubjpass	4	SENT_36	[p3l1669t1939r1976b2020],
3	was	VBD	O	be	auxpass	4	SENT_36	[p3l2005t1959r2140b2003],
4	obtained	VBN	O	obtain	_	0	SENT_36	[p3l9t2051r318b2115],
5	from	IN	O	from	_	0	SENT_36	[p3l379t2051r550b2115],
6	the	DT	O	the	det	9	SENT_36	[p3l608t2051r716b2115],
7	Medical	NNP	ORGANIZATION	Medical	nn	9	SENT_36	[p3l777t2051r1070b2115],
8	Ethical	NNP	ORGANIZATION	Ethical	nn	9	SENT_36	[p3l1130t2051r1383b2115],
9	Committee	NNP	ORGANIZATION	Committee	prep_from	4	SENT_36	[p3l1444t2051r1840b2115],
10	of	IN	O	of	_	0	SENT_36	[p3l1903t2051r1985b2115],
11	the	DT	O	the	det	13	SENT_36	[p3l2033t2051r2141b2115],
12	Erasmus	NNP	O	Erasmus	nn	13	SENT_36	[p3l7t2165r309b2225],
13	MC	NNP	O	MC	prep_of	9	SENT_36	[p3l342t2163r496b2225],
14	.	.	O	.	_	0	SENT_36	[p3l342t2163r496b2225],

1	The	DT	O	the	det	3	SENT_37	[p3l110t2272r246b2336],
2	study	NN	O	study	nn	3	SENT_37	[p3l310t2272r503b2354],
3	sample	NN	O	sample	nsubj	4	SENT_37	[p3l565t2272r815b2353],
4	consisted	VBD	O	consist	_	0	SENT_37	[p3l878t2272r1213b2336],
5	of	IN	O	of	_	0	SENT_37	[p3l1274t2272r1356b2336],
6	all	DT	O	all	det	7	SENT_37	[p3l1407t2272r1493b2335],
7	subjects	NNS	O	subject	prep_of	4	SENT_37	[p3l1557t2272r1842b2354],
8	in	IN	O	in	_	0	SENT_37	[p3l1906t2272r1973b2335],
9	the	DT	O	the	det	11	SENT_37	[p3l2032t2272r2140b2336],
10	Rotterdam	NNP	LOCATION	Rotterdam	nn	11	SENT_37	[p3l7t2383r381b2447],
11	Study	NNP	O	Study	prep_in	4	SENT_37	[p3l415t2383r617b2465],
12	who	WP	O	who	nsubj	13	SENT_37	[p3l649t2383r799b2447],
13	had	VBD	O	have	rcmod	11	SENT_37	[p3l833t2383r961b2447],
14	a	DT	O	a	det	16	SENT_37	[p3l994t2404r1031b2447],
15	first	JJ	ORDINAL	first	amod	16	SENT_37	[p3l1063t2383r1201b2447],
16	prescription	NN	O	prescription	dobj	13	SENT_37	[p3l1230t2383r1653b2465],
17	for	IN	O	for	_	0	SENT_37	[p3l1687t2384r1787b2447],
18	levodopa	NN	O	levodopa	prep_for	16	SENT_37	[p3l1819t2383r2143b2465],
19	between	IN	O	between	_	0	SENT_37	[p3l6t2494r301b2558],
20	July	NNP	DATE	July	prep_between	18	SENT_37	[p3l339t2494r485b2576],
21	1st	CD	DATE	1st	num	20	SENT_37	[p3l531t2496r625b2558],
22	1991	CD	DATE	1991	dep	20	SENT_37	[p3l670t2496r828b2558],
23	and	CC	O	and	_	0	SENT_37	[p3l877t2494r1003b2558],
24	January	NNP	DATE	January	prep_between	18	SENT_37	[p3l1040t2497r1314b2576],
25	1st	JJ	DATE	1st	amod	24	SENT_37	[p3l1360t2496r1454b2558],
26	2008	CD	DATE	2008	tmod	25	SENT_37	[p3l1491t2496r1684b2558],
27	.	.	O	.	_	0	SENT_37	[p3l1491t2496r1684b2558],

1	Participants	NNS	O	participant	nsubjpass	16	SENT_38	[p3l1727t2494r2139b2576],
2	who	WP	O	who	nsubj	3	SENT_38	[p3l6t2605r157b2669],
3	had	VBD	O	have	rcmod	1	SENT_38	[p3l203t2605r331b2669],
4	prescriptions	NNS	O	prescription	dobj	3	SENT_38	[p3l372t2605r827b2687],
5	for	IN	O	for	_	0	SENT_38	[p3l874t2605r975b2669],
6	levodopa	NN	O	levodopa	prep_for	4	SENT_38	[p3l1018t2605r1342b2687],
7	between	IN	O	between	_	0	SENT_38	[p3l1383t2605r1678b2669],
8	January	NNP	DATE	January	prep_between	6	SENT_38	[p3l1723t2608r1997b2687],
9	1st	JJ	DATE	1st	amod	8	SENT_38	[p3l2049t2607r2143b2669],
10	1991	CD	DATE	1991	tmod	9	SENT_38	[p3l17t2717r174b2780],
11	and	CC	O	and	_	0	SENT_38	[p3l219t2716r345b2780],
12	July	NNP	DATE	July	prep_for	4	SENT_38	[p3l378t2716r524b2797],
13	1st	CD	DATE	1st	num	12	SENT_38	[p3l567t2717r661b2780],
14	1991	CD	DATE	1991	dep	12	SENT_38	[p3l702t2717r859b2780],
15	were	VBD	O	be	auxpass	16	SENT_38	[p3l902t2736r1071b2780],
16	excluded	VBN	O	exclude	_	0	SENT_38	[p3l1108t2716r1426b2780],
17	to	TO	O	to	aux	18	SENT_38	[p3l1457t2725r1523b2780],
18	ensure	VB	O	ensure	xcomp	16	SENT_38	[p3l1561t2736r1787b2780],
19	that	IN	O	that	complm	25	SENT_38	[p3l1820t2716r1953b2779],
20	only	RB	O	only	advmod	25	SENT_38	[p3l1987t2716r2142b2797],
21	incident	NN	O	incident	nn	23	SENT_38	[p3l8t2827r293b2891],
22	levodopa	NN	O	levodopa	nn	23	SENT_38	[p3l332t2827r656b2908],
23	users	NNS	O	user	nsubjpass	25	SENT_38	[p3l693t2847r872b2891],
24	were	VBD	O	be	auxpass	25	SENT_38	[p3l913t2847r1082b2891],
25	included	VBN	O	include	ccomp	18	SENT_38	[p3l1124t2827r1443b2891],
26	.	.	O	.	_	0	SENT_38	[p3l1124t2827r1443b2891],

1	We	PRP	O	we	nsubj	3	SENT_39	[p3l1488t2829r1602b2891],
2	also	RB	O	also	advmod	3	SENT_39	[p3l1645t2827r1781b2891],
3	excluded	VBD	O	exclude	_	0	SENT_39	[p3l1825t2827r2143b2891],
4	all	DT	O	all	det	5	SENT_39	[p3l9t2938r96b3001],
5	participants	NNS	O	participant	dobj	3	SENT_39	[p3l156t2938r585b3019],
6	who	WP	O	who	nsubjpass	8	SENT_39	[p3l647t2938r801b3002],
7	were	VBD	O	be	auxpass	8	SENT_39	[p3l864t2958r1039b3002],
8	prescribed	VBN	O	prescribe	rcmod	5	SENT_39	[p3l1100t2938r1485b3019],
9	less	JJR	O	less	mwe	10	SENT_39	[p3l1547t2938r1679b3002],
10	than	IN	O	than	quantmod	11	SENT_39	[p3l1742t2938r1899b3001],
11	three	CD	NUMBER	three	num	12	SENT_39	[p3l1959t2938r2140b3002],
12	prescriptions	NNS	O	prescription	dobj	8	SENT_39	[p3l6t3049r460b3131],
13	for	IN	O	for	_	0	SENT_39	[p3l501t3049r602b3113],
14	levodopa	NN	O	levodopa	prep_for	8	SENT_39	[p3l638t3049r979b3131],
15	,	,	O	,	_	0	SENT_39	[p3l638t3049r979b3131],
16	because	RB	O	because	advmod	8	SENT_39	[p3l1018t3049r1317b3126],
17	,	,	O	,	_	0	SENT_39	[p3l1018t3049r1317b3126],
18	most	RBS	O	most	advmod	19	SENT_39	[p3l1357t3058r1529b3113],
19	likely	RB	O	likely	advmod	24	SENT_39	[p3l1566t3049r1777b3131],
20	,	,	O	,	_	0	SENT_39	[p3l1566t3049r1777b3131],
21	levodopa	NN	O	levodopa	nn	22	SENT_39	[p3l1819t3049r2143b3131],
22	treatment	NN	O	treatment	nsubjpass	24	SENT_39	[p3l7t3169r340b3224],
23	was	VBD	O	be	auxpass	24	SENT_39	[p3l374t3181r508b3224],
24	used	VBN	O	use	dep	16	SENT_39	[p3l545t3160r709b3224],
25	as	IN	O	as	_	0	SENT_39	[p3l747t3181r815b3224],
26	a	DT	O	a	det	28	SENT_39	[p3l855t3181r892b3224],
27	diagnostic	JJ	O	diagnostic	amod	28	SENT_39	[p3l928t3160r1287b3242],
28	tool	NN	O	tool	prep_as	24	SENT_39	[p3l1325t3160r1478b3224],
29	.	.	O	.	_	0	SENT_39	[p3l1325t3160r1478b3224],

1	Participants	NNS	O	participant	nsubjpass	3	SENT_40	[p3l1521t3160r1933b3242],
2	were	VBD	O	be	auxpass	3	SENT_40	[p3l1972t3181r2140b3224],
3	genotyped	VBN	O	genotype	_	0	SENT_40	[p3l8t3271r378b3353],
4	with	IN	O	with	_	0	SENT_40	[p3l407t3271r564b3335],
5	the	DT	O	the	det	9	SENT_40	[p3l595t3271r700b3335],
6	Illumina	NNP	ORGANIZATION	Illumina	nn	9	SENT_40	[p3l734t3271r1031b3335],
7	550k	NN	O	550k	nn	9	SENT_40	[p3l1064t3271r1240b3335],
8	SNP	NN	O	snp	nn	9	SENT_40	[p3l1274t3272r1430b3335],
9	array	NN	O	array	prep_with	3	SENT_40	[p3l1465t3291r1642b3353],
10	[	CD	NUMBER	[	number	11	SENT_40	[p3l1679t3272r1833b3351],
11	11	CD	NUMBER	11	num	12	SENT_40	[p3l1679t3272r1833b3351],
12	]	NN	O	]	dep	3	SENT_40	[p3l1679t3272r1833b3351],
13	.	.	O	.	_	0	SENT_40	[p3l1679t3272r1833b3351],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_41	[p3l109t3382r385b3446],
2	were	VBD	O	be	auxpass	3	SENT_41	[p3l438t3403r607b3446],
3	followed	VBN	O	follow	_	0	SENT_41	[p3l663t3382r975b3446],
4	from	IN	O	from	_	0	SENT_41	[p3l1028t3382r1197b3446],
5	the	DT	O	the	det	7	SENT_41	[p3l1247t3382r1353b3446],
6	first	JJ	ORDINAL	first	amod	7	SENT_41	[p3l1408t3382r1547b3446],
7	prescription	NN	O	prescription	prep_from	3	SENT_41	[p3l1596t3382r2018b3464],
8	of	IN	O	of	_	0	SENT_41	[p3l2071t3382r2153b3446],
9	levodopa	NN	O	levodopa	nn	10	SENT_41	[p3l9t3493r333b3575],
10	onwards	NNS	O	onward	prep_of	7	SENT_41	[p3l366t3493r683b3570],
11	,	,	O	,	_	0	SENT_41	[p3l366t3493r683b3570],
12	irrespective	RB	O	irrespective	_	0	SENT_41	[p3l721t3493r1128b3575],
13	of	IN	O	of	_	0	SENT_41	[p3l1163t3493r1244b3557],
14	whether	IN	O	whether	complm	16	SENT_41	[p3l1266t3493r1553b3557],
15	they	PRP	O	they	nsubj	16	SENT_41	[p3l1583t3493r1735b3575],
16	used	VBD	O	use	prepc_irrespective_of	3	SENT_41	[p3l1766t3493r1929b3557],
17	other	JJ	O	other	amod	19	SENT_41	[p3l1963t3493r2144b3557],
18	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	19	SENT_41	[p3l9t3604r630b3668],
19	drugs	NNS	O	drug	dobj	16	SENT_41	[p3l675t3604r867b3686],
20	at	IN	O	at	_	0	SENT_41	[p3l915t3613r975b3668],
21	or	CC	O	or	_	0	SENT_41	[p3l1019t3625r1092b3668],
22	before	IN	O	before	_	0	SENT_41	[p3l1131t3604r1355b3668],
23	the	DT	O	the	det	24	SENT_41	[p3l1399t3604r1505b3668],
24	date	NN	O	date	prep_at	16	SENT_41	[p3l1551t3604r1694b3668],
25	of	IN	O	of	_	0	SENT_41	[p3l1740t3604r1821b3668],
26	the	DT	O	the	det	29	SENT_41	[p3l1853t3604r1958b3668],
27	first	JJ	ORDINAL	first	amod	29	SENT_41	[p3l2004t3604r2142b3668],
28	levodopa	NN	O	levodopa	nn	29	SENT_41	[p3l9t3715r333b3796],
29	prescription	NN	O	prescription	prep_of	24	SENT_41	[p3l353t3715r792b3796],
30	.	.	O	.	_	0	SENT_41	[p3l353t3715r792b3796],

1	We	PRP	O	we	nsubj	2	SENT_42	[p3l821t3717r934b3779],
2	used	VBD	O	use	_	0	SENT_42	[p3l958t3715r1121b3779],
3	two	CD	NUMBER	two	num	4	SENT_42	[p3l1143t3723r1272b3779],
4	types	NNS	O	type	dobj	2	SENT_42	[p3l1297t3723r1481b3796],
5	of	IN	O	of	_	0	SENT_42	[p3l1508t3715r1589b3779],
6	study	NN	O	study	nn	7	SENT_42	[p3l1604t3715r1792b3796],
7	outcome	NN	O	outcome	prep_of	4	SENT_42	[p3l1817t3723r2136b3779],
8	.	.	O	.	_	0	SENT_42	[p3l1817t3723r2136b3779],

1	First	RB	ORDINAL	first	advmod	25	SENT_43	[p4l7t22r185b99],
2	,	,	O	,	_	0	SENT_43	[p4l7t22r185b99],
3	for	IN	O	for	_	0	SENT_43	[p4l240t22r341b86],
4	every	DT	O	every	det	5	SENT_43	[p4l390t42r583b103],
5	prescription	NN	O	prescription	prep_for	25	SENT_43	[p4l631t22r1053b103],
6	of	IN	O	of	_	0	SENT_43	[p4l1104t22r1185b86],
7	levodopa	NN	O	levodopa	prep_of	5	SENT_43	[p4l1225t22r1567b103],
8	,	,	O	,	_	0	SENT_43	[p4l1225t22r1567b103],
9	the	DT	O	the	det	10	SENT_43	[p4l1619t22r1725b85],
10	change	NN	O	change	nsubj	25	SENT_43	[p4l1777t22r2024b103],
11	in	IN	O	in	_	0	SENT_43	[p4l2076t22r2142b85],
12	prescribed	JJ	O	prescribed	amod	14	SENT_43	[p4l6t133r374b215],
13	daily	JJ	SET	daily	amod	14	SENT_43	[p4l424t133r598b215],
14	dose	NN	O	dose	prep_in	10	SENT_43	[p4l648t133r807b197],
15	of	IN	O	of	_	0	SENT_43	[p4l858t133r940b197],
16	levodopa	NN	O	levodopa	prep_of	14	SENT_43	[p4l978t133r1303b215],
17	plus	CC	O	plus	prep	16	SENT_43	[p4l1348t133r1494b215],
18	the	DT	O	the	det	19	SENT_43	[p4l1545t133r1650b197],
19	dose	NN	O	dose	dep	17	SENT_43	[p4l1702t133r1860b197],
20	of	IN	O	of	_	0	SENT_43	[p4l1912t133r1993b197],
21	coprescribed	JJ	O	coprescribed	amod	24	SENT_43	[p4l2032t154r2140b197, p4l6t244r374b326],
22	other	JJ	O	other	amod	24	SENT_43	[p4l428t244r609b308],
23	anti-Parkinsonian	JJ	O	anti-parkinsonian	amod	24	SENT_43	[p4l662t244r1283b308],
24	drugs	NNS	O	drug	prep_of	19	SENT_43	[p4l1338t244r1530b326],
25	(	VBP	O	(	_	0	SENT_43	[p4l1587t244r2140b326],
26	anticholinergic	JJ	O	anticholinergic	amod	43	SENT_43	[p4l1587t244r2140b326],
27	drugs	NNS	O	drug	tmod	26	SENT_43	[p4l9t355r225b437],
28	,	,	O	,	_	0	SENT_43	[p4l9t355r225b437],
29	amantadine	NN	O	amantadine	appos	27	SENT_43	[p4l284t355r713b432],
30	,	,	O	,	_	0	SENT_43	[p4l284t355r713b432],
31	bromocriptine	NN	O	bromocriptine	appos	27	SENT_43	[p4l769t355r1296b437],
32	,	,	O	,	_	0	SENT_43	[p4l769t355r1296b437],
33	pergolide	NN	O	pergolide	appos	27	SENT_43	[p4l1352t355r1709b437],
34	,	,	O	,	_	0	SENT_43	[p4l1352t355r1709b437],
35	ropinirole	NN	O	ropinirole	conj_and	29	SENT_43	[p4l1766t355r2138b437],
36	,	,	O	,	_	0	SENT_43	[p4l1766t355r2138b437],
37	pramipexole	NN	O	pramipexole	conj_and	29	SENT_43	[p4l6t466r467b548],
38	,	,	O	,	_	0	SENT_43	[p4l6t466r467b548],
39	selegiline	NN	O	selegiline	conj_and	29	SENT_43	[p4l513t466r865b548],
40	,	,	O	,	_	0	SENT_43	[p4l513t466r865b548],
41	and	CC	O	and	_	0	SENT_43	[p4l911t466r1037b530],
42	entacapone	NN	O	entacapone	conj_and	29	SENT_43	[p4l1077t467r1500b548],
43	)	NN	O	)	nsubjpass	58	SENT_43	[p4l1077t467r1500b548],
44	compared	VBN	O	compare	_	0	SENT_43	[p4l1543t466r1890b548],
45	to	TO	O	to	prepc_compared_to	43	SENT_43	[p4l1929t475r1994b530],
46	the	DT	O	the	det	49	SENT_43	[p4l2034t466r2140b530],
47	prescribed	VBN	O	prescribe	amod	49	SENT_43	[p4l6t577r375b659],
48	daily	JJ	SET	daily	amod	49	SENT_43	[p4l405t577r579b659],
49	doses	NNS	O	dose	pobj	43	SENT_43	[p4l610t577r802b641],
50	at	IN	O	at	_	0	SENT_43	[p4l836t586r897b641],
51	the	DT	O	the	det	52	SENT_43	[p4l924t577r1030b641],
52	time	NN	O	time	prep_at	49	SENT_43	[p4l1061t577r1214b641],
53	of	IN	O	of	_	0	SENT_43	[p4l1247t577r1328b641],
54	the	DT	O	the	det	56	SENT_43	[p4l1346t577r1452b641],
55	first	JJ	ORDINAL	first	amod	56	SENT_43	[p4l1485t577r1623b641],
56	levodopa	NN	O	levodopa	prep_of	52	SENT_43	[p4l1653t577r1977b659],
57	was	VBD	O	be	auxpass	58	SENT_43	[p4l2005t598r2140b641],
58	calculated	VBN	O	calculate	ccomp	25	SENT_43	[p4l9t688r381b752],
59	.	.	O	.	_	0	SENT_43	[p4l9t688r381b752],

1	To	TO	O	to	aux	2	SENT_44	[p4l421t691r509b752],
2	make	VB	O	make	purpcl	16	SENT_44	[p4l545t688r735b752],
3	the	DT	O	the	det	5	SENT_44	[p4l770t688r875b752],
4	prescribed	JJ	O	prescribed	amod	5	SENT_44	[p4l909t688r1278b770],
5	doses	NNS	O	dose	nsubj	10	SENT_44	[p4l1313t688r1505b752],
6	of	IN	O	of	_	0	SENT_44	[p4l1543t688r1625b752],
7	different	JJ	O	different	amod	9	SENT_44	[p4l1649t688r1950b752],
8	antiParkinsonian	JJ	O	antiparkinsonian	amod	9	SENT_44	[p4l1984t688r2140b752, p4l7t799r469b863],
9	drugs	NNS	O	drug	prep_of	5	SENT_44	[p4l509t799r702b881],
10	comparable	JJ	O	comparable	xcomp	2	SENT_44	[p4l744t799r1152b880],
11	to	TO	O	to	_	0	SENT_44	[p4l1192t808r1258b863],
12	each	DT	O	each	det	13	SENT_44	[p4l1301t799r1459b863],
13	other	JJ	O	other	prep_to	10	SENT_44	[p4l1500t799r1694b876],
14	,	,	O	,	_	0	SENT_44	[p4l1500t799r1694b876],
15	we	PRP	O	we	nsubj	16	SENT_44	[p4l1735t820r1837b863],
16	divided	VBD	O	divide	_	0	SENT_44	[p4l1878t799r2142b863],
17	the	DT	O	the	det	20	SENT_44	[p4l7t910r112b974],
18	prescribed	VBN	O	prescribe	amod	20	SENT_44	[p4l141t910r509b991],
19	daily	JJ	SET	daily	amod	20	SENT_44	[p4l539t910r713b991],
20	dose	NN	O	dose	dobj	16	SENT_44	[p4l743t910r902b974],
21	by	IN	O	by	_	0	SENT_44	[p4l931t910r1020b991],
22	the	DT	O	the	det	27	SENT_44	[p4l1048t910r1153b973],
23	deﬁned	JJ	O	deﬁned	amod	27	SENT_44	[p4l1185t910r1448b974],
24	daily	JJ	SET	daily	amod	27	SENT_44	[p4l1478t910r1651b991],
25	dose	NN	O	dose	nn	27	SENT_44	[p4l1682t910r1840b974],
26	(	NN	O	(	nn	27	SENT_44	[p4l1873t910r2136b991],
27	DDD	NN	O	ddd	prep_by	16	SENT_44	[p4l1873t910r2136b991],
28	)	CD	NUMBER	)	dep	27	SENT_44	[p4l1873t910r2136b991],
29	.	.	O	.	_	0	SENT_44	[p4l1873t910r2136b991],

1	The	DT	O	the	det	2	SENT_45	[p4l8t1021r142b1085],
2	DDD	NNP	ORGANIZATION	DDD	nsubj	7	SENT_45	[p4l168t1023r357b1083],
3	is	VBZ	O	be	cop	7	SENT_45	[p4l385t1021r439b1085],
4	a	DT	O	a	det	7	SENT_45	[p4l467t1041r504b1084],
5	standardized	JJ	O	standardized	amod	7	SENT_45	[p4l530t1021r974b1085],
6	dosing	NN	O	dosing	nn	7	SENT_45	[p4l999t1021r1233b1102],
7	measure	NN	O	measure	_	0	SENT_45	[p4l1258t1041r1549b1085],
8	representing	VBG	O	represent	partmod	7	SENT_45	[p4l1575t1021r2010b1102],
9	the	DT	O	the	det	12	SENT_45	[p4l2034t1021r2140b1085],
10	recommended	VBN	O	recommend	amod	12	SENT_45	[p4l6t1132r509b1196],
11	daily	JJ	SET	daily	amod	12	SENT_45	[p4l534t1132r707b1214],
12	dose	NN	O	dose	dobj	8	SENT_45	[p4l733t1132r892b1196],
13	for	IN	O	for	_	0	SENT_45	[p4l919t1132r1019b1196],
14	the	DT	O	the	det	16	SENT_45	[p4l1041t1132r1146b1196],
15	main	JJ	O	main	amod	16	SENT_45	[p4l1171t1132r1347b1196],
16	indication	NN	O	indication	prep_for	8	SENT_45	[p4l1372t1132r1723b1196],
17	in	IN	O	in	_	0	SENT_45	[p4l1748t1132r1814b1195],
18	an	DT	O	a	det	19	SENT_45	[p4l1840t1153r1920b1196],
19	adult	NN	O	adult	prep_in	16	SENT_45	[p4l1946t1132r2136b1196],
20	.	.	O	.	_	0	SENT_45	[p4l1946t1132r2136b1196],

1	The	DT	O	the	det	4	SENT_46	[p4l8t1243r142b1307],
2	defined	VBN	O	define	amod	4	SENT_46	[p4l198t1243r460b1307],
3	daily	JJ	SET	daily	amod	4	SENT_46	[p4l514t1243r688b1325],
4	doses	NNS	O	dose	_	0	SENT_46	[p4l742t1243r934b1307],
5	of	IN	O	of	_	0	SENT_46	[p4l990t1243r1071b1307],
6	controlled	JJ	O	controlled	amod	8	SENT_46	[p4l1114t1243r1471b1307],
7	release	NN	O	release	nn	8	SENT_46	[p4l1521t1243r1764b1307],
8	levodopa	NN	O	levodopa	prep_of	4	SENT_46	[p4l1819t1243r2143b1325],

1	Table	NNP	O	Table	nsubjpass	7	SENT_47	[p4l8t1473r183b1525],
2	1	CD	NUMBER	1	num	5	SENT_47	[p4l214t1472r242b1524],
3	Baseline	NN	O	baseline	nn	5	SENT_47	[p4l296t1471r552b1525],
4	characteristics	NNS	O	characteristic	nn	5	SENT_47	[p4l581t1471r1003b1525],
5	prescriptions	NNS	O	prescription	dep	1	SENT_47	[p4l6t1572r460b1654],
6	were	VBD	O	be	auxpass	7	SENT_47	[p4l501t1592r671b1636],
7	multiplied	VBN	O	multiply	_	0	SENT_47	[p4l711t1572r1074b1653],
8	by	IN	O	by	_	0	SENT_47	[p4l1113t1572r1202b1654],
9	0.7	CD	NUMBER	0.7	agent	7	SENT_47	[p4l1243t1573r1349b1636],
10	to	TO	O	to	aux	11	SENT_47	[p4l1391t1581r1456b1636],
11	correct	VB	O	correct	xcomp	7	SENT_47	[p4l1500t1580r1742b1636],
12	for	IN	O	for	_	0	SENT_47	[p4l1783t1572r1884b1636],
13	differences	NNS	O	difference	prep_for	11	SENT_47	[p4l1923t1572r2140b1636, p4l9t1704r200b1747],
14	in	IN	O	in	_	0	SENT_47	[p4l225t1683r291b1746],
15	bioavailability	NN	O	bioavailability	prep_in	13	SENT_47	[p4l312t1683r834b1765],
16	.	.	O	.	_	0	SENT_47	[p4l312t1683r834b1765],

1	Associations	NNS	O	association	nsubjpass	17	SENT_48	[p4l861t1683r1311b1747],
2	between	IN	O	between	_	0	SENT_48	[p4l1333t1683r1629b1747],
3	the	DT	O	the	det	4	SENT_48	[p4l1650t1683r1755b1747],
4	number	NN	O	number	prep_between	1	SENT_48	[p4l1777t1683r2051b1747],
5	of	IN	O	of	_	0	SENT_48	[p4l2071t1683r2153b1747],
6	rs622342	NN	O	rs622342	nn	9	SENT_48	[p4l6t1796r340b1858],
7	variant	NN	O	variant	nn	9	SENT_48	[p4l397t1794r647b1858],
8	C	NN	O	c	nn	9	SENT_48	[p4l702t1796r756b1858],
9	alleles	NNS	O	allele	prep_of	4	SENT_48	[p4l814t1794r1038b1858],
10	and	CC	O	and	_	0	SENT_48	[p4l1096t1794r1224b1858],
11	changes	NNS	O	change	conj_and	4	SENT_48	[p4l1279t1794r1565b1876],
12	in	IN	O	in	_	0	SENT_48	[p4l1622t1794r1689b1857],
13	cumulative	JJ	O	cumulative	amod	15	SENT_48	[p4l1745t1794r2141b1858],
14	prescribed	JJ	O	prescribed	amod	15	SENT_48	[p4l6t1905r375b1987],
15	doses	NNS	O	dose	prep_in	11	SENT_48	[p4l421t1905r613b1969],
16	were	VBD	O	be	auxpass	17	SENT_48	[p4l660t1926r830b1969],
17	analyzed	VBN	O	analyze	_	0	SENT_48	[p4l878t1905r1191b1987],
18	using	VBG	O	use	xcomp	17	SENT_48	[p4l1234t1905r1426b1987],
19	multivariate	JJ	O	multivariate	amod	21	SENT_48	[p4l1472t1905r1896b1969],
20	linear	JJ	O	linear	amod	21	SENT_48	[p4l1945t1905r2144b1969],
21	regression	NN	O	regression	dobj	18	SENT_48	[p4l6t2016r386b2097],
22	.	.	O	.	_	0	SENT_48	[p4l6t2016r386b2097],

1	We	PRP	O	we	nsubj	3	SENT_49	[p4l414t2018r528b2080],
2	separately	RB	O	separately	advmod	3	SENT_49	[p4l555t2016r909b2097],
3	analyzed	VBD	O	analyze	_	0	SENT_49	[p4l934t2016r1246b2097],
4	the	DT	O	the	det	5	SENT_49	[p4l1268t2016r1374b2080],
5	associations	NNS	O	association	dobj	3	SENT_49	[p4l1400t2016r1823b2080],
6	between	IN	O	between	_	0	SENT_49	[p4l1847t2016r2142b2080],
7	genotype	NN	O	genotype	prep_between	5	SENT_49	[p4l8t2135r331b2208],
8	and	CC	O	and	_	0	SENT_49	[p4l361t2127r487b2191],
9	start	NN	O	start	prep_between	5	SENT_49	[p4l516t2135r664b2190],
10	of	IN	O	of	_	0	SENT_49	[p4l691t2127r773b2191],
11	dopamine	NN	O	dopamine	nn	13	SENT_49	[p4l791t2127r1137b2208],
12	agonist	NN	O	agonist	nn	13	SENT_49	[p4l1167t2127r1421b2208],
13	therapy	NN	O	therapy	prep_of	5	SENT_49	[p4l1447t2127r1711b2208],
14	and	CC	O	and	_	0	SENT_49	[p4l1740t2127r1866b2191],
15	time	NN	O	time	prep_of	5	SENT_49	[p4l1892t2127r2046b2191],
16	to	TO	O	to	_	0	SENT_49	[p4l2074t2135r2139b2191],
17	discontinuation	NN	O	discontinuation	prep_to	3	SENT_49	[p4l9t2238r553b2302],
18	of	IN	O	of	_	0	SENT_49	[p4l586t2238r667b2302],
19	levodopa	NN	O	levodopa	nn	20	SENT_49	[p4l689t2238r1014b2320],
20	therapy	NN	O	therapy	prep_of	17	SENT_49	[p4l1043t2238r1308b2320],
21	with	IN	O	with	_	0	SENT_49	[p4l1338t2238r1495b2302],
22	Cox	NN	ORGANIZATION	cox	nn	25	SENT_49	[p4l1528t2240r1673b2303],
23	proportional	JJ	O	proportional	amod	25	SENT_49	[p4l1704t2238r2141b2320],
24	hazard	NN	O	hazard	nn	25	SENT_49	[p4l7t2349r242b2413],
25	models	NNS	O	model	prep_with	3	SENT_49	[p4l265t2349r537b2413],
26	.	.	O	.	_	0	SENT_49	[p4l265t2349r537b2413],

1	Second	RB	ORDINAL	second	advmod	4	SENT_50	[p4l571t2349r846b2426],
2	,	,	O	,	_	0	SENT_50	[p4l571t2349r846b2426],
3	we	PRP	O	we	nsubj	4	SENT_50	[p4l874t2370r975b2413],
4	analyzed	VBD	O	analyze	_	0	SENT_50	[p4l1003t2349r1314b2431],
5	the	DT	O	the	det	6	SENT_50	[p4l1338t2349r1444b2413],
6	difference	NN	O	difference	dobj	4	SENT_50	[p4l1471t2349r1821b2413],
7	between	IN	O	between	_	0	SENT_50	[p4l1847t2349r2142b2413],
8	rs622342	NN	O	rs622342	nn	9	SENT_50	[p4l6t2461r335b2524],
9	genotypes	NNS	O	genotype	prep_between	6	SENT_50	[p4l375t2469r731b2542],
10	in	IN	O	in	_	0	SENT_50	[p4l769t2460r835b2523],
11	time	NN	O	time	prep_in	9	SENT_50	[p4l871t2460r1025b2524],
12	from	IN	O	from	_	0	SENT_50	[p4l1063t2460r1232b2524],
13	the	DT	O	the	det	15	SENT_50	[p4l1267t2460r1373b2524],
14	first	JJ	ORDINAL	first	amod	15	SENT_50	[p4l1412t2460r1550b2524],
15	prescription	NN	O	prescription	prep_from	4	SENT_50	[p4l1583t2460r2006b2542],
16	for	IN	O	for	_	0	SENT_50	[p4l2043t2460r2144b2524],
17	levodopa	NN	O	levodopa	prep_for	15	SENT_50	[p4l9t2571r333b2652],
18	until	IN	O	until	_	0	SENT_50	[p4l353t2571r514b2635],
19	death	NN	O	death	prep_until	4	SENT_50	[p4l539t2571r728b2635],
20	due	JJ	O	due	_	0	SENT_50	[p4l752t2571r876b2635],
21	to	TO	O	to	_	0	SENT_50	[p4l899t2580r965b2635],
22	any	DT	O	any	det	23	SENT_50	[p4l991t2592r1117b2653],
23	cause	NN	O	cause	prep_due_to	4	SENT_50	[p4l1141t2592r1332b2635],
24	with	IN	O	with	_	0	SENT_50	[p4l1356t2571r1512b2635],
25	Cox	NN	ORGANIZATION	cox	nn	28	SENT_50	[p4l1537t2572r1682b2635],
26	proportional	JJ	O	proportional	amod	28	SENT_50	[p4l1704t2571r2141b2653],
27	hazard	NN	O	hazard	nn	28	SENT_50	[p4l7t2682r242b2746],
28	models	NNS	O	model	prep_with	23	SENT_50	[p4l266t2682r539b2746],
29	.	.	O	.	_	0	SENT_50	[p4l266t2682r539b2746],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_51	[p4l569t2682r892b2764],
2	were	VBD	O	be	auxpass	3	SENT_51	[p4l919t2703r1088b2746],
3	adjusted	VBN	O	adjust	_	0	SENT_51	[p4l1118t2682r1410b2764],
4	for	IN	O	for	_	0	SENT_51	[p4l1438t2682r1539b2746],
5	age	NN	O	age	prep_for	3	SENT_51	[p4l1565t2703r1683b2764],
6	and	CC	O	and	_	0	SENT_51	[p4l1711t2682r1837b2746],
7	sex	NN	O	sex	prep_for	3	SENT_51	[p4l1866t2703r1996b2746],
8	.	.	O	.	_	0	SENT_51	[p4l1866t2703r1996b2746],

1	Results	NNS	O	result	_	0	SENT_52	[p4l7t2926r279b2987],

1	In	IN	O	in	_	0	SENT_53	[p4l8t3149r79b3209],
2	the	DT	O	the	det	4	SENT_53	[p4l104t3146r209b3210],
3	Rotterdam	NNP	LOCATION	Rotterdam	nn	4	SENT_53	[p4l237t3146r609b3210],
4	Study	NNP	O	Study	prep_in	9	SENT_53	[p4l639t3146r854b3228],
5	,	,	O	,	_	0	SENT_53	[p4l639t3146r854b3228],
6	99	CD	NUMBER	99	num	7	SENT_53	[p4l885t3148r967b3210],
7	participants	NNS	O	participant	nsubjpass	9	SENT_53	[p4l994t3146r1405b3228],
8	were	VBD	O	be	auxpass	9	SENT_53	[p4l1431t3167r1601b3210],
9	identified	VBN	O	identify	_	0	SENT_53	[p4l1629t3146r1965b3210],
10	who	WP	O	who	nsubj	14	SENT_53	[p4l1989t3146r2139b3210],
11	were	VBD	O	be	cop	14	SENT_53	[p4l6t3278r175b3321],
12	incident	NN	O	incident	nn	14	SENT_53	[p4l219t3257r502b3321],
13	levodopa	NN	O	levodopa	nn	14	SENT_53	[p4l543t3257r868b3339],
14	users	NNS	O	user	ccomp	9	SENT_53	[p4l906t3278r1085b3321],
15	(	VBP	O	(	rcmod	14	SENT_53	[p4l1130t3257r1349b3338],
16	Table	NNP	O	Table	nn	18	SENT_53	[p4l1130t3257r1349b3338],
17	l	NN	O	l	nn	18	SENT_53	[p4l1401t3257r1480b3338],
18	)	NN	O	)	dobj	15	SENT_53	[p4l1401t3257r1480b3338],
19	.	.	O	.	_	0	SENT_53	[p4l1401t3257r1480b3338],

1	The	DT	O	the	det	4	SENT_54	[p4l1527t3257r1661b3321],
2	minor	JJ	O	minor	amod	4	SENT_54	[p4l1702t3257r1915b3321],
3	allele	NN	O	allele	nn	4	SENT_54	[p4l1955t3257r2140b3321],
4	frequency	NN	O	frequency	nsubj	12	SENT_54	[p4l9t3368r370b3450],
5	of	IN	O	of	_	0	SENT_54	[p4l432t3368r515b3432],
6	rs622342	NN	O	rs622342	nn	7	SENT_54	[p4l564t3369r901b3432],
7	(	NN	O	(	prep_of	4	SENT_54	[p4l967t3368r1050b3449],
8	C	NN	O	c	nn	10	SENT_54	[p4l967t3368r1050b3449],
9	allele	NN	O	allele	nn	10	SENT_54	[p4l1116t3368r1337b3449],
10	)	NN	O	)	dep	7	SENT_54	[p4l1116t3368r1337b3449],
11	was	VBD	O	be	cop	12	SENT_54	[p4l1399t3388r1536b3432],
12	0.36	CD	NUMBER	0.36	_	0	SENT_54	[p4l1601t3369r1778b3445],
13	,	,	O	,	_	0	SENT_54	[p4l1601t3369r1778b3445],
14	and	CC	O	and	_	0	SENT_54	[p4l1844t3368r1973b3432],
15	the	DT	O	the	det	17	SENT_54	[p4l2032t3368r2140b3432],
16	genotype	NN	O	genotype	nn	17	SENT_54	[p4l8t3488r331b3561],
17	distribution	NN	O	distribution	nsubj	18	SENT_54	[p4l370t3479r775b3543],
18	was	VBD	O	be	conj_and	12	SENT_54	[p4l810t3500r945b3543],
19	in	IN	O	in	_	0	SENT_54	[p4l985t3479r1051b3542],
20	Hardy	NNP	LOCATION	Hardy	prep_in	18	SENT_54	[p4l1087t3479r1693b3561],
21	.	.	O	.	_	0	SENT_54	[p4l1087t3479r1693b3561],

1	—	NN	O	—	_	0	SENT_55	[p4l1087t3479r1693b3561],
2	.	.	O	.	_	0	SENT_55	[p4l1087t3479r1693b3561],

1	Weinberg	NNP	PERSON	Weinberg	nn	4	SENT_56	[p4l1087t3479r1693b3561],
2	equilibrium	NN	O	equilibrium	nn	4	SENT_56	[p4l1733t3479r2142b3560],
3	(	NN	O	(	nn	4	SENT_56	[p4l9t3590r346b3672],
4	p	NN	O	p	nsubj	5	SENT_56	[p4l9t3590r346b3672],
5	=	JJ	O	=	_	0	SENT_56	[p4l9t3590r346b3672],
6	O.	NNP	O	O.	iobj	5	SENT_56	[p4l9t3590r346b3672],
7	45	CD	NUMBER	45	num	8	SENT_56	[p4l9t3590r346b3672],
8	)	CD	NUMBER	)	dobj	5	SENT_56	[p4l9t3590r346b3672],
9	.	.	O	.	_	0	SENT_56	[p4l9t3590r346b3672],

1	No	DT	O	no	det	4	SENT_57	[p4l374t3593r482b3654],
2	statistically	RB	O	statistically	advmod	3	SENT_57	[p4l512t3590r907b3672],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_57	[p4l935t3590r1305b3672],
4	differences	NNS	O	difference	nsubjpass	6	SENT_57	[p4l1329t3590r1715b3654],
5	were	VBD	O	be	auxpass	6	SENT_57	[p4l1740t3611r1910b3654],
6	found	VBN	O	find	_	0	SENT_57	[p4l1937t3590r2142b3654],
7	in	IN	O	in	_	0	SENT_57	[p4l8t3701r75b3764],
8	time	NN	O	time	prep_in	6	SENT_57	[p4l101t3701r255b3765],
9	until	IN	O	until	_	0	SENT_57	[p4l282t3701r444b3765],
10	the	DT	O	the	det	12	SENT_57	[p4l471t3701r576b3765],
11	first	JJ	ORDINAL	first	amod	12	SENT_57	[p4l607t3701r745b3765],
12	prescription	NN	O	prescription	prep_until	6	SENT_57	[p4l769t3701r1192b3783],
13	for	IN	O	for	_	0	SENT_57	[p4l1221t3701r1322b3765],
14	levodopa	NN	O	levodopa	prep_for	12	SENT_57	[p4l1348t3701r1673b3783],
15	in	IN	O	in	_	0	SENT_57	[p4l1700t3701r1766b3764],
16	the	DT	O	the	det	17	SENT_57	[p4l1792t3701r1898b3765],
17	whole	NN	O	whole	prep_in	14	SENT_57	[p4l1926t3701r2140b3765],

1	Rotterdam	NNP	LOCATION	Rotterdam	nn	2	SENT_58	[p5l7t21r381b85],
2	Study	NNP	O	Study	_	0	SENT_58	[p5l416t21r632b103],
3	,	,	O	,	_	0	SENT_58	[p5l416t21r632b103],
4	the	DT	O	the	det	6	SENT_58	[p5l667t21r773b85],
5	prescribed	JJ	O	prescribed	amod	6	SENT_58	[p5l806t21r1175b103],
6	doses	NNS	O	dose	appos	2	SENT_58	[p5l1209t21r1401b85],
7	at	IN	O	at	_	0	SENT_58	[p5l1437t30r1498b85],
8	start	NN	O	start	prep_at	6	SENT_58	[p5l1533t30r1681b85],
9	of	IN	O	of	_	0	SENT_58	[p5l1714t21r1795b85],
10	levodopa	NN	O	levodopa	nn	11	SENT_58	[p5l1819t21r2143b103],
11	therapy	NN	O	therapy	prep_of	8	SENT_58	[p5l7t132r285b213],
12	,	,	O	,	_	0	SENT_58	[p5l7t132r285b213],
13	or	CC	O	or	_	0	SENT_58	[p5l324t152r397b196],
14	use	NN	O	use	prep_at	6	SENT_58	[p5l428t152r544b196],
15	of	IN	O	of	_	0	SENT_58	[p5l582t132r663b196],
16	other	JJ	O	other	amod	18	SENT_58	[p5l688t132r869b196],
17	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	18	SENT_58	[p5l903t132r1525b196],
18	drugs	NNS	O	drug	prep_of	14	SENT_58	[p5l1561t132r1753b213],
19	at	IN	O	at	_	0	SENT_58	[p5l1791t140r1853b195],
20	start	NN	O	start	prep_at	18	SENT_58	[p5l1889t140r2037b196],
21	of	IN	O	of	_	0	SENT_58	[p5l2071t132r2153b196],
22	levodopa	NN	O	levodopa	nn	23	SENT_58	[p5l9t243r342b324],
23	therapy	NN	O	therapy	prep_of	20	SENT_58	[p5l401t243r686b324],
24	.	.	O	.	_	0	SENT_58	[p5l401t243r686b324],

1	The	DT	O	the	det	3	SENT_59	[p5l753t243r889b306],
2	average	JJ	O	average	amod	3	SENT_59	[p5l952t263r1230b324],
3	time	NN	O	time	nsubj	14	SENT_59	[p5l1291t243r1450b307],
4	that	WDT	O	that	dobj	7	SENT_59	[p5l1511t243r1647b306],
5	drugs	NNS	O	drug	nsubjpass	7	SENT_59	[p5l1708t243r1906b324],
6	were	VBD	O	be	auxpass	7	SENT_59	[p5l1967t263r2140b307],
7	dispensed	VBN	O	dispense	rcmod	3	SENT_59	[p5l9t354r357b436],
8	for	IN	O	for	prep	7	SENT_59	[p5l409t354r509b418],
9	per	IN	O	per	pcomp	8	SENT_59	[p5l556t375r672b436],
10	levodopa	NN	O	levodopa	nn	11	SENT_59	[p5l721t354r1045b436],
11	prescription	NN	O	prescription	pobj	9	SENT_59	[p5l1093t354r1516b436],
12	was	VBD	O	be	cop	14	SENT_59	[p5l1565t375r1700b418],
13	52.5	CD	DURATION	52.5	num	14	SENT_59	[p5l1755t356r1902b418],
14	days	NNS	NUMBER	day	_	0	SENT_59	[p5l1959t354r2138b436],
15	,	,	O	,	_	0	SENT_59	[p5l1959t354r2138b436],
16	and	CC	O	and	_	0	SENT_59	[p5l9t465r135b529],
17	the	DT	O	the	det	19	SENT_59	[p5l178t465r284b529],
18	rs622342	NN	O	rs622342	nn	19	SENT_59	[p5l329t467r656b529],
19	genotype	NN	O	genotype	nsubjpass	22	SENT_59	[p5l705t474r1027b547],
20	was	VBD	O	be	auxpass	22	SENT_59	[p5l1072t486r1206b529],
21	not	RB	O	not	neg	22	SENT_59	[p5l1252t474r1366b529],
22	associated	VBN	O	associate	conj_and	14	SENT_59	[p5l1411t465r1772b529],
23	with	IN	O	with	_	0	SENT_59	[p5l1815t465r1972b529],
24	this	DT	O	this	det	25	SENT_59	[p5l2015t465r2140b529],
25	duration	NN	O	duration	prep_with	22	SENT_59	[p5l9t577r318b641],
26	.	.	O	.	_	0	SENT_59	[p5l9t577r318b641],

1	The	DT	O	the	det	4	SENT_60	[p5l110t688r247b752],
2	average	JJ	O	average	amod	4	SENT_60	[p5l309t709r588b770],
3	prescribed	JJ	O	prescribed	amod	4	SENT_60	[p5l647t688r1030b770],
4	dose	NN	O	dose	_	0	SENT_60	[p5l1089t688r1253b752],
5	of	IN	O	of	_	0	SENT_60	[p5l1313t689r1396b752],
6	levodopa	NN	O	levodopa	prep_of	4	SENT_60	[p5l1446t688r1781b770],
7	and	CC	O	and	_	0	SENT_60	[p5l1841t688r1970b752],
8	coprescribed	VBD	O	coprescribe	conj_and	4	SENT_60	[p5l2029t709r2139b752, p5l6t799r375b881],
9	drugs	NNS	O	drug	dobj	8	SENT_60	[p5l412t799r604b881],
10	increased	VBN	O	increase	partmod	9	SENT_60	[p5l644t799r975b863],
11	after	IN	O	after	_	0	SENT_60	[p5l1013t799r1171b863],
12	start	NN	O	start	prep_after	10	SENT_60	[p5l1209t808r1356b863],
13	of	IN	O	of	_	0	SENT_60	[p5l1394t799r1475b863],
14	levodopa	NN	O	levodopa	nn	15	SENT_60	[p5l1501t799r1826b881],
15	therapy	NN	O	therapy	prep_of	12	SENT_60	[p5l1860t799r2136b881],
16	.	.	O	.	_	0	SENT_60	[p5l1860t799r2136b881],

1	The	DT	O	the	det	2	SENT_61	[p5l8t910r142b974],
2	increase	NN	O	increase	nsubj	4	SENT_61	[p5l167t910r452b974],
3	was	VBD	O	be	cop	4	SENT_61	[p5l474t931r609b974],
4	higher	JJR	O	higher	_	0	SENT_61	[p5l633t910r860b992],
5	with	IN	O	with	mark	12	SENT_61	[p5l880t910r1036b974],
6	the	DT	O	the	det	7	SENT_61	[p5l1058t910r1164b974],
7	number	NN	O	number	nsubj	12	SENT_61	[p5l1187t910r1460b974],
8	of	IN	O	of	_	0	SENT_61	[p5l1480t910r1561b974],
9	variant	JJ	O	variant	amod	11	SENT_61	[p5l1572t910r1818b974],
10	C	NN	O	c	nn	11	SENT_61	[p5l1841t912r1894b974],
11	alleles	NNS	O	allele	prep_of	7	SENT_61	[p5l1920t910r2139b974],
12	(	VBP	O	(	ccomp	4	SENT_61	[p5l9t1021r169b1102],
13	Fig	NN	O	fig	dobj	12	SENT_61	[p5l9t1021r169b1102],
14	.	.	O	.	_	0	SENT_61	[p5l9t1021r169b1102],

1	1	CD	NUMBER	1	_	0	SENT_62	[p5l209t1021r288b1102],
2	)	NN	O	)	dep	1	SENT_62	[p5l209t1021r288b1102],
3	.	.	O	.	_	0	SENT_62	[p5l209t1021r288b1102],

1	With	IN	O	with	_	0	SENT_63	[p5l321t1021r494b1085],
2	each	DT	O	each	det	5	SENT_63	[p5l524t1021r682b1085],
3	minor	JJ	O	minor	amod	5	SENT_63	[p5l709t1021r921b1085],
4	C	NN	O	c	nn	5	SENT_63	[p5l948t1022r1001b1085],
5	allele	NN	O	allele	prep_with	27	SENT_63	[p5l1033t1021r1238b1098],
6	,	,	O	,	_	0	SENT_63	[p5l1033t1021r1238b1098],
7	the	DT	O	the	det	8	SENT_63	[p5l1269t1021r1375b1084],
8	change	NN	O	change	nsubj	27	SENT_63	[p5l1405t1021r1652b1102],
9	in	IN	O	in	_	0	SENT_63	[p5l1682t1021r1748b1083],
10	prescribed	JJ	O	prescribed	amod	12	SENT_63	[p5l1774t1021r2142b1102],
11	daily	JJ	SET	daily	amod	12	SENT_63	[p5l9t1132r183b1213],
12	dose	NN	O	dose	prep_in	8	SENT_63	[p5l219t1132r378b1196],
13	of	IN	O	of	_	0	SENT_63	[p5l416t1132r497b1196],
14	all	DT	O	all	det	16	SENT_63	[p5l523t1132r607b1195],
15	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	16	SENT_63	[p5l644t1132r1266b1196],
16	drugs	NNS	O	drug	prep_of	12	SENT_63	[p5l1302t1132r1494b1213],
17	between	IN	O	between	_	0	SENT_63	[p5l1531t1132r1826b1196],
18	the	DT	O	the	det	22	SENT_63	[p5l1861t1132r1966b1195],
19	first	JJ	ORDINAL	first	amod	22	SENT_63	[p5l2005t1132r2143b1196],
20	and	CC	O	and	_	0	SENT_63	[p5l9t1243r135b1307],
21	ﬁfth	JJ	O	ﬁfth	conj_and	19	SENT_63	[p5l170t1243r317b1306],
22	prescriptions	NNS	O	prescription	prep_between	16	SENT_63	[p5l349t1243r804b1324],
23	for	IN	O	for	_	0	SENT_63	[p5l842t1243r943b1307],
24	levodopa	NN	O	levodopa	prep_for	22	SENT_63	[p5l976t1243r1301b1324],
25	was	VBD	O	be	cop	27	SENT_63	[p5l1333t1263r1467b1307],
26	0.34	CD	NUMBER	0.34	num	27	SENT_63	[p5l1505t1244r1656b1306],
27	DDD	NNP	O	DDD	_	0	SENT_63	[p5l1692t1245r1881b1305],
28	higher	JJR	O	higher	advmod	27	SENT_63	[p5l1916t1243r2143b1324],
29	(	CD	PERCENT	(	number	30	SENT_63	[p5l9t1354r199b1435],
30	95	CD	PERCENT	95	num	31	SENT_63	[p5l9t1354r199b1435],
31	%	NN	PERCENT	%	attr	27	SENT_63	[p5l9t1354r199b1435],
32	CI	NN	O	ci	dep	31	SENT_63	[p5l263t1355r349b1418],
33	0.064	CD	NUMBER	0.064	num	32	SENT_63	[p5l411t1356r633b1431],
34	,	,	O	,	_	0	SENT_63	[p5l411t1356r633b1431],
35	0.62	CD	NUMBER	0.62	num	36	SENT_63	[p5l699t1354r903b1435],
36	)	NN	O	)	appos	31	SENT_63	[p5l699t1354r903b1435],
37	.	.	O	.	_	0	SENT_63	[p5l699t1354r903b1435],

1	The	DT	O	the	det	4	SENT_64	[p5l970t1354r1106b1418],
2	prescribed	VBN	O	prescribe	amod	4	SENT_64	[p5l1166t1354r1545b1436],
3	daily	JJ	SET	daily	amod	4	SENT_64	[p5l1606t1354r1784b1436],
4	dose	NN	O	dose	nsubj	9	SENT_64	[p5l1846t1354r2008b1418],
5	of	IN	O	of	_	0	SENT_64	[p5l2071t1354r2153b1418],
6	levodopa	NN	O	levodopa	prep_of	4	SENT_64	[p5l9t1465r333b1547],
7	was	VBD	O	be	cop	9	SENT_64	[p5l371t1486r507b1529],
8	0.01	CD	NUMBER	0.01	num	9	SENT_64	[p5l551t1467r694b1529],
9	DDD	NNP	O	DDD	_	0	SENT_64	[p5l745t1468r933b1528],
10	higher	JJR	O	higher	advmod	9	SENT_64	[p5l976t1465r1203b1547],
11	(	CD	PERCENT	(	number	12	SENT_64	[p5l1244t1465r1431b1546],
12	95	CD	PERCENT	95	num	13	SENT_64	[p5l1244t1465r1431b1546],
13	%	NN	PERCENT	%	attr	9	SENT_64	[p5l1244t1465r1431b1546],
14	CI	NN	O	ci	dep	13	SENT_64	[p5l1475t1466r1559b1529],
15	-0.035	CD	NUMBER	-0.035	num	14	SENT_64	[p5l1601t1467r1869b1542],
16	,	,	O	,	_	0	SENT_64	[p5l1601t1467r1869b1542],
17	0.062	CD	NUMBER	0.062	num	18	SENT_64	[p5l1915t1465r2139b1546],
18	)	NN	O	)	appos	13	SENT_64	[p5l1915t1465r2139b1546],

1	rs622342	NN	O	rs622342	nn	4	SENT_65	[p5l52t1660r181b1685],
2	AA	NN	O	aa	nn	4	SENT_65	[p5l1476t1660r1526b1684],
3	AC	NN	O	ac	nn	4	SENT_65	[p5l1717t1660r1764b1685],
4	CC	NN	O	cc	_	0	SENT_65	[p5l1959t1660r2004b1685],

1	N	NN	O	n	nn	2	SENT_66	[p5l6t1767r52b1806],
2	Gender	NN	O	gender	dep	13	SENT_66	[p5l9t1836r187b1887],
3	,	,	O	,	_	0	SENT_66	[p5l9t1836r187b1887],
4	male	JJ	O	male	amod	6	SENT_66	[p5l209t1836r319b1878],
5	(	CD	PERCENT	(	num	6	SENT_66	[p5l341t1836r422b1889],
6	%	NN	PERCENT	%	appos	2	SENT_66	[p5l341t1836r422b1889],
7	)	CD	NUMBER	)	num	8	SENT_66	[p5l341t1836r422b1889],
8	Age	NNP	O	Age	dep	6	SENT_66	[p5l8t1911r115b1963],
9	,	,	O	,	_	0	SENT_66	[p5l8t1911r115b1963],
10	year	NN	DURATION	year	dep	2	SENT_66	[p5l137t1923r237b1963],
11	(	CD	NUMBER	(	num	12	SENT_66	[p5l257t1910r364b1962],
12	SD	NN	O	sd	dep	13	SENT_66	[p5l257t1910r364b1962],
13	)	CD	NUMBER	)	dep	18	SENT_66	[p5l257t1910r364b1962],
14	Follow-up	JJ	O	follow-up	dep	13	SENT_66	[p5l8t1982r259b2035],
15	,	,	O	,	_	0	SENT_66	[p5l8t1982r259b2035],
16	year	NN	DURATION	year	appos	14	SENT_66	[p5l281t1995r380b2035],
17	(	CD	NUMBER	(	num	16	SENT_66	[p5l401t1982r508b2034],
18	SD	NN	O	sd	dep	20	SENT_66	[p5l401t1982r508b2034],
19	)	CD	NUMBER	)	num	18	SENT_66	[p5l401t1982r508b2034],
20	In	IN	O	in	_	0	SENT_66	[p5l1382t1984r1428b2022],
21	Rotterdam	NNP	LOCATION	Rotterdam	nn	22	SENT_66	[p5l1448t1982r1690b2023],
22	Study	NNP	O	Study	pobj	20	SENT_66	[p5l1712t1982r1843b2035],
23	After	IN	O	after	dep	20	SENT_66	[p5l1381t2054r1502b2096],
24	start	NN	O	start	nn	25	SENT_66	[p5l1523t2060r1618b2096],
25	levodopa	NN	O	levodopa	pobj	23	SENT_66	[p5l1639t2054r1849b2107],

1	Body-mass	JJ	MISC	body-mass	amod	2	SENT_67	[p5l8t2126r265b2179],
2	index	NN	O	index	_	0	SENT_67	[p5l288t2126r426b2176],
3	,	,	O	,	_	0	SENT_67	[p5l288t2126r426b2176],
4	kg/m2	NN	O	kg/m2	nn	7	SENT_67	[p5l448t2114r586b2179],
5	(	CD	NUMBER	(	num	7	SENT_67	[p5l609t2126r716b2179],
6	SD	NN	O	sd	nn	7	SENT_67	[p5l609t2126r716b2179],
7	)	NN	O	)	appos	2	SENT_67	[p5l609t2126r716b2179],
8	3	CD	NUMBER	3	num	10	SENT_67	[p5l738t2122r756b2141],
9	Creatinine	NN	MISC	creatinine	nn	10	SENT_67	[p5l10t2198r245b2239],
10	level	NN	O	level	dep	7	SENT_67	[p5l267t2198r388b2248],
11	,	,	O	,	_	0	SENT_67	[p5l267t2198r388b2248],
12	umol/1	NN	O	umol/1	appos	2	SENT_67	[p5l416t2198r566b2250],
13	(	CD	NUMBER	(	num	12	SENT_67	[p5l588t2198r695b2250],
14	SD	NN	O	sd	dep	12	SENT_67	[p5l588t2198r695b2250],
15	)	CD	NUMBER	)	num	14	SENT_67	[p5l588t2198r695b2250],
16	a	DT	O	a	det	18	SENT_67	[p5l717t2195r736b2213],
17	Prior	JJ	O	prior	amod	18	SENT_67	[p5l8t2270r123b2311],
18	use	NN	O	use	dep	2	SENT_67	[p5l141t2284r216b2311],
19	before	IN	O	before	_	0	SENT_67	[p5l237t2270r382b2311],
20	start	NN	O	start	nn	24	SENT_67	[p5l405t2276r500b2311],
21	levodopa	NN	O	levodopa	nn	24	SENT_67	[p5l521t2270r731b2323],
22	therapy	NN	O	therapy	nn	24	SENT_67	[p5l750t2270r922b2323],
23	Anticholinergic	JJ	O	anticholinergic	amod	24	SENT_67	[p5l1381t2270r1739b2323],
24	drugs	NNS	O	drug	prep_before	18	SENT_67	[p5l1761t2270r1886b2323],

1	Dopamine	NN	O	dopamine	nn	2	SENT_68	[p5l1381t2343r1619b2396],
2	agonists	NNS	O	agonist	_	0	SENT_68	[p5l1641t2343r1826b2396],
3	Amantadine	NNP	O	Amantadine	nn	4	SENT_68	[p5l1381t2415r1660b2456],
4	Selegiline	NNP	O	Selegiline	dep	2	SENT_68	[p5l1384t2487r1608b2540],

1	Average	JJ	O	average	nsubj	2	SENT_69	[p5l8t2561r197b2613],
2	prescribed	VBN	O	prescribe	_	0	SENT_69	[p5l217t2560r456b2613],
3	dose	NN	O	dose	dobj	2	SENT_69	[p5l476t2560r579b2602],
4	of	IN	O	of	_	0	SENT_69	[p5l601t2560r654b2601],
5	non-levodopa	JJ	O	non-levodopa	amod	7	SENT_69	[p5l667t2560r984b2613],
6	anti-Parkinsonian	JJ	O	anti-parkinsonian	amod	7	SENT_69	[p5l1005t2560r1407b2601],
7	drugs	NNS	O	drug	prep_of	3	SENT_69	[p5l1429t2560r1553b2613],
8	at	IN	O	at	_	0	SENT_69	[p5l1576t2566r1615b2601],
9	start	NN	O	start	nn	11	SENT_69	[p5l1637t2566r1732b2601],
10	levodopa	NN	O	levodopa	nn	11	SENT_69	[p5l1753t2560r1963b2613],
11	therapy	NN	O	therapy	prep_at	2	SENT_69	[p5l1982t2560r2153b2613],

1	0.80	CD	NUMBER	0.80	_	0	SENT_70	[p6l830t1091r1033b1174],
2	DDD	NNP	O	DDD	dep	1	SENT_70	[p6l1078t1093r1331b1172],
3	0.68	CD	NUMBER	0.68	num	2	SENT_70	[p6l1653t1091r1852b1174],
4	DDD	NNP	O	DDD	dep	1	SENT_70	[p6l1900t1092r2154b1172],

1	o.	NN	O	o.	_	0	SENT_71	[p6l8t1091r86b1174],
2	8	CD	NUMBER	8	number	3	SENT_71	[p6l101t1091r148b1174],
3	4	CD	NUMBER	4	num	15	SENT_71	[p6l156t1091r211b1172],
4	DDD	NNP	ORGANIZATION	DDD	nn	15	SENT_71	[p6l256t1093r510b1172],
5	aAt	IN	O	aat	amod	15	SENT_71	[p6l53t1231r103b1258],
6	the	DT	O	the	det	7	SENT_71	[p6l114t1234r153b1258],
7	time	NN	O	time	dep	5	SENT_71	[p6l165t1234r222b1258],
8	of	IN	O	of	_	0	SENT_71	[p6l234t1234r265b1258],
9	entrance	NN	O	entrance	prep_of	7	SENT_71	[p6l273t1238r382b1258],
10	in	IN	O	in	_	0	SENT_71	[p6l394t1234r419b1258],
11	the	DT	O	the	det	14	SENT_71	[p6l430t1234r469b1258],
12	Rotterd	NNP	O	Rotterd	nn	14	SENT_71	[p6l481t1234r579b1258],
13	Study	NNP	O	Study	nn	14	SENT_71	[p6l632t1234r707b1265],
14	pringer	NN	O	pringer	prep_in	9	SENT_71	[p6l113t1356r211b1381],
15	rogenetics	NNS	O	rogenetic	nsubj	16	SENT_71	[p6l111t1390r253b1422],
16	(	VBP	O	(	rcmod	1	SENT_71	[p6l267t1390r357b1422],
17	2011	CD	DATE	2011	num	18	SENT_71	[p6l267t1390r357b1422],
18	)	CD	NUMBER	)	dobj	16	SENT_71	[p6l267t1390r357b1422],
19	12:79	CD	NUMBER	12:79	num	20	SENT_71	[p6l374t1391r502b1415],
20	-82	CD	NUMBER	-82	dep	18	SENT_71	[p6l374t1391r502b1415],

1	.	.	O	.	_	0	SENT_72	[p6l133t2409r182b2467],

1	o	NN	O	o	nn	2	SENT_73	[p6l133t2409r182b2467],
2	A	NN	O	a	_	0	SENT_73	[p6l189t2408r224b2457],

1	Change	NNP	O	Change	_	0	SENT_74	[p6l21t2681r87b2926],
2	in	IN	O	in	advmod	3	SENT_74	[p6l22t2604r72b2656],
3	prescribed	VBN	O	prescribe	partmod	1	SENT_74	[p6l22t2237r86b2577],
4	dose	NN	O	dose	nn	5	SENT_74	[p6l22t2058r73b2213],
5	(	NN	O	(	nsubj	11	SENT_74	[p6l21t1958r86b2035],
6	in	IN	O	in	_	0	SENT_74	[p6l21t1958r86b2035],
7	DDD	NNP	ORGANIZATION	DDD	nn	8	SENT_74	[p6l22t1790r72b1930],
8	units	NNS	O	unit	prep_in	5	SENT_74	[p6l21t1586r86b1765],
9	)	CD	NUMBER	)	num	11	SENT_74	[p6l21t1586r86b1765],
10	_	NN	O	_	nn	11	SENT_74	[p6l111t2934r182b2993],
11	c	NN	O	c	xcomp	3	SENT_74	[p6l111t2934r182b2993],
12	'	''	O	'	_	0	SENT_74	[p6l111t2934r182b2993],
13	>	JJR	O	>	amod	15	SENT_74	[p6l111t2934r182b2993],
14	o	NN	O	o	nn	15	SENT_74	[p6l133t2584r167b2634],
15	o	NN	O	o	dep	20	SENT_74	[p6l133t2234r167b2283],
16	|	CD	NUMBER	|	dep	15	SENT_74	[p6l190t2934r223b2983],
17	\	NN	O	\	dep	20	SENT_74	[p6l190t2934r223b2983],
18	)	CD	NUMBER	)	num	17	SENT_74	[p6l190t2934r223b2983],
19	|	CD	NUMBER	|	num	20	SENT_74	[p6l190t2584r223b2632],
20	\	NN	O	\	dep	22	SENT_74	[p6l190t2584r223b2632],
21	)	CD	NUMBER	)	dep	20	SENT_74	[p6l190t2584r223b2632],
22	O	NN	O	o	dep	1	SENT_74	[p6l190t2234r224b2283],
23	)	CD	NUMBER	)	num	22	SENT_74	[p6l190t2234r224b2283],

1	r	NN	O	r	nn	4	SENT_75	[p6l609t2480r627b2498],
2	’	CD	NUMBER	’	num	4	SENT_75	[p6l649t2457r664b2472],
3	Z	NN	O	z	nn	4	SENT_75	[p6l1151t2475r1206b2498],
4	—	NN	O	—	_	0	SENT_75	[p6l1313t2453r1365b2461],
5	1	CD	NUMBER	1	dep	4	SENT_75	[p6l1394t2449r1447b2457],

1	-	:	O	-	_	0	SENT_76	[p6l257t2433r2137b2603],
2	i	FW	O	i	_	0	SENT_76	[p6l257t2433r2137b2603],

1	I	PRP	O	I	nsubj	2	SENT_77	[p6l335t2705r350b2719],
2	’	VBP	O	’	_	0	SENT_77	[p6l369t2671r383b2686],
3	/	:	O	/	punct	2	SENT_77	[p6l715t2660r760b2701],

1	O	NN	O	o	_	0	SENT_78	[p6l190t2759r224b2809],
2	"	''	O	"	punct	1	SENT_78	[p6l306t2738r383b2760],
3	‘	CD	NUMBER	‘	num	1	SENT_78	[p6l490t2716r542b2731],
4	§	SYM	O	§	dep	1	SENT_78	[p6l571t2726r623b2742],
5	-	:	O	-	_	0	SENT_78	[p6l647t2773r662b2780],
6	o	NN	O	o	dep	1	SENT_78	[p6l1215t2731r2075b2780],
7	>	JJR	O	>	amod	8	SENT_78	[p6l1215t2731r2075b2780],
8	t	NN	O	t	dep	6	SENT_78	[p6l1215t2731r2075b2780],
9	+	CC	O	+	rcmod	8	SENT_78	[p6l1215t2731r2075b2780],

1	Sequence	NN	O	sequence	_	0	SENT_79	[p6l608t3020r926b3085],
2	of	IN	O	of	_	0	SENT_79	[p6l948t3021r1010b3072],
3	levodopa	NN	O	levodopa	nn	4	SENT_79	[p6l1033t3021r1325b3085],
4	prescriptions	NNS	O	prescription	prep_of	1	SENT_79	[p6l1350t3021r1774b3085],

1	.	.	O	.	_	0	SENT_80	[p6l792t3152r1031b3198],

1	—	NN	O	—	_	0	SENT_81	[p6l792t3152r1031b3198],
2	.	.	O	.	_	0	SENT_81	[p6l792t3152r1031b3198],

1	AA	NN	O	aa	_	0	SENT_82	[p6l792t3152r1031b3198],
2	.	.	O	.	_	0	SENT_82	[p6l1065t3151r1303b3199],

1	—	NN	O	—	_	0	SENT_83	[p6l1065t3151r1303b3199],
2	.	.	O	.	_	0	SENT_83	[p6l1065t3151r1303b3199],

1	.	.	O	.	_	0	SENT_84	[p6l1065t3151r1303b3199],

1	—	NN	O	—	_	0	SENT_85	[p6l1065t3151r1303b3199],
2	.	.	O	.	_	0	SENT_85	[p6l1065t3151r1303b3199],

1	AC	NN	O	ac	_	0	SENT_86	[p6l1065t3151r1303b3199],
2	----	CD	NUMBER	----	num	3	SENT_86	[p6l1353t3151r1594b3200],
3	CC	NN	O	cc	dep	1	SENT_86	[p6l1353t3151r1594b3200],

1	Fig	NN	O	fig	_	0	SENT_87	[p6l7t3326r126b3395],
2	.	.	O	.	_	0	SENT_87	[p6l7t3326r126b3395],

1	1	CD	NUMBER	1	num	3	SENT_88	[p6l166t3326r193b3378],
2	Rs622342	NN	O	rs622342	nn	3	SENT_88	[p6l248t3326r552b3379],
3	genotype	NN	O	genotype	nsubj	12	SENT_88	[p6l587t3333r861b3395],
4	and	CC	O	and	_	0	SENT_88	[p6l896t3325r1003b3379],
5	change	NN	O	change	conj_and	3	SENT_88	[p6l1036t3325r1246b3395],
6	in	IN	O	in	_	0	SENT_88	[p6l1282t3325r1338b3378],
7	prescribed	JJ	O	prescribed	amod	8	SENT_88	[p6l1368t3325r1681b3394],
8	doses	NNS	O	dose	prep_in	5	SENT_88	[p6l1715t3325r1879b3379],
9	of	IN	O	of	_	0	SENT_88	[p6l1915t3325r1983b3379],
10	antiParkinsonian	JJ	O	antiparkinsonian	amod	11	SENT_88	[p6l2008t3325r2140b3379, p6l7t3413r399b3467],
11	drugs	NNS	O	drug	prep_of	8	SENT_88	[p6l427t3413r590b3483],
12	(	VBP	O	(	_	0	SENT_88	[p6l621t3413r775b3482],
13	bars	NNS	O	bar	nsubj	14	SENT_88	[p6l621t3413r775b3482],
14	represent	VB	O	represent	ccomp	12	SENT_88	[p6l802t3421r1076b3483],
15	standard	JJ	O	standard	amod	17	SENT_88	[p6l1105t3413r1356b3467],
16	error	NN	O	error	nn	17	SENT_88	[p6l1384t3414r1548b3482],
17	)	NN	O	)	dobj	14	SENT_88	[p6l1384t3414r1548b3482],

1	and	CC	O	and	cc	12	SENT_89	[p6l9t3645r135b3709],
2	the	DT	O	the	det	5	SENT_89	[p6l179t3645r285b3709],
3	prescribed	VBN	O	prescribe	amod	5	SENT_89	[p6l331t3645r700b3727],
4	daily	JJ	SET	daily	amod	5	SENT_89	[p6l747t3645r921b3727],
5	dose	NN	O	dose	nsubj	12	SENT_89	[p6l969t3645r1127b3709],
6	of	IN	O	of	_	0	SENT_89	[p6l1176t3646r1257b3709],
7	other	JJ	O	other	amod	9	SENT_89	[p6l1294t3645r1475b3709],
8	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	9	SENT_89	[p6l1521t3645r2142b3709],
9	drugs	NNS	O	drug	prep_of	5	SENT_89	[p7l9t21r201b103],
10	was	VBD	O	be	cop	12	SENT_89	[p7l245t42r380b85],
11	0.33	CD	NUMBER	0.33	num	12	SENT_89	[p7l428t23r574b85],
12	DDD	NNP	O	DDD	_	0	SENT_89	[p7l624t24r813b84],
13	higher	JJR	O	higher	advmod	12	SENT_89	[p7l858t21r1085b103],
14	(	CD	PERCENT	(	number	15	SENT_89	[p7l1129t21r1315b103],
15	95	CD	PERCENT	95	num	16	SENT_89	[p7l1129t21r1315b103],
16	%	NN	PERCENT	%	attr	12	SENT_89	[p7l1129t21r1315b103],
17	CI	NN	O	ci	dep	16	SENT_89	[p7l1363t23r1447b85],
18	0.049	CD	NUMBER	0.049	num	17	SENT_89	[p7l1493t23r1709b99],
19	,	,	O	,	_	0	SENT_89	[p7l1493t23r1709b99],
20	0.61	CD	NUMBER	0.61	num	21	SENT_89	[p7l1758t21r1956b103],
21	)	NN	O	)	appos	16	SENT_89	[p7l1758t21r1956b103],
22	.	.	O	.	_	0	SENT_89	[p7l1758t21r1956b103],

1	The	DT	O	the	det	2	SENT_90	[p7l2007t21r2141b85],
2	change	NN	O	change	nsubj	13	SENT_90	[p7l9t132r256b214],
3	in	IN	O	in	_	0	SENT_90	[p7l308t132r374b195],
4	prescribed	JJ	O	prescribed	amod	6	SENT_90	[p7l422t132r791b214],
5	daily	JJ	SET	daily	amod	6	SENT_90	[p7l841t132r1015b214],
6	dose	NN	O	dose	prep_in	2	SENT_90	[p7l1066t132r1225b196],
7	was	VBD	O	be	cop	13	SENT_90	[p7l1275t153r1410b196],
8	0.038	CD	NUMBER	0.038	num	13	SENT_90	[p7l1464t134r1657b196],
9	DDD	NNP	O	DDD	nn	13	SENT_90	[p7l1711t135r1899b195],
10	(	CD	PERCENT	(	num	13	SENT_90	[p7l1954t133r2140b213],
11	95	CD	PERCENT	95	number	12	SENT_90	[p7l1954t133r2140b213],
12	%	NN	PERCENT	%	amod	13	SENT_90	[p7l1954t133r2140b213],
13	CI	NN	O	ci	_	0	SENT_90	[p7l9t244r93b307],
14	-0.007	CD	NUMBER	-0.007	dep	13	SENT_90	[p7l125t244r394b320],
15	,	,	O	,	_	0	SENT_90	[p7l125t244r394b320],
16	0.083	CD	NUMBER	0.083	num	17	SENT_90	[p7l431t243r655b324],
17	)	NN	O	)	appos	13	SENT_90	[p7l431t243r655b324],
18	for	IN	O	for	_	0	SENT_90	[p7l691t243r792b307],
19	the	DT	O	the	det	28	SENT_90	[p7l820t243r926b307],
20	anticholinergic	JJ	O	anticholinergic	amod	28	SENT_90	[p7l960t243r1486b324],
21	drugs	NNS	O	drug	tmod	20	SENT_90	[p7l1519t243r1732b324],
22	,	,	O	,	_	0	SENT_90	[p7l1519t243r1732b324],
23	0.11	CD	NUMBER	0.11	appos	21	SENT_90	[p7l1769t244r1909b306],
24	DDD	NNP	O	DDD	nn	28	SENT_90	[p7l1950t245r2139b305],
25	(	CD	PERCENT	(	num	28	SENT_90	[p7l9t354r196b435],
26	95	CD	PERCENT	95	number	27	SENT_90	[p7l9t354r196b435],
27	%	NN	PERCENT	%	amod	28	SENT_90	[p7l9t354r196b435],
28	CI	NN	O	ci	prep_for	17	SENT_90	[p7l235t355r320b418],
29	0.01	CD	NUMBER	0.01	dep	28	SENT_90	[p7l358t355r530b431],
30	,	,	O	,	_	0	SENT_90	[p7l358t355r530b431],
31	0.20	CD	NUMBER	0.20	num	32	SENT_90	[p7l572t354r752b435],
32	)	NN	O	)	conj_and	28	SENT_90	[p7l572t354r752b435],
33	for	IN	O	for	_	0	SENT_90	[p7l792t354r893b418],
34	amantadine	NN	O	amantadine	prep_for	32	SENT_90	[p7l929t354r1332b418],
35	and	CC	O	and	_	0	SENT_90	[p7l1372t354r1498b418],
36	0.19	CD	NUMBER	0.19	num	37	SENT_90	[p7l1535t355r1685b418],
37	DDD	NN	O	ddd	conj_and	28	SENT_90	[p7l1724t356r1913b416],
38	(	CD	PERCENT	(	number	39	SENT_90	[p7l1954t354r2140b435],
39	95	CD	PERCENT	95	num	40	SENT_90	[p7l1954t354r2140b435],
40	%	NN	PERCENT	%	dep	37	SENT_90	[p7l1954t354r2140b435],
41	CI	NN	O	ci	dep	37	SENT_90	[p7l9t466r93b529],
42	-0.07	CD	NUMBER	-0.07	num	41	SENT_90	[p7l155t466r356b542],
43	,	,	O	,	_	0	SENT_90	[p7l155t466r356b542],
44	0.45	CD	NUMBER	0.45	num	45	SENT_90	[p7l420t465r602b546],
45	)	NN	O	)	appos	13	SENT_90	[p7l420t465r602b546],
46	for	IN	O	for	_	0	SENT_90	[p7l664t465r765b529],
47	selegiline	NN	O	selegiline	prep_for	45	SENT_90	[p7l824t465r1177b546],
48	.	.	O	.	_	0	SENT_90	[p7l824t465r1177b546],

1	Only	RB	O	only	quantmod	2	SENT_91	[p7l1243t465r1419b546],
2	six	CD	NUMBER	six	num	3	SENT_91	[p7l1480t465r1578b529],
3	patients	NNS	O	patient	nsubjpass	5	SENT_91	[p7l1636t465r1911b546],
4	were	VBD	O	be	auxpass	5	SENT_91	[p7l1971t485r2141b529],
5	prescribed	VBN	O	prescribe	conj_and	5	SENT_91	[p7l6t576r374b658],
6	dopamine	NN	O	dopamine	nn	7	SENT_91	[p7l413t576r759b658],
7	agonists	NNS	O	agonist	dobj	5	SENT_91	[p7l800t576r1085b658],
8	at	IN	O	at	_	0	SENT_91	[p7l1128t585r1188b640],
9	the	DT	O	the	det	11	SENT_91	[p7l1225t576r1330b640],
10	ﬁfth	JJ	O	ﬁfth	amod	11	SENT_91	[p7l1371t576r1519b639],
11	prescription	NN	O	prescription	prep_at	5	SENT_91	[p7l1554t576r1977b658],
12	and	CC	O	and	_	0	SENT_91	[p7l2017t576r2142b640],
13	in	IN	O	in	_	0	SENT_91	[p7l8t687r75b750],
14	none	NN	O	none	prep_in	5	SENT_91	[p7l122t708r293b751],
15	of	IN	O	of	_	0	SENT_91	[p7l344t687r425b751],
16	these	DT	O	these	det	17	SENT_91	[p7l462t687r641b751],
17	patients	NNS	O	patient	prep_of	14	SENT_91	[p7l689t687r961b769],
18	the	DT	O	the	det	21	SENT_91	[p7l1012t687r1117b751],
19	prescribed	JJ	O	prescribed	amod	21	SENT_91	[p7l1165t687r1534b769],
20	daily	JJ	SET	daily	amod	21	SENT_91	[p7l1583t687r1758b769],
21	dose	NN	O	dose	nsubj	23	SENT_91	[p7l1807t687r1966b751],
22	had	VBD	O	have	aux	23	SENT_91	[p7l2014t687r2142b751],
23	changed	VBN	O	change	dep	5	SENT_91	[p7l9t798r302b880],
24	between	IN	O	between	_	0	SENT_91	[p7l338t798r633b862],
25	the	DT	O	the	det	30	SENT_91	[p7l668t798r774b862],
26	first	JJ	ORDINAL	first	amod	30	SENT_91	[p7l814t798r953b862],
27	and	CC	O	and	_	0	SENT_91	[p7l990t798r1116b862],
28	ﬁfth	JJ	O	ﬁfth	conj_and	26	SENT_91	[p7l1153t798r1300b862],
29	levodopa	NN	O	levodopa	nn	30	SENT_91	[p7l1339t798r1663b880],
30	prescription	NN	O	prescription	prep_between	23	SENT_91	[p7l1697t798r2136b880],
31	.	.	O	.	_	0	SENT_91	[p7l1697t798r2136b880],

1	Therefore	RB	O	therefore	advmod	10	SENT_92	[p7l8t909r372b987],
2	,	,	O	,	_	0	SENT_92	[p7l8t909r372b987],
3	changes	NNS	O	change	nsubj	10	SENT_92	[p7l433t909r714b991],
4	in	IN	O	in	_	0	SENT_92	[p7l773t909r839b972],
5	dopamine	NN	O	dopamine	nn	7	SENT_92	[p7l896t909r1242b991],
6	agonist	NN	O	agonist	nn	7	SENT_92	[p7l1301t909r1556b991],
7	doses	NNS	O	dose	prep_in	3	SENT_92	[p7l1612t909r1804b973],
8	did	VBD	O	do	aux	10	SENT_92	[p7l1863t909r1975b973],
9	not	RB	O	not	neg	10	SENT_92	[p7l2029t918r2143b973],
10	contribute	VB	O	contribute	_	0	SENT_92	[p7l9t1020r363b1084],
11	to	TO	O	to	_	0	SENT_92	[p7l403t1029r469b1084],
12	the	DT	O	the	det	13	SENT_92	[p7l510t1020r616b1084],
13	change	NN	O	change	prep_to	10	SENT_92	[p7l658t1020r905b1102],
14	in	IN	O	in	_	0	SENT_92	[p7l948t1020r1014b1083],
15	total	JJ	O	total	amod	18	SENT_92	[p7l1052t1020r1208b1084],
16	prescribed	JJ	O	prescribed	amod	18	SENT_92	[p7l1246t1020r1614b1102],
17	daily	JJ	SET	daily	amod	18	SENT_92	[p7l1655t1020r1830b1102],
18	dose	NN	O	dose	prep_in	13	SENT_92	[p7l1871t1020r2029b1084],
19	of	IN	O	of	_	0	SENT_92	[p7l2071t1020r2153b1084],
20	anti-Parkinson	JJ	O	anti-parkinson	amod	21	SENT_92	[p7l9t1131r531b1195],
21	drugs	NNS	O	drug	prep_of	18	SENT_92	[p7l592t1131r807b1213],
22	.	.	O	.	_	0	SENT_92	[p7l592t1131r807b1213],

1	No	DT	O	no	det	3	SENT_93	[p7l869t1133r977b1195],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_93	[p7l1043t1131r1419b1213],
3	associations	NNS	O	association	nsubjpass	5	SENT_93	[p7l1479t1131r1909b1195],
4	were	VBD	O	be	auxpass	5	SENT_93	[p7l1969t1152r2140b1195],
5	found	VBN	O	find	_	0	SENT_93	[p7l9t1242r225b1306],
6	between	IN	O	between	_	0	SENT_93	[p7l285t1242r596b1306],
7	the	DT	O	the	det	9	SENT_93	[p7l658t1242r768b1306],
8	rs622342	NN	O	rs622342	nn	9	SENT_93	[p7l833t1243r1179b1306],
9	genotype	NN	O	genotype	prep_between	5	SENT_93	[p7l1245t1250r1586b1323],
10	and	CC	O	and	_	0	SENT_93	[p7l1651t1242r1783b1306],
11	start	NN	O	start	prep_between	5	SENT_93	[p7l1848t1250r2006b1306],
12	of	IN	O	of	_	0	SENT_93	[p7l2069t1242r2153b1306],
13	dopamine	NN	O	dopamine	nn	15	SENT_93	[p7l9t1353r355b1434],
14	agonist	NN	O	agonist	nn	15	SENT_93	[p7l402t1353r657b1434],
15	therapy	NN	O	therapy	prep_of	9	SENT_93	[p7l698t1353r963b1434],
16	(	CD	NUMBER	(	num	17	SENT_93	[p7l1009t1353r1159b1434],
17	HR	NN	DURATION	hr	dep	22	SENT_93	[p7l1009t1353r1159b1434],
18	0.99	CD	PERCENT	0.99	num	20	SENT_93	[p7l1204t1354r1354b1417],
19	95	CD	PERCENT	95	num	20	SENT_93	[p7l1402t1354r1561b1418],
20	%	NN	PERCENT	%	dep	17	SENT_93	[p7l1402t1354r1561b1418],
21	CI	NN	O	ci	dep	22	SENT_93	[p7l1608t1354r1692b1417],
22	0.45	CD	NUMBER	0.45	dep	32	SENT_93	[p7l1738t1354r1910b1430],
23	,	,	O	,	_	0	SENT_93	[p7l1738t1354r1910b1430],
24	2.19	CD	NUMBER	2.19	number	25	SENT_93	[p7l1958t1353r2140b1434],
25	)	CD	NUMBER	)	appos	22	SENT_93	[p7l1958t1353r2140b1434],
26	or	CC	O	or	_	0	SENT_93	[p7l9t1485r81b1528],
27	discontinuation	NN	O	discontinuation	conj_or	22	SENT_93	[p7l136t1464r680b1528],
28	of	IN	O	of	_	0	SENT_93	[p7l738t1464r819b1528],
29	levodopa	NN	O	levodopa	nn	30	SENT_93	[p7l865t1464r1189b1546],
30	therapy	NN	O	therapy	prep_of	27	SENT_93	[p7l1243t1464r1508b1546],
31	(	CD	NUMBER	(	num	32	SENT_93	[p7l1565t1464r1716b1545],
32	HR	NN	DURATION	hr	dep	36	SENT_93	[p7l1565t1464r1716b1545],
33	1.13	CD	PERCENT	1.13	num	35	SENT_93	[p7l1779t1466r1918b1528],
34	95	CD	PERCENT	95	num	35	SENT_93	[p7l1983t1465r2140b1529],
35	%	NN	PERCENT	%	dep	32	SENT_93	[p7l1983t1465r2140b1529],
36	CI	NN	O	ci	dep	9	SENT_93	[p7l9t1576r93b1639],
37	0.72	CD	NUMBER	0.72	num	36	SENT_93	[p7l127t1577r299b1652],
38	,	,	O	,	_	0	SENT_93	[p7l127t1577r299b1652],
39	1.76	CD	NUMBER	1.76	num	40	SENT_93	[p7l343t1575r534b1656],
40	)	NN	O	)	appos	9	SENT_93	[p7l343t1575r534b1656],
41	.	.	O	.	_	0	SENT_93	[p7l343t1575r534b1656],

1	The	DT	O	the	det	4	SENT_94	[p7l110t1686r244b1750],
2	average	JJ	O	average	amod	4	SENT_94	[p7l274t1707r544b1768],
3	survival	NN	O	survival	nn	4	SENT_94	[p7l576t1686r856b1750],
4	time	NN	O	time	nsubj	10	SENT_94	[p7l882t1686r1037b1750],
5	after	IN	O	after	_	0	SENT_94	[p7l1067t1686r1226b1750],
6	start	NN	O	start	prep_after	4	SENT_94	[p7l1254t1695r1401b1750],
7	of	IN	O	of	_	0	SENT_94	[p7l1429t1686r1510b1750],
8	levodopa	NN	O	levodopa	nn	9	SENT_94	[p7l1528t1686r1852b1768],
9	therapy	NN	O	therapy	prep_of	6	SENT_94	[p7l1877t1686r2142b1768],
10	differed	VBD	O	differ	_	0	SENT_94	[p7l9t1797r284b1861],
11	between	IN	O	between	_	0	SENT_94	[p7l309t1797r605b1861],
12	rs622342	NN	O	rs622342	nn	13	SENT_94	[p7l629t1799r957b1861],
13	genotypes	NNS	O	genotype	prep_between	10	SENT_94	[p7l989t1806r1363b1879],
14	.	.	O	.	_	0	SENT_94	[p7l989t1806r1363b1879],

1	The	DT	O	the	det	4	SENT_95	[p7l1397t1797r1530b1861],
2	average	JJ	O	average	amod	4	SENT_95	[p7l1560t1818r1830b1879],
3	survival	NN	O	survival	nn	4	SENT_95	[p7l1861t1797r2141b1861],
4	time	NN	O	time	nsubj	7	SENT_95	[p7l7t1908r160b1972],
5	was	VBD	O	be	cop	7	SENT_95	[p7l210t1929r345b1972],
6	6.9	CD	DURATION	6.9	num	7	SENT_95	[p7l398t1910r503b1972],
7	years	NNS	NUMBER	year	_	0	SENT_95	[p7l554t1929r737b1990],
8	for	IN	O	for	_	0	SENT_95	[p7l790t1909r891b1972],
9	patients	NNS	O	patient	prep_for	7	SENT_95	[p7l936t1908r1208b1990],
10	with	IN	O	with	_	0	SENT_95	[p7l1259t1908r1415b1972],
11	the	DT	O	the	det	13	SENT_95	[p7l1464t1908r1569b1972],
12	AA	NNP	O	AA	nn	13	SENT_95	[p7l1619t1910r1746b1971],
13	genotype	NN	O	genotype	prep_with	9	SENT_95	[p7l1796t1917r2138b1990],
14	,	,	O	,	_	0	SENT_95	[p7l1796t1917r2138b1990],
15	5.2	CD	DURATION	5.2	num	16	SENT_95	[p7l10t2021r114b2083],
16	years	NNS	NUMBER	year	conj_and	7	SENT_95	[p7l148t2040r331b2101],
17	for	IN	O	for	_	0	SENT_95	[p7l366t2019r467b2083],
18	patients	NNS	O	patient	prep_for	16	SENT_95	[p7l495t2019r767b2101],
19	with	IN	O	with	_	0	SENT_95	[p7l800t2019r957b2083],
20	the	DT	O	the	det	22	SENT_95	[p7l988t2019r1094b2083],
21	AC	NN	O	ac	nn	22	SENT_95	[p7l1125t2021r1245b2083],
22	genotype	NN	O	genotype	prep_with	18	SENT_95	[p7l1281t2028r1623b2101],
23	,	,	O	,	_	0	SENT_95	[p7l1281t2028r1623b2101],
24	and	CC	O	and	_	0	SENT_95	[p7l1659t2019r1786b2083],
25	4.4	CD	DURATION	4.4	num	26	SENT_95	[p7l1816t2021r1924b2083],
26	years	NNS	NUMBER	year	conj_and	7	SENT_95	[p7l1956t2040r2139b2101],
27	for	IN	O	for	_	0	SENT_95	[p7l9t2130r110b2194],
28	patients	NNS	O	patient	prep_for	26	SENT_95	[p7l137t2130r411b2211],
29	with	IN	O	with	_	0	SENT_95	[p7l443t2130r599b2194],
30	the	DT	O	the	det	32	SENT_95	[p7l629t2130r735b2194],
31	CC	NN	O	cc	nn	32	SENT_95	[p7l769t2131r883b2194],
32	genotype	NN	O	genotype	prep_with	28	SENT_95	[p7l918t2139r1258b2212],
33	.	.	O	.	_	0	SENT_95	[p7l918t2139r1258b2212],

1	The	DT	O	the	det	3	SENT_96	[p7l1296t2130r1430b2194],
2	mortality	NN	O	mortality	nn	3	SENT_96	[p7l1461t2130r1784b2212],
3	ratio	NN	O	ratio	nsubjpass	6	SENT_96	[p7l1815t2130r1972b2194],
4	was	VBD	O	be	auxpass	6	SENT_96	[p7l2005t2151r2140b2194],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_96	[p7l10t2241r448b2322],
6	raised	VBN	O	raise	dep	14	SENT_96	[p7l473t2241r684b2305],
7	with	IN	O	with	_	0	SENT_96	[p7l709t2241r865b2305],
8	the	DT	O	the	det	9	SENT_96	[p7l892t2241r997b2304],
9	number	NN	O	number	prep_with	6	SENT_96	[p7l1024t2241r1297b2305],
10	of	IN	O	of	_	0	SENT_96	[p7l1323t2241r1404b2305],
11	minor	JJ	O	minor	amod	13	SENT_96	[p7l1419t2241r1632b2305],
12	C	NN	O	c	nn	13	SENT_96	[p7l1658t2242r1712b2305],
13	alleles	NNS	O	allele	prep_of	9	SENT_96	[p7l1743t2241r1962b2305],
14	(	VBP	O	(	_	0	SENT_96	[p7l1993t2241r2143b2322],
15	HR	NN	DURATION	hr	dobj	14	SENT_96	[p7l1993t2241r2143b2322],
16	1.47	CD	NUMBER	1.47	num	15	SENT_96	[p7l17t2353r182b2429],
17	;	:	O	;	_	0	SENT_96	[p7l17t2353r182b2429],
18	95	CD	PERCENT	95	number	19	SENT_96	[p7l220t2353r378b2417],
19	%	NN	PERCENT	%	amod	15	SENT_96	[p7l220t2353r378b2417],
20	CI	NN	O	ci	nsubj	14	SENT_96	[p7l413t2353r497b2416],
21	1.01	CD	NUMBER	1.01	num	20	SENT_96	[p7l538t2353r702b2429],
22	,	,	O	,	_	0	SENT_96	[p7l538t2353r702b2429],
23	2.13	CD	NUMBER	2.13	num	24	SENT_96	[p7l738t2352r937b2433],
24	)	NN	O	)	appos	20	SENT_96	[p7l738t2352r937b2433],
25	.	.	O	.	_	0	SENT_96	[p7l738t2352r937b2433],

1	Discussion	NN	O	discussion	_	0	SENT_97	[p7l7t2595r403b2657],

1	In	IN	O	in	_	0	SENT_98	[p7l8t2819r79b2879],
2	this	DT	O	this	det	5	SENT_98	[p7l108t2816r233b2880],
3	population-based	JJ	O	population-based	amod	5	SENT_98	[p7l263t2816r876b2898],
4	cohort	NN	O	cohort	nn	5	SENT_98	[p7l907t2816r1131b2880],
5	study	NN	O	study	prep_in	24	SENT_98	[p7l1163t2816r1365b2898],
6	,	,	O	,	_	0	SENT_98	[p7l1163t2816r1365b2898],
7	the	DT	O	the	det	10	SENT_98	[p7l1397t2816r1503b2880],
8	minor	JJ	O	minor	amod	10	SENT_98	[p7l1534t2816r1746b2880],
9	C	NN	O	c	nn	10	SENT_98	[p7l1776t2818r1829b2880],
10	allele	NN	O	allele	nsubjpass	24	SENT_98	[p7l1863t2816r2049b2880],
11	at	IN	O	at	_	0	SENT_98	[p7l2082t2825r2143b2880],
12	rs622342	NN	O	rs622342	prep_at	10	SENT_98	[p7l6t2929r334b2991],
13	in	IN	O	in	_	0	SENT_98	[p7l380t2927r446b2990],
14	the	DT	O	the	det	16	SENT_98	[p7l487t2927r592b2991],
15	SLC22A1	NN	O	slc22a1	nn	16	SENT_98	[p7l635t2929r970b2991],
16	gene	NN	O	gene	prep_in	12	SENT_98	[p7l1019t2948r1202b3009],
17	,	,	O	,	_	0	SENT_98	[p7l1019t2948r1202b3009],
18	encoding	VBG	O	encode	partmod	24	SENT_98	[p7l1249t2927r1571b3009],
19	the	DT	O	the	det	21	SENT_98	[p7l1612t2927r1718b2991],
20	transporter	NN	O	transporter	nn	21	SENT_98	[p7l1761t2936r2144b3009],
21	OCT1	NN	O	oct1	dobj	18	SENT_98	[p7l9t3039r246b3115],
22	,	,	O	,	_	0	SENT_98	[p7l9t3039r246b3115],
23	was	VBD	O	be	auxpass	24	SENT_98	[p7l277t3059r412b3102],
24	associated	VBN	O	associate	_	0	SENT_98	[p7l443t3038r804b3102],
25	with	IN	O	with	_	0	SENT_98	[p7l830t3038r986b3102],
26	higher	JJR	O	higher	amod	28	SENT_98	[p7l1013t3038r1240b3120],
27	prescribed	JJ	O	prescribed	amod	28	SENT_98	[p7l1265t3038r1633b3119],
28	doses	NNS	O	dose	prep_with	24	SENT_98	[p7l1662t3038r1854b3102],
29	of	IN	O	of	_	0	SENT_98	[p7l1885t3038r1966b3102],
30	antiParkinsonian	JJ	O	antiparkinsonian	amod	31	SENT_98	[p7l1984t3038r2140b3101, p7l7t3149r469b3213],
31	drugs	NNS	O	drug	prep_of	28	SENT_98	[p7l522t3149r714b3230],
32	and	CC	O	and	_	0	SENT_98	[p7l768t3149r894b3213],
33	a	DT	O	a	det	35	SENT_98	[p7l946t3169r983b3212],
34	shorter	JJR	O	shorter	amod	35	SENT_98	[p7l1035t3149r1278b3213],
35	survival	NN	O	survival	prep_of	28	SENT_98	[p7l1329t3149r1610b3213],
36	after	IN	O	after	_	0	SENT_98	[p7l1662t3149r1821b3213],
37	start	NN	O	start	prep_after	24	SENT_98	[p7l1873t3157r2021b3213],
38	of	IN	O	of	_	0	SENT_98	[p7l2071t3149r2153b3213],
39	levodopa	NN	O	levodopa	nn	40	SENT_98	[p7l9t3260r341b3341],
40	therapy	NN	O	therapy	prep_of	37	SENT_98	[p7l400t3260r684b3341],
41	.	.	O	.	_	0	SENT_98	[p7l400t3260r684b3341],

1	This	DT	O	this	det	2	SENT_99	[p7l751t3260r907b3324],
2	polymorphism	NN	O	polymorphism	nsubjpass	5	SENT_99	[p7l967t3260r1500b3341],
3	was	VBD	O	be	auxpass	5	SENT_99	[p7l1559t3280r1696b3324],
4	previously	RB	DATE	previously	advmod	5	SENT_99	[p7l1756t3260r2142b3341],
5	associated	VBN	O	associate	dep	17	SENT_99	[p7l9t3371r374b3435],
6	with	IN	O	with	_	0	SENT_99	[p7l431t3371r589b3435],
7	metformin	NN	O	metformin	nn	8	SENT_99	[p7l648t3371r1024b3435],
8	response	NN	O	response	prep_with	5	SENT_99	[p7l1082t3392r1394b3453],
9	and	CC	O	and	_	0	SENT_99	[p7l1455t3371r1583b3435],
10	the	DT	O	the	det	11	SENT_99	[p7l1640t3371r1747b3435],
11	rs622342	NN	O	rs622342	prep_with	5	SENT_99	[p7l1806t3373r2139b3435],
12	minor	JJ	O	minor	amod	14	SENT_99	[p7l7t3482r223b3546],
13	C	NN	O	c	nn	14	SENT_99	[p7l283t3483r336b3546],
14	allele	NN	O	allele	nsubj	17	SENT_99	[p7l400t3482r590b3546],
15	is	VBZ	O	be	cop	17	SENT_99	[p7l652t3482r706b3546],
16	most	RBS	O	most	advmod	17	SENT_99	[p7l767t3491r943b3546],
17	likely	JJ	O	likely	_	0	SENT_99	[p7l1002t3482r1205b3564],
18	associated	VBN	O	associate	dep	17	SENT_99	[p7l1266t3482r1634b3546],
19	with	IN	O	with	_	0	SENT_99	[p7l1693t3482r1852b3546],
20	a	DT	O	a	det	24	SENT_99	[p7l1914t3503r1951b3546],
21	less	RBR	O	less	advmod	22	SENT_99	[p7l2011t3482r2140b3546],
22	functioning	VBG	O	function	amod	24	SENT_99	[p7l9t3593r406b3675],
23	OCT1	NN	O	oct1	nn	24	SENT_99	[p7l436t3594r642b3657],
24	transporter	NN	O	transporter	prep_with	18	SENT_99	[p7l680t3601r1064b3674],
25	.	.	O	.	_	0	SENT_99	[p7l680t3601r1064b3674],

1	We	PRP	O	we	nsubj	5	SENT_100	[p7l1097t3595r1210b3657],
2	could	MD	O	could	aux	5	SENT_100	[p7l1241t3593r1433b3657],
3	not	RB	O	not	neg	5	SENT_100	[p7l1459t3602r1572b3657],
4	exactly	RB	O	exactly	advmod	5	SENT_100	[p7l1600t3593r1847b3675],
5	identify	VB	O	identify	_	0	SENT_100	[p7l1876t3593r2143b3675],
6	which	WDT	O	which	dobj	10	SENT_100	[p7l6t3704r219b3768],
7	drug	NN	O	drug	nsubj	10	SENT_100	[p7l239t3704r396b3786],
8	or	CC	O	or	_	0	SENT_100	[p7l416t3725r489b3768],
9	drugs	NNS	O	drug	nsubj	10	SENT_100	[p7l505t3704r694b3786],
10	contributed	VBD	O	contribute	ccomp	5	SENT_100	[p7l716t3704r1109b3768],
11	to	TO	O	to	_	0	SENT_100	[p7l1126t3713r1191b3768],
12	the	DT	O	the	det	13	SENT_100	[p7l1210t3704r1314b3768],
13	difference	NN	O	difference	prep_to	10	SENT_100	[p7l1336t3704r1679b3768],
14	in	IN	O	in	_	0	SENT_100	[p7l1700t3704r1766b3767],
15	prescribed	JJ	O	prescribed	amod	17	SENT_100	[p7l1781t3704r2144b3786],
16	daily	JJ	SET	daily	amod	17	SENT_100	[p8l9t21r180b103],
17	dose	NN	O	dose	prep_in	10	SENT_100	[p8l219t21r376b85],
18	of	IN	O	of	_	0	SENT_100	[p8l417t21r498b85],
19	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	20	SENT_100	[p8l527t21r1134b85],
20	drugs	NNS	O	drug	prep_of	17	SENT_100	[p8l1174t21r1382b103],
21	.	.	O	.	_	0	SENT_100	[p8l1174t21r1382b103],

1	The	DT	O	the	det	4	SENT_101	[p8l1427t21r1559b85],
2	only	JJ	O	only	amod	4	SENT_101	[p8l1600t21r1754b103],
3	individual	JJ	O	individual	amod	4	SENT_101	[p8l1793t21r2142b85],
4	drug	NN	O	drug	nsubj	19	SENT_101	[p8l9t132r166b214],
5	for	IN	O	for	_	0	SENT_101	[p8l198t132r298b196],
6	which	WDT	O	which	rel	13	SENT_101	[p8l324t132r537b196],
7	the	DT	O	the	nsubjpass	13	SENT_101	[p8l567t132r671b196],
8	prescribed	VBN	O	prescribe	partmod	7	SENT_101	[p8l700t132r1062b214],
9	daily	JJ	SET	daily	amod	10	SENT_101	[p8l1092t132r1263b214],
10	doses	NNS	O	dose	dobj	8	SENT_101	[p8l1294t132r1483b196],
11	were	VBD	O	be	auxpass	13	SENT_101	[p8l1514t153r1682b196],
12	significantly	RB	O	significantly	advmod	13	SENT_101	[p8l1715t132r2142b214],
13	associated	VBN	O	associate	rcmod	4	SENT_101	[p8l9t243r363b307],
14	with	IN	O	with	_	0	SENT_101	[p8l390t243r546b307],
15	the	DT	O	the	det	17	SENT_101	[p8l574t243r678b307],
16	rs622342	NN	O	rs622342	nn	17	SENT_101	[p8l709t244r1031b307],
17	genotype	NN	O	genotype	prep_with	13	SENT_101	[p8l1065t251r1382b324],
18	was	VBD	O	be	cop	19	SENT_101	[p8l1412t263r1545b307],
19	amantadine	NN	O	amantadine	_	0	SENT_101	[p8l1579t243r1993b307],
20	.	.	O	.	_	0	SENT_101	[p8l1579t243r1993b307],

1	We	PRP	O	we	nsubj	4	SENT_102	[p8l2027t245r2141b307],
2	can	MD	O	can	aux	4	SENT_102	[p8l9t363r240b419],
3	not	RB	O	not	neg	4	SENT_102	[p8l9t363r240b419],
4	exclude	VB	O	exclude	_	0	SENT_102	[p8l261t355r527b419],
5	that	IN	O	that	complm	12	SENT_102	[p8l548t355r679b418],
6	the	DT	O	the	det	10	SENT_102	[p8l697t355r801b419],
7	rs622342	NN	O	rs622342	nn	10	SENT_102	[p8l822t356r1145b419],
8	variant	NN	O	variant	nn	10	SENT_102	[p8l1167t355r1408b419],
9	C	NN	O	c	nn	10	SENT_102	[p8l1429t356r1482b419],
10	allele	NN	O	allele	nsubjpass	12	SENT_102	[p8l1508t355r1689b419],
11	is	VBZ	O	be	auxpass	12	SENT_102	[p8l1712t355r1766b419],
12	associated	VBN	O	associate	ccomp	4	SENT_102	[p8l1790t355r2144b419],
13	with	IN	O	with	_	0	SENT_102	[p8l6t466r161b530],
14	a	DT	O	a	det	16	SENT_102	[p8l186t487r223b530],
15	lower	JJR	O	lower	amod	16	SENT_102	[p8l246t466r442b530],
16	response	NN	O	response	prep_with	12	SENT_102	[p8l463t487r766b548],
17	to	TO	O	to	_	0	SENT_102	[p8l789t475r855b530],
18	levodopa	NN	O	levodopa	nn	19	SENT_102	[p8l880t466r1200b548],
19	therapy	NN	O	therapy	prep_to	16	SENT_102	[p8l1220t466r1480b548],
20	and	CC	O	and	_	0	SENT_102	[p8l1505t466r1629b530],
21	that	IN	O	that	complm	25	SENT_102	[p8l1651t466r1781b530],
22	this	DT	O	this	det	23	SENT_102	[p8l1802t466r1925b530],
23	effect	NN	O	effect	nsubjpass	25	SENT_102	[p8l1951t466r2144b530],
24	is	VBZ	O	be	auxpass	25	SENT_102	[p8l8t577r62b641],
25	compensated	VBN	O	compensate	conj_and	12	SENT_102	[p8l95t577r547b659],
26	with	IN	O	with	_	0	SENT_102	[p8l575t577r730b641],
27	higher	JJR	O	higher	amod	29	SENT_102	[p8l759t577r983b659],
28	prescribed	JJ	O	prescribed	amod	29	SENT_102	[p8l1008t577r1370b659],
29	doses	NNS	O	dose	prep_with	25	SENT_102	[p8l1400t577r1589b641],
30	of	IN	O	of	_	0	SENT_102	[p8l1622t577r1703b641],
31	amantadine	NN	O	amantadine	prep_of	29	SENT_102	[p8l1723t577r2138b655],
32	,	,	O	,	_	0	SENT_102	[p8l1723t577r2138b655],
33	selegiline	NN	O	selegiline	prep_of	29	SENT_102	[p8l10t688r354b770],
34	,	,	O	,	_	0	SENT_102	[p8l10t688r354b770],
35	and	CC	O	and	_	0	SENT_102	[p8l399t688r523b752],
36	possibly	RB	O	possibly	advmod	31	SENT_102	[p8l560t688r850b770],
37	other	JJ	O	other	amod	39	SENT_102	[p8l891t688r1068b752],
38	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	39	SENT_102	[p8l1107t688r1715b752],
39	drugs	NNS	O	drug	prep_of	29	SENT_102	[p8l1756t688r1964b770],
40	.	.	O	.	_	0	SENT_102	[p8l1756t688r1964b770],

1	The	DT	O	the	det	4	SENT_103	[p8l2009t688r2141b752],
2	shorter	JJR	O	shorter	amod	4	SENT_103	[p8l10t799r254b863],
3	survival	NN	O	survival	nn	4	SENT_103	[p8l309t799r591b863],
4	period	NN	O	period	nsubj	12	SENT_103	[p8l643t799r872b880],
5	associated	VBN	O	associate	partmod	4	SENT_103	[p8l927t799r1290b863],
6	with	IN	O	with	_	0	SENT_103	[p8l1342t799r1499b863],
7	the	DT	O	the	det	9	SENT_103	[p8l1552t799r1659b863],
8	C	NN	O	c	nn	9	SENT_103	[p8l1716t800r1770b863],
9	allele	NN	O	allele	prep_with	5	SENT_103	[p8l1828t799r2014b863],
10	of	IN	O	of	_	0	SENT_103	[p8l2071t799r2153b863],
11	rs622342	NN	O	rs622342	prep_of	9	SENT_103	[p8l6t912r329b974],
12	suggests	VBZ	O	suggest	_	0	SENT_103	[p8l367t919r656b992],
13	that	IN	O	that	complm	18	SENT_103	[p8l690t910r820b974],
14	multiple	JJ	O	multiple	amod	16	SENT_103	[p8l850t910r1138b992],
15	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	16	SENT_103	[p8l1173t910r1780b974],
16	drugs	NNS	O	drug	nsubjpass	18	SENT_103	[p8l1815t910r2004b992],
17	are	VBP	O	be	auxpass	18	SENT_103	[p8l2040t931r2141b974],
18	involved	VBN	O	involve	ccomp	12	SENT_103	[p8l8t1021r312b1085],
19	and	CC	O	and	_	0	SENT_103	[p8l350t1021r475b1085],
20	that	IN	O	that	complm	32	SENT_103	[p8l511t1021r642b1085],
21	the	DT	O	the	det	23	SENT_103	[p8l677t1021r781b1085],
22	lower	JJR	O	lower	amod	23	SENT_103	[p8l822t1021r1018b1085],
23	response	NN	O	response	nsubjpass	32	SENT_103	[p8l1053t1042r1356b1103],
24	to	TO	O	to	_	0	SENT_103	[p8l1394t1030r1459b1085],
25	one	CD	NUMBER	one	num	29	SENT_103	[p8l1500t1042r1623b1085],
26	or	CC	O	or	_	0	SENT_103	[p8l1663t1042r1735b1085],
27	more	JJR	O	more	num	29	SENT_103	[p8l1770t1042r1948b1085],
28	antiParkinsonian	JJ	O	antiparkinsonian	amod	29	SENT_103	[p8l1988t1021r2140b1085, p8l7t1132r460b1196],
29	drugs	NNS	O	drug	prep_to	23	SENT_103	[p8l490t1132r679b1214],
30	is	VBZ	O	be	auxpass	32	SENT_103	[p8l711t1132r765b1196],
31	not	RB	O	not	neg	32	SENT_103	[p8l795t1141r907b1196],
32	compensated	VBN	O	compensate	conj_and	18	SENT_103	[p8l937t1132r1389b1214],
33	by	IN	O	by	_	0	SENT_103	[p8l1416t1132r1505b1214],
34	higher	JJR	O	higher	amod	36	SENT_103	[p8l1533t1132r1757b1214],
35	prescribed	JJ	O	prescribed	amod	36	SENT_103	[p8l1781t1132r2144b1214],
36	doses	NNS	O	dose	agent	32	SENT_103	[p8l9t1243r198b1307],
37	of	IN	O	of	_	0	SENT_103	[p8l226t1243r307b1307],
38	other	JJ	O	other	amod	39	SENT_103	[p8l322t1243r499b1307],
39	drugs	NNS	O	drug	prep_of	36	SENT_103	[p8l524t1243r732b1324],
40	.	.	O	.	_	0	SENT_103	[p8l524t1243r732b1324],

1	More	RBR	O	more	advmod	6	SENT_104	[p8l109t1356r297b1418],
2	transporters	NNS	O	transporter	pobj	1	SENT_104	[p8l319t1362r724b1435],
3	than	IN	O	than	_	0	SENT_104	[p8l748t1354r899b1417],
4	OCTl	NN	O	octl	prep_than	6	SENT_104	[p8l922t1355r1129b1418],
5	are	VBP	O	be	auxpass	6	SENT_104	[p8l1163t1374r1264b1417],
6	involved	VBN	O	involve	_	0	SENT_104	[p8l1290t1354r1594b1418],
7	in	IN	O	in	_	0	SENT_104	[p8l1617t1354r1682b1416],
8	the	DT	O	the	det	9	SENT_104	[p8l1704t1354r1809b1418],
9	transportation	NN	O	transportation	prep_in	6	SENT_104	[p8l1832t1362r2140b1435, p8l7t1465r203b1529],
10	of	IN	O	of	_	0	SENT_104	[p8l235t1466r316b1529],
11	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	12	SENT_104	[p8l339t1465r947b1529],
12	drugs	NNS	O	drug	prep_of	9	SENT_104	[p8l979t1465r1188b1547],
13	,	,	O	,	_	0	SENT_104	[p8l979t1465r1188b1547],
14	such	JJ	O	such	_	0	SENT_104	[p8l1226t1465r1383b1529],
15	as	IN	O	as	_	0	SENT_104	[p8l1415t1486r1483b1529],
16	OCT2	NN	O	oct2	prep_such_as	6	SENT_104	[p8l1518t1467r1732b1530],
17	and	CC	O	and	_	0	SENT_104	[p8l1768t1465r1893b1529],
18	OCT3	NN	O	oct3	prep_such_as	6	SENT_104	[p8l1925t1467r2136b1530],
19	and	CC	O	and	_	0	SENT_104	[p8l9t1576r133b1640],
20	the	DT	O	the	det	24	SENT_104	[p8l166t1576r270b1640],
21	L-type	JJ	MISC	l-type	amod	24	SENT_104	[p8l306t1579r535b1658],
22	amino	NN	O	amino	nn	24	SENT_104	[p8l571t1576r785b1640],
23	acid	NN	O	acid	nn	24	SENT_104	[p8l823t1576r965b1640],
24	transporterl	NN	O	transporterl	prep_such_as	6	SENT_104	[p8l997t1578r1405b1658],
25	and	CC	O	and	_	0	SENT_104	[p8l1450t1576r1575b1640],
26	2	CD	NUMBER	2	conj_and	24	SENT_104	[p8l1608t1578r1668b1640],
27	.	.	O	.	_	0	SENT_104	[p8l1608t1578r1668b1640],

1	These	DT	O	these	det	2	SENT_105	[p8l1708t1576r1912b1640],
2	transporters	NNS	O	transporter	nsubj	3	SENT_105	[p8l1947t1585r2141b1640, p8l6t1696r251b1769],
3	differ	VBP	O	differ	_	0	SENT_105	[p8l309t1687r506b1751],
4	in	IN	O	in	_	0	SENT_105	[p8l560t1687r626b1750],
5	their	PRP$	O	they	poss	6	SENT_105	[p8l680t1687r845b1751],
6	expression	NN	O	expression	prep_in	3	SENT_105	[p8l899t1687r1280b1768],
7	throughout	IN	O	throughout	_	0	SENT_105	[p8l1334t1687r1729b1769],
8	the	DT	O	the	det	9	SENT_105	[p8l1782t1687r1889b1751],
9	body	NN	O	body	prep_throughout	3	SENT_105	[p8l1944t1687r2137b1769],
10	,	,	O	,	_	0	SENT_105	[p8l1944t1687r2137b1769],
11	distinguishing	VBG	O	distinguish	xcomp	3	SENT_105	[p8l9t1798r497b1880],
12	different	JJ	O	different	amod	13	SENT_105	[p8l531t1798r824b1862],
13	roles	NNS	O	role	dobj	11	SENT_105	[p8l853t1798r1018b1862],
14	in	IN	O	in	_	0	SENT_105	[p8l1052t1798r1118b1861],
15	absorption	NN	O	absorption	prep_in	11	SENT_105	[p8l1150t1798r1532b1879],
16	,	,	O	,	_	0	SENT_105	[p8l1150t1798r1532b1879],
17	distribution	NN	O	distribution	conj_and	15	SENT_105	[p8l1568t1798r1982b1875],
18	,	,	O	,	_	0	SENT_105	[p8l1568t1798r1982b1875],
19	and	CC	O	and	_	0	SENT_105	[p8l2018t1798r2143b1862],
20	elimination	NN	O	elimination	prep_in	11	SENT_105	[p8l9t1909r400b1973],
21	of	IN	O	of	_	0	SENT_105	[p8l421t1909r502b1973],
22	levodopa	NN	O	levodopa	prep_of	15	SENT_105	[p8l513t1909r846b1991],
23	.	.	O	.	_	0	SENT_105	[p8l513t1909r846b1991],

1	OCTl	NN	O	octl	nsubjpass	3	SENT_106	[p8l874t1911r1081b1973],
2	is	VBZ	O	be	auxpass	3	SENT_106	[p8l1112t1909r1166b1973],
3	expressed	VBN	O	express	_	0	SENT_106	[p8l1189t1909r1529b1991],
4	in	IN	O	in	_	0	SENT_106	[p8l1550t1909r1617b1972],
5	the	DT	O	the	det	6	SENT_106	[p8l1635t1909r1739b1973],
6	liver	NN	O	liver	prep_in	3	SENT_106	[p8l1762t1909r1932b1987],
7	,	,	O	,	_	0	SENT_106	[p8l1762t1909r1932b1987],
8	small	JJ	O	small	amod	9	SENT_106	[p8l1959t1909r2141b1973],
9	intestine	NN	O	intestine	appos	6	SENT_106	[p8l8t2020r316b2098],
10	,	,	O	,	_	0	SENT_106	[p8l8t2020r316b2098],
11	and	CC	O	and	_	0	SENT_106	[p8l349t2020r492b2098],
12	,	,	O	,	_	0	SENT_106	[p8l349t2020r492b2098],
13	in	IN	O	in	dep	3	SENT_106	[p8l525t2020r589b2083],
14	small	JJ	O	small	amod	15	SENT_106	[p8l621t2020r803b2084],
15	amounts	NNS	O	amount	pobj	13	SENT_106	[p8l834t2029r1145b2098],
16	,	,	O	,	_	0	SENT_106	[p8l834t2029r1145b2098],
17	in	IN	O	in	_	0	SENT_106	[p8l1177t2020r1244b2083],
18	the	DT	O	the	det	22	SENT_106	[p8l1270t2020r1374b2084],
19	brain	NN	O	brain	nn	22	SENT_106	[p8l1403t2020r1581b2084],
20	[	NN	O	[	nn	22	SENT_106	[p8l1615t2022r1725b2101],
21	1	CD	NUMBER	1	num	22	SENT_106	[p8l1615t2022r1725b2101],
22	]	NN	O	]	conj_and	6	SENT_106	[p8l1615t2022r1725b2101],
23	.	.	O	.	_	0	SENT_106	[p8l1615t2022r1725b2101],

1	We	PRP	O	we	nsubj	4	SENT_107	[p8l1763t2023r1876b2084],
2	do	VBP	O	do	aux	4	SENT_107	[p8l1913t2020r1996b2084],
3	not	RB	O	not	neg	4	SENT_107	[p8l2031t2029r2143b2084],
4	know	VB	O	know	_	0	SENT_107	[p8l7t2131r203b2195],
5	the	DT	O	the	det	6	SENT_107	[p8l229t2131r333b2195],
6	location	NN	O	location	dobj	4	SENT_107	[p8l364t2131r641b2195],
7	of	IN	O	of	_	0	SENT_107	[p8l669t2131r750b2195],
8	transporters	NNS	O	transporter	prep_of	6	SENT_107	[p8l766t2140r1171b2213],
9	that	WDT	O	that	nsubj	11	SENT_107	[p8l1200t2131r1331b2195],
10	are	VBP	O	be	cop	11	SENT_107	[p8l1358t2152r1460b2195],
11	responsible	JJ	O	responsible	dep	4	SENT_107	[p8l1488t2131r1881b2213],
12	for	IN	O	for	_	0	SENT_107	[p8l1912t2131r2011b2195],
13	the	DT	O	the	det	15	SENT_107	[p8l2037t2131r2141b2195],
14	observed	VBN	O	observe	amod	15	SENT_107	[p8l9t2242r322b2306],
15	difference	NN	O	difference	prep_for	11	SENT_107	[p8l353t2242r696b2306],
16	and	CC	O	and	_	0	SENT_107	[p8l731t2242r855b2306],
17	why	WRB	O	why	advmod	26	SENT_107	[p8l884t2242r1036b2323],
18	an	DT	O	a	det	19	SENT_107	[p8l1069t2262r1149b2305],
19	effect	NN	O	effect	nsubjpass	26	SENT_107	[p8l1181t2242r1374b2306],
20	on	IN	O	on	_	0	SENT_107	[p8l1404t2262r1491b2306],
21	OCT1	NN	O	oct1	nn	23	SENT_107	[p8l1522t2243r1730b2306],
22	transporter	NN	O	transporter	nn	23	SENT_107	[p8l1770t2250r2145b2323],
23	capacity	NN	O	capacity	prep_on	19	SENT_107	[p8l9t2353r295b2434],
24	is	VBZ	O	be	auxpass	26	SENT_107	[p8l332t2353r386b2417],
25	not	RB	O	not	neg	26	SENT_107	[p8l423t2361r536b2417],
26	compensated	VBN	O	compensate	conj_and	11	SENT_107	[p8l573t2353r1025b2434],
27	for	IN	O	for	prep	26	SENT_107	[p8l1063t2353r1162b2417],
28	by	IN	O	by	pcomp	27	SENT_107	[p8l1196t2353r1285b2434],
29	other	JJ	O	other	amod	30	SENT_107	[p8l1323t2353r1500b2417],
30	transporters	NNS	O	transporter	pobj	28	SENT_107	[p8l1534t2361r1956b2434],
31	.	.	O	.	_	0	SENT_107	[p8l1534t2361r1956b2434],

1	It	PRP	O	it	nsubj	3	SENT_108	[p8l1999t2355r2051b2416],
2	is	VBZ	O	be	cop	3	SENT_108	[p8l2087t2353r2140b2417],
3	possible	JJ	O	possible	_	0	SENT_108	[p8l6t2464r290b2546],
4	that	IN	O	that	complm	9	SENT_108	[p8l319t2464r450b2528],
5	the	DT	O	the	det	8	SENT_108	[p8l477t2464r581b2528],
6	rs622342	NN	O	rs622342	nn	8	SENT_108	[p8l611t2466r933b2528],
7	C	NN	O	c	nn	8	SENT_108	[p8l967t2465r1021b2528],
8	allele	NN	O	allele	nsubj	9	SENT_108	[p8l1055t2464r1237b2528],
9	results	VBZ	O	result	ccomp	3	SENT_108	[p8l1266t2464r1488b2528],
10	in	IN	O	in	_	0	SENT_108	[p8l1521t2464r1587b2527],
11	a	DT	O	a	det	15	SENT_108	[p8l1618t2485r1655b2528],
12	reduced	VBN	O	reduce	amod	15	SENT_108	[p8l1682t2464r1957b2528],
13	antiParkinson	NN	O	antiparkinson	nn	15	SENT_108	[p8l1988t2464r2140b2528, p8l7t2575r355b2639],
14	drug	NN	O	drug	nn	15	SENT_108	[p8l383t2575r539b2657],
15	uptake	NN	O	uptake	prep_in	9	SENT_108	[p8l566t2575r798b2657],
16	from	IN	O	from	_	0	SENT_108	[p8l827t2575r994b2639],
17	the	DT	O	the	det	19	SENT_108	[p8l1019t2575r1123b2639],
18	small	JJ	O	small	amod	19	SENT_108	[p8l1155t2575r1337b2639],
19	intestine	NN	O	intestine	prep_from	15	SENT_108	[p8l1366t2575r1654b2639],
20	resulting	VBG	O	result	partmod	19	SENT_108	[p8l1682t2575r1983b2657],
21	in	IN	O	in	_	0	SENT_108	[p8l2012t2575r2078b2638],
22	a	DT	O	a	det	25	SENT_108	[p8l2106t2596r2143b2639],
23	decreased	VBN	O	decrease	amod	25	SENT_108	[p8l9t2686r348b2750],
24	biological	JJ	O	biological	amod	25	SENT_108	[p8l394t2686r740b2768],
25	availability	NN	O	availability	prep_in	20	SENT_108	[p8l790t2686r1175b2768],
26	[	CD	NUMBER	[	num	28	SENT_108	[p8l1228t2687r1381b2766],
27	12	CD	NUMBER	12	num	28	SENT_108	[p8l1228t2687r1381b2766],
28	]	NN	O	]	dep	25	SENT_108	[p8l1228t2687r1381b2766],
29	.	.	O	.	_	0	SENT_108	[p8l1228t2687r1381b2766],

1	However	RB	O	however	advmod	6	SENT_109	[p8l1434t2688r1768b2763],
2	,	,	O	,	_	0	SENT_109	[p8l1434t2688r1768b2763],
3	OCTl	NN	O	octl	nsubjpass	6	SENT_109	[p8l1821t2687r2027b2750],
4	is	VBZ	O	be	auxpass	6	SENT_109	[p8l2087t2686r2140b2750],
5	also	RB	O	also	advmod	6	SENT_109	[p8l9t2798r144b2862],
6	located	VBN	O	locate	_	0	SENT_109	[p8l181t2798r429b2862],
7	in	IN	O	in	_	0	SENT_109	[p8l464t2798r530b2861],
8	small	JJ	O	small	amod	9	SENT_109	[p8l566t2798r749b2862],
9	amounts	NNS	O	amount	prep_in	6	SENT_109	[p8l785t2807r1075b2862],
10	in	IN	O	in	_	0	SENT_109	[p8l1113t2798r1179b2861],
11	the	DT	O	the	det	12	SENT_109	[p8l1211t2798r1316b2862],
12	brains	NNS	O	brain	prep_in	9	SENT_109	[p8l1350t2798r1578b2876],
13	,	,	O	,	_	0	SENT_109	[p8l1350t2798r1578b2876],
14	and	CC	O	and	_	0	SENT_109	[p8l1619t2798r1743b2862],
15	we	PRP	O	we	nsubj	18	SENT_109	[p8l1775t2819r1876b2862],
16	can	MD	O	can	aux	18	SENT_109	[p8l1913t2808r2144b2862],
17	not	RB	O	not	neg	18	SENT_109	[p8l1913t2808r2144b2862],
18	exclude	VB	O	exclude	conj_and	6	SENT_109	[p8l9t2909r275b2973],
19	that	IN	O	that	complm	22	SENT_109	[p8l326t2909r456b2973],
20	these	DT	O	these	det	21	SENT_109	[p8l503t2909r680b2973],
21	transporters	NNS	O	transporter	nsubj	22	SENT_109	[p8l730t2918r1135b2991],
22	are	VBP	O	be	ccomp	18	SENT_109	[p8l1188t2930r1289b2973],
23	for	IN	O	for	_	0	SENT_109	[p8l1342t2909r1441b2973],
24	example	NN	O	example	prep_for	22	SENT_109	[p8l1491t2909r1781b2991],
25	the	DT	O	the	det	27	SENT_109	[p8l1832t2909r1936b2973],
26	ratelimiting	JJ	O	ratelimiting	amod	27	SENT_109	[p8l1986t2918r2140b2973, p8l9t3020r279b3102],
27	step	NN	O	step	nsubj	48	SENT_109	[p8l313t3029r447b3102],
28	for	IN	O	for	_	0	SENT_109	[p8l482t3020r581b3084],
29	uptake	NN	O	uptake	prep_for	27	SENT_109	[p8l609t3020r840b3102],
30	of	IN	O	of	_	0	SENT_109	[p8l873t3020r954b3084],
31	anti-Parkinson	JJ	O	anti-parkinson	amod	32	SENT_109	[p8l976t3020r1478b3084],
32	drugs	NNS	O	drug	prep_of	29	SENT_109	[p8l1510t3020r1699b3102],
33	in	IN	O	in	_	0	SENT_109	[p8l1734t3020r1800b3083],
34	the	DT	O	the	det	35	SENT_109	[p8l1829t3020r1933b3084],
35	brain	NN	O	brain	prep_in	32	SENT_109	[p8l1964t3020r2142b3084],
36	and	CC	O	and	_	0	SENT_109	[p8l9t3131r133b3195],
37	responsible	JJ	O	responsible	amod	44	SENT_109	[p8l180t3131r572b3212],
38	for	IN	O	for	_	0	SENT_109	[p8l624t3131r723b3195],
39	the	DT	O	the	det	40	SENT_109	[p8l768t3131r873b3195],
40	difference	NN	O	difference	prep_for	37	SENT_109	[p8l924t3131r1267b3195],
41	in	IN	O	in	_	0	SENT_109	[p8l1318t3131r1384b3193],
42	anti-Parkinson	JJ	MISC	anti-parkinson	amod	43	SENT_109	[p8l1434t3131r1936b3195],
43	drug	NN	O	drug	prep_in	40	SENT_109	[p8l1985t3131r2142b3212],
44	response	NN	O	response	conj_and	32	SENT_109	[p8l6t3262r309b3323],
45	between	IN	O	between	_	0	SENT_109	[p8l339t3242r630b3306],
46	rs622342	NN	O	rs622342	nn	47	SENT_109	[p8l658t3243r981b3306],
47	genotypes	NNS	O	genotype	prep_between	44	SENT_109	[p8l1015t3250r1364b3323],
48	[	VBP	O	[	rcmod	24	SENT_109	[p8l1402t3243r1512b3322],
49	1	CD	NUMBER	1	number	50	SENT_109	[p8l1402t3243r1512b3322],
50	]	CD	NUMBER	]	dobj	48	SENT_109	[p8l1402t3243r1512b3322],
51	.	.	O	.	_	0	SENT_109	[p8l1402t3243r1512b3322],

1	The	DT	O	the	det	3	SENT_110	[p8l110t3353r242b3417],
2	rs622342	NN	O	rs622342	nn	3	SENT_110	[p8l264t3354r586b3417],
3	polymorphism	NN	O	polymorphism	nsubj	5	SENT_110	[p8l608t3353r1118b3434],
4	is	VBZ	O	be	cop	5	SENT_110	[p8l1139t3353r1192b3417],
5	located	JJ	O	located	_	0	SENT_110	[p8l1216t3353r1464b3417],
6	in	IN	O	in	_	0	SENT_110	[p8l1485t3353r1551b3416],
7	an	DT	O	a	det	9	SENT_110	[p8l1573t3373r1654b3416],
8	intron	NN	O	intron	nn	9	SENT_110	[p8l1675t3353r1880b3417],
9	region	NN	O	region	prep_in	5	SENT_110	[p8l1899t3353r2138b3434],
10	,	,	O	,	_	0	SENT_110	[p8l1899t3353r2138b3434],
11	not	RB	O	not	neg	12	SENT_110	[p8l6t3473r120b3528],
12	coding	VBG	O	code	xcomp	5	SENT_110	[p8l173t3464r410b3546],
13	for	IN	O	for	_	0	SENT_110	[p8l465t3464r565b3528],
14	an	DT	O	a	det	16	SENT_110	[p8l617t3485r697b3528],
15	amino-acid	JJ	O	amino-acid	amod	16	SENT_110	[p8l752t3464r1144b3528],
16	change	NN	O	change	prep_for	12	SENT_110	[p8l1197t3464r1460b3546],
17	.	.	O	.	_	0	SENT_110	[p8l1197t3464r1460b3546],

1	Most	RBS	O	most	advmod	2	SENT_111	[p8l1518t3467r1699b3528],
2	likely	RB	O	likely	advmod	6	SENT_111	[p8l1752t3464r1960b3546],
3	,	,	O	,	_	0	SENT_111	[p8l1752t3464r1960b3546],
4	this	DT	O	this	det	5	SENT_111	[p8l2016t3464r2140b3528],
5	polymorphism	NN	O	polymorphism	nsubj	6	SENT_111	[p8l6t3575r515b3657],
6	is	VBZ	O	be	_	0	SENT_111	[p8l545t3575r599b3639],
7	in	IN	O	in	_	0	SENT_111	[p8l631t3575r697b3638],
8	linkage	NN	O	linkage	nn	9	SENT_111	[p8l727t3575r979b3657],
9	disequilibrium	NN	O	disequilibrium	prep_in	6	SENT_111	[p8l1011t3575r1515b3657],
10	with	IN	O	with	_	0	SENT_111	[p8l1541t3575r1697b3639],
11	a	DT	O	a	det	13	SENT_111	[p8l1727t3596r1764b3639],
12	functional	JJ	O	functional	amod	13	SENT_111	[p8l1795t3575r2142b3639],
13	polymorphism	NN	O	polymorphism	prep_with	9	SENT_111	[p8l6t3686r533b3768],
14	,	,	O	,	_	0	SENT_111	[p8l6t3686r533b3768],
15	although	IN	O	although	mark	19	SENT_111	[p8l558t3686r861b3768],
16	we	PRP	O	we	nsubj	19	SENT_111	[p8l879t3707r980b3750],
17	can	MD	O	can	aux	19	SENT_111	[p8l1002t3695r1234b3750],
18	not	RB	O	not	neg	19	SENT_111	[p8l1002t3695r1234b3750],
19	exclude	VB	O	exclude	advcl	6	SENT_111	[p8l1253t3686r1520b3750],
20	that	IN	O	that	complm	22	SENT_111	[p8l1540t3686r1671b3749],
21	it	PRP	O	it	nsubj	22	SENT_111	[p8l1690t3686r1737b3749],
22	has	VBZ	O	have	ccomp	19	SENT_111	[p8l1754t3686r1868b3750],
23	a	DT	O	a	det	25	SENT_111	[p8l1891t3707r1928b3749],
24	direct	JJ	O	direct	amod	25	SENT_111	[p8l1949t3686r2144b3750],
25	effect	NN	O	effect	dobj	22	SENT_111	[p9l9t21r217b99],
26	,	,	O	,	_	0	SENT_111	[p9l9t21r217b99],
27	for	IN	O	for	_	0	SENT_111	[p9l248t22r347b85],
28	example	NN	O	example	prep_for	25	SENT_111	[p9l372t21r682b103],
29	,	,	O	,	_	0	SENT_111	[p9l372t21r682b103],
30	by	IN	O	by	_	0	SENT_111	[p9l709t21r798b103],
31	affecting	VBG	O	affect	prepc_by	25	SENT_111	[p9l824t21r1125b103],
32	gene	NN	O	gene	nn	33	SENT_111	[p9l1152t42r1313b103],
33	expression	NN	O	expression	dobj	31	SENT_111	[p9l1341t21r1725b103],
34	.	.	O	.	_	0	SENT_111	[p9l1341t21r1725b103],

1	In	IN	O	in	_	0	SENT_112	[p9l110t135r181b195],
2	population-based	JJ	O	population-based	amod	3	SENT_112	[p9l205t132r818b214],
3	studies	NNS	O	study	prep_in	7	SENT_112	[p9l847t132r1106b209],
4	,	,	O	,	_	0	SENT_112	[p9l847t132r1106b209],
5	bias	NN	O	bias	nsubj	7	SENT_112	[p9l1136t132r1276b196],
6	may	MD	O	may	aux	7	SENT_112	[p9l1304t153r1455b214],
7	affect	VB	O	affect	_	0	SENT_112	[p9l1483t132r1680b196],
8	the	DT	O	the	det	10	SENT_112	[p9l1705t132r1810b196],
9	obtained	VBN	O	obtain	amod	10	SENT_112	[p9l1839t132r2142b196],
10	results	NNS	O	result	dobj	7	SENT_112	[p9l6t243r252b307],
11	.	.	O	.	_	0	SENT_112	[p9l6t243r252b307],

1	We	PRP	O	we	nsubj	2	SENT_113	[p9l296t246r410b307],
2	believe	VBP	O	believe	_	0	SENT_113	[p9l448t243r701b307],
3	that	IN	O	that	complm	9	SENT_113	[p9l741t243r873b307],
4	bias	NN	O	bias	nsubj	9	SENT_113	[p9l909t243r1049b307],
5	in	IN	O	in	_	0	SENT_113	[p9l1090t243r1157b306],
6	our	PRP$	O	we	poss	7	SENT_113	[p9l1196t264r1313b307],
7	study	NN	O	study	prep_in	4	SENT_113	[p9l1352t243r1540b325],
8	is	VBZ	O	be	cop	9	SENT_113	[p9l1580t243r1633b307],
9	minimal	JJ	O	minimal	ccomp	2	SENT_113	[p9l1673t243r1983b307],
10	.	.	O	.	_	0	SENT_113	[p9l1673t243r1983b307],

1	We	PRP	O	we	nsubj	2	SENT_114	[p9l2027t246r2141b307],
2	identiﬁed	VBD	O	identiﬁed	_	0	SENT_114	[p9l8t354r345b418],
3	all	DT	O	all	det	6	SENT_114	[p9l400t354r483b417],
4	incident	NN	O	incident	nn	6	SENT_114	[p9l539t354r823b418],
5	levodopa	NN	O	levodopa	nn	6	SENT_114	[p9l877t354r1201b435],
6	users	NNS	O	user	dobj	2	SENT_114	[p9l1253t374r1432b418],
7	in	IN	O	in	_	0	SENT_114	[p9l1489t354r1556b416],
8	the	DT	O	the	det	10	SENT_114	[p9l1608t354r1714b417],
9	Rotterdam	NNP	LOCATION	Rotterdam	nn	10	SENT_114	[p9l1770t354r2142b418],
10	Study	NNP	O	Study	prep_in	2	SENT_114	[p9l11t465r227b546],
11	,	,	O	,	_	0	SENT_114	[p9l11t465r227b546],
12	and	CC	O	and	_	0	SENT_114	[p9l257t465r384b529],
13	information	NN	O	information	nsubjpass	15	SENT_114	[p9l410t465r824b529],
14	was	VBD	O	be	auxpass	15	SENT_114	[p9l849t485r984b529],
15	collected	VBN	O	collect	conj_and	2	SENT_114	[p9l1013t465r1329b529],
16	prospectively	RB	O	prospectively	advmod	15	SENT_114	[p9l1352t465r1843b546],
17	,	,	O	,	_	0	SENT_114	[p9l1352t465r1843b546],
18	without	IN	O	without	_	0	SENT_114	[p9l1871t465r2143b529],
19	prior	JJ	O	prior	amod	20	SENT_114	[p9l6t576r179b657],
20	knowledge	NN	O	knowledge	prep_without	15	SENT_114	[p9l209t576r597b657],
21	of	IN	O	of	_	0	SENT_114	[p9l632t576r714b640],
22	the	DT	O	the	det	24	SENT_114	[p9l735t576r841b640],
23	study	NN	O	study	nn	24	SENT_114	[p9l877t576r1066b657],
24	hypothesis	NN	O	hypothesis	prep_of	20	SENT_114	[p9l1098t576r1496b657],
25	,	,	O	,	_	0	SENT_114	[p9l1098t576r1496b657],
26	making	VBG	O	make	xcomp	15	SENT_114	[p9l1531t576r1796b657],
27	selection	NN	O	selection	nn	30	SENT_114	[p9l1832t576r2142b640],
28	and	CC	O	and	_	0	SENT_114	[p9l9t687r138b751],
29	information	NN	O	information	nn	30	SENT_114	[p9l199t687r629b751],
30	bias	NN	O	bias	nsubj	31	SENT_114	[p9l689t687r833b751],
31	unlikely	JJ	O	unlikely	xcomp	26	SENT_114	[p9l895t687r1209b769],
32	.	.	O	.	_	0	SENT_114	[p9l895t687r1209b769],

1	We	PRP	O	we	nsubj	4	SENT_115	[p9l1275t690r1391b751],
2	did	VBD	O	do	aux	4	SENT_115	[p9l1455t687r1569b751],
3	not	RB	O	not	neg	4	SENT_115	[p9l1629t696r1746b751],
4	ﬁnd	VB	O	ﬁnd	_	0	SENT_115	[p9l1807t687r1952b751],
5	any	DT	O	any	det	6	SENT_115	[p9l2014t708r2142b769],
6	difference	NN	O	difference	dobj	4	SENT_115	[p9l9t798r360b862],
7	in	IN	O	in	_	0	SENT_115	[p9l402t798r468b861],
8	time	NN	O	time	prep_in	6	SENT_115	[p9l506t798r660b862],
9	to	TO	O	to	_	0	SENT_115	[p9l699t807r764b862],
10	levodopa	NN	O	levodopa	nn	11	SENT_115	[p9l807t798r1131b880],
11	therapy	NN	O	therapy	prep_to	4	SENT_115	[p9l1168t798r1445b880],
12	,	,	O	,	_	0	SENT_115	[p9l1168t798r1445b880],
13	prior	RB	O	prior	advmod	14	SENT_115	[p9l1486t798r1660b880],
14	use	NN	O	use	appos	11	SENT_115	[p9l1695t819r1811b862],
15	of	IN	O	of	_	0	SENT_115	[p9l1853t798r1934b862],
16	other	JJ	O	other	amod	18	SENT_115	[p9l1963t798r2143b862],
17	anti-Parkinson	JJ	O	anti-parkinson	amod	18	SENT_115	[p9l9t909r522b973],
18	medication	NN	O	medication	prep_of	14	SENT_115	[p9l578t909r989b986],
19	,	,	O	,	_	0	SENT_115	[p9l578t909r989b986],
20	or	CC	O	or	_	0	SENT_115	[p9l1051t929r1124b973],
21	prescribed	VBN	O	prescribe	conj_or	4	SENT_115	[p9l1176t909r1545b990],
22	doses	NNS	O	dose	dobj	21	SENT_115	[p9l1603t909r1795b973],
23	of	IN	O	of	_	0	SENT_115	[p9l1855t909r1937b973],
24	antiParkinson	NN	O	antiparkinson	nn	25	SENT_115	[p9l1984t909r2140b972, p9l7t1020r361b1084],
25	drugs	NNS	O	drug	prep_of	22	SENT_115	[p9l411t1020r603b1102],
26	at	IN	O	at	_	0	SENT_115	[p9l655t1029r716b1084],
27	start	NN	O	start	prep_at	21	SENT_115	[p9l765t1029r914b1084],
28	of	IN	O	of	_	0	SENT_115	[p9l962t1020r1043b1084],
29	levodopa	NN	O	levodopa	nn	30	SENT_115	[p9l1082t1020r1406b1102],
30	therapy	NN	O	therapy	prep_of	27	SENT_115	[p9l1452t1020r1730b1102],
31	,	,	O	,	_	0	SENT_115	[p9l1452t1020r1730b1102],
32	making	VBG	O	make	partmod	21	SENT_115	[p9l1781t1020r2046b1102],
33	it	PRP	O	it	nsubj	34	SENT_115	[p9l2097t1020r2143b1084],
34	unlikely	JJ	O	unlikely	xcomp	32	SENT_115	[p9l6t1131r308b1213],
35	that	IN	O	that	complm	39	SENT_115	[p9l367t1131r505b1195],
36	the	DT	O	the	det	38	SENT_115	[p9l564t1131r673b1195],
37	rs622342	NN	O	rs622342	nn	38	SENT_115	[p9l734t1133r1072b1195],
38	polymorphism	NN	O	polymorphism	nsubj	39	SENT_115	[p9l1135t1131r1671b1213],
39	affects	VBZ	O	affect	ccomp	32	SENT_115	[p9l1733t1131r1969b1195],
40	the	DT	O	the	det	41	SENT_115	[p9l2031t1131r2140b1195],
41	progression	NN	O	progression	dobj	39	SENT_115	[p9l6t1242r431b1324],
42	to	TO	O	to	_	0	SENT_115	[p9l490t1251r557b1306],
43	Parkinson	NNP	O	Parkinson	poss	45	SENT_115	[p9l620t1242r1041b1306],
44	’s	POS	O	’s	_	0	SENT_115	[p9l620t1242r1041b1306],
45	disease	NN	O	disease	prep_to	39	SENT_115	[p9l1104t1242r1381b1306],
46	.	.	O	.	_	0	SENT_115	[p9l1104t1242r1381b1306],

1	We	PRP	O	we	nsubj	4	SENT_116	[p9l1447t1245r1562b1306],
2	did	VBD	O	do	aux	4	SENT_116	[p9l1625t1242r1739b1306],
3	not	RB	O	not	neg	4	SENT_116	[p9l1797t1251r1914b1306],
4	have	VB	O	have	_	0	SENT_116	[p9l1972t1242r2140b1306],
5	information	NN	O	information	dobj	4	SENT_116	[p9l8t1353r424b1417],
6	on	IN	O	on	_	0	SENT_116	[p9l467t1373r553b1417],
7	the	DT	O	the	det	8	SENT_116	[p9l595t1353r701b1417],
8	indication	NN	O	indication	prep_on	5	SENT_116	[p9l746t1353r1097b1417],
9	of	IN	O	of	_	0	SENT_116	[p9l1141t1353r1222b1417],
10	levodopa	NN	O	levodopa	nn	11	SENT_116	[p9l1255t1353r1579b1434],
11	use	NN	O	use	prep_of	8	SENT_116	[p9l1619t1373r1757b1430],
12	;	:	O	;	_	0	SENT_116	[p9l1619t1373r1757b1430],
13	therefore	RB	O	therefore	advmod	18	SENT_116	[p9l1803t1353r2137b1430],
14	,	,	O	,	_	0	SENT_116	[p9l1803t1353r2137b1430],
15	we	PRP	O	we	nsubj	18	SENT_116	[p9l6t1484r107b1528],
16	can	MD	O	can	aux	18	SENT_116	[p9l142t1472r377b1528],
17	not	RB	O	not	neg	18	SENT_116	[p9l142t1472r377b1528],
18	stratify	VB	O	stratify	parataxis	4	SENT_116	[p9l410t1464r654b1545],
19	on	IN	O	on	_	0	SENT_116	[p9l687t1484r774b1528],
20	these	DT	O	these	det	21	SENT_116	[p9l804t1464r983b1528],
21	indications	NNS	O	indication	prep_on	18	SENT_116	[p9l1017t1464r1420b1528],
22	.	.	O	.	_	0	SENT_116	[p9l1017t1464r1420b1528],

1	Nine	CD	NUMBER	nine	num	2	SENT_117	[p9l106t1575r279b1638],
2	participants	NNS	O	participant	nsubj	10	SENT_117	[p9l303t1575r713b1656],
3	were	VBD	O	be	auxpass	4	SENT_117	[p9l739t1595r909b1639],
4	prescribed	VBN	O	prescribe	_	0	SENT_117	[p9l933t1575r1303b1656],
5	dopamine	NN	O	dopamine	nn	6	SENT_117	[p9l1328t1575r1674b1656],
6	agonists	NNS	O	agonist	dobj	4	SENT_117	[p9l1702t1575r1988b1656],
7	and	CC	O	and	_	0	SENT_117	[p9l2017t1575r2143b1639],
8	did	VBD	O	do	aux	10	SENT_117	[p9l9t1686r120b1750],
9	not	RB	O	not	neg	10	SENT_117	[p9l144t1695r258b1750],
10	receive	VB	O	receive	conj_and	4	SENT_117	[p9l280t1686r533b1750],
11	prescriptions	NNS	O	prescription	dobj	10	SENT_117	[p9l558t1686r1013b1768],
12	for	IN	O	for	_	0	SENT_117	[p9l1042t1686r1143b1750],
13	levodopa	NN	O	levodopa	prep_for	11	SENT_117	[p9l1168t1686r1492b1768],
14	during	IN	O	during	_	0	SENT_117	[p9l1518t1686r1745b1768],
15	follow-up	NN	O	follow-up	prep_during	10	SENT_117	[p9l1773t1686r2136b1768],
16	.	.	O	.	_	0	SENT_117	[p9l1773t1686r2136b1768],

1	These	DT	O	these	det	2	SENT_118	[p9l8t1797r216b1861],
2	participants	NNS	O	participant	nsubjpass	5	SENT_118	[p9l247t1797r657b1879],
3	were	VBD	O	be	auxpass	5	SENT_118	[p9l689t1818r858b1861],
4	not	RB	O	not	neg	5	SENT_118	[p9l890t1806r1003b1861],
5	included	VBN	O	include	_	0	SENT_118	[p9l1034t1797r1338b1861],
6	in	IN	O	in	_	0	SENT_118	[p9l1370t1797r1436b1860],
7	this	DT	O	this	det	8	SENT_118	[p9l1466t1797r1590b1861],
8	study	NN	O	study	prep_in	5	SENT_118	[p9l1626t1797r1828b1879],
9	,	,	O	,	_	0	SENT_118	[p9l1626t1797r1828b1879],
10	because	IN	O	because	prep	5	SENT_118	[p9l1862t1797r2140b1861],

1	‘	NN	O	‘	dep	3	SENT_119	[p9l1803t2031r1875b2121],
2	@	SYM	O	@	dep	3	SENT_119	[p9l1803t2031r1875b2121],
3	Springer	NNP	PERSON	Springer	_	0	SENT_119	[p9l1901t2054r2146b2124],

1	82	CD	NUMBER	82	num	3	SENT_120	[p9l54t2200r86b2224],
2	Neuro	NNP	O	Neuro	nn	3	SENT_120	[p9l1656t2200r1743b2224],
3	genetics	NNS	O	genetics	nsubj	4	SENT_120	[p9l1745t2199r1858b2231],
4	(	VBP	O	(	_	0	SENT_120	[p9l1872t2199r1962b2231],
5	2011	CD	DATE	2011	num	6	SENT_120	[p9l1872t2199r1962b2231],
6	)	CD	NUMBER	)	dobj	4	SENT_120	[p9l1872t2199r1962b2231],
7	12:79	CD	NUMBER	12:79	num	8	SENT_120	[p9l1979t2199r2106b2224],
8	-82	CD	NUMBER	-82	dep	6	SENT_120	[p9l1979t2199r2106b2224],

1	we	PRP	O	we	nsubj	4	SENT_121	[p9l6t2393r109b2436],
2	can	MD	O	can	aux	4	SENT_121	[p9l173t2381r416b2436],
3	not	RB	O	not	neg	4	SENT_121	[p9l173t2381r416b2436],
4	exclude	VB	O	exclude	_	0	SENT_121	[p9l477t2372r757b2436],
5	that	IN	O	that	complm	10	SENT_121	[p9l819t2372r956b2435],
6	the	DT	O	the	det	8	SENT_121	[p9l1015t2372r1124b2436],
7	dopamine	NN	O	dopamine	nn	8	SENT_121	[p9l1188t2372r1545b2454],
8	agonists	NNS	O	agonist	nsubjpass	10	SENT_121	[p9l1608t2372r1904b2454],
9	were	VBD	O	be	auxpass	10	SENT_121	[p9l1967t2392r2140b2436],
10	prescribed	VBN	O	prescribe	ccomp	4	SENT_121	[p9l6t2483r375b2565],
11	for	IN	O	for	_	0	SENT_121	[p9l407t2483r508b2547],
12	other	JJ	O	other	amod	13	SENT_121	[p9l539t2483r719b2547],
13	indications	NNS	O	indication	prep_for	10	SENT_121	[p9l750t2483r1153b2547],
14	.	.	O	.	_	0	SENT_121	[p9l750t2483r1153b2547],

1	The	DT	O	the	det	2	SENT_122	[p9l110t2594r244b2658],
2	number	NN	O	number	nsubjpass	9	SENT_122	[p9l288t2594r561b2658],
3	of	IN	O	of	_	0	SENT_122	[p9l605t2594r685b2658],
4	participants	NNS	O	participant	prep_of	2	SENT_122	[p9l717t2594r1127b2676],
5	in	IN	O	in	_	0	SENT_122	[p9l1174t2594r1241b2657],
6	this	DT	O	this	det	7	SENT_122	[p9l1284t2594r1408b2658],
7	study	NN	O	study	prep_in	4	SENT_122	[p9l1457t2594r1645b2676],
8	was	VBD	O	be	auxpass	9	SENT_122	[p9l1689t2615r1824b2658],
9	limited	VBN	O	limit	_	0	SENT_122	[p9l1871t2594r2137b2672],
10	;	:	O	;	_	0	SENT_122	[p9l1871t2594r2137b2672],
11	therefore	RB	O	therefore	advmod	16	SENT_122	[p9l7t2706r342b2784],
12	,	,	O	,	_	0	SENT_122	[p9l7t2706r342b2784],
13	we	PRP	O	we	nsubj	16	SENT_122	[p9l379t2727r481b2770],
14	can	MD	O	can	aux	16	SENT_122	[p9l518t2715r752b2770],
15	not	RB	O	not	neg	16	SENT_122	[p9l518t2715r752b2770],
16	exclude	VB	O	exclude	parataxis	9	SENT_122	[p9l788t2706r1059b2770],
17	that	IN	O	that	complm	23	SENT_122	[p9l1093t2706r1226b2770],
18	our	PRP$	O	we	poss	19	SENT_122	[p9l1261t2727r1378b2770],
19	results	NNS	O	result	nsubj	23	SENT_122	[p9l1409t2706r1636b2770],
20	were	VBD	O	be	cop	23	SENT_122	[p9l1672t2727r1842b2770],
21	a	DT	O	a	det	23	SENT_122	[p9l1879t2727r1916b2770],
22	falsepositive	JJ	O	falsepositive	amod	23	SENT_122	[p9l1951t2706r2139b2770, p9l6t2817r284b2898],
23	ﬁnding	NN	O	ﬁnding	ccomp	16	SENT_122	[p9l321t2817r593b2898],
24	,	,	O	,	_	0	SENT_122	[p9l321t2817r593b2898],
25	and	CC	O	and	_	0	SENT_122	[p9l631t2817r757b2881],
26	replication	NN	O	replication	nsubjpass	34	SENT_122	[p9l788t2817r1166b2898],
27	of	IN	O	of	_	0	SENT_122	[p9l1200t2817r1281b2881],
28	these	DT	O	these	det	29	SENT_122	[p9l1302t2817r1481b2881],
29	results	NNS	O	result	prep_of	26	SENT_122	[p9l1515t2817r1743b2881],
30	in	IN	O	in	_	0	SENT_122	[p9l1779t2817r1845b2879],
31	another	DT	O	another	det	32	SENT_122	[p9l1879t2817r2144b2881],
32	cohort	NN	O	cohort	prep_in	29	SENT_122	[p9l9t2929r233b2993],
33	is	VBZ	O	be	auxpass	34	SENT_122	[p9l265t2929r318b2993],
34	indicated	VBN	O	indicate	conj_and	16	SENT_122	[p9l353t2929r691b2993],
35	.	.	O	.	_	0	SENT_122	[p9l353t2929r691b2993],

1	To	TO	O	to	aux	2	SENT_123	[p9l110t3042r198b3104],
2	conclude	VB	O	conclude	purpcl	25	SENT_123	[p9l243t3040r572b3117],
3	,	,	O	,	_	0	SENT_123	[p9l243t3040r572b3117],
4	in	IN	O	in	_	0	SENT_123	[p9l619t3040r685b3102],
5	this	DT	O	this	det	8	SENT_123	[p9l725t3040r848b3104],
6	population-based	JJ	O	population-based	amod	8	SENT_123	[p9l889t3040r1490b3121],
7	cohort	NN	O	cohort	nn	8	SENT_123	[p9l1531t3040r1752b3104],
8	study	NN	O	study	prep_in	2	SENT_123	[p9l1794t3040r1992b3121],
9	,	,	O	,	_	0	SENT_123	[p9l1794t3040r1992b3121],
10	the	DT	O	the	det	15	SENT_123	[p9l2037t3040r2141b3104],
11	rs622342	NN	O	rs622342	nn	15	SENT_123	[p9l6t3153r331b3215],
12	minor	JJ	O	minor	dep	13	SENT_123	[p9l385t3151r596b3215],
13	C	NN	O	c	amod	15	SENT_123	[p9l647t3152r701b3215],
14	variant	JJ	O	variant	amod	15	SENT_123	[p9l755t3151r997b3215],
15	allele	NN	O	allele	nsubjpass	25	SENT_123	[p9l1049t3151r1232b3215],
16	in	IN	O	in	_	0	SENT_123	[p9l1286t3151r1352b3214],
17	the	DT	O	the	det	19	SENT_123	[p9l1403t3151r1508b3215],
18	SLC22AI	NN	O	slc22aus	nn	19	SENT_123	[p9l1561t3152r1891b3215],
19	gene	NN	O	gene	prep_in	15	SENT_123	[p9l1957t3172r2139b3233],
20	,	,	O	,	_	0	SENT_123	[p9l1957t3172r2139b3233],
21	encoding	VBG	O	encode	partmod	25	SENT_123	[p9l9t3262r327b3344],
22	OCTI	NNP	O	OCTI	dobj	21	SENT_123	[p9l387t3263r622b3340],
23	,	,	O	,	_	0	SENT_123	[p9l387t3263r622b3340],
24	was	VBD	O	be	auxpass	25	SENT_123	[p9l683t3283r817b3326],
25	associated	VBN	O	associate	_	0	SENT_123	[p9l878t3262r1234b3326],
26	with	IN	O	with	_	0	SENT_123	[p9l1289t3262r1444b3326],
27	higher	JJR	O	higher	amod	29	SENT_123	[p9l1501t3262r1726b3344],
28	prescribed	JJ	O	prescribed	amod	29	SENT_123	[p9l1779t3262r2143b3344],
29	doses	NNS	O	dose	prep_with	25	SENT_123	[p9l9t3373r198b3437],
30	of	IN	O	of	_	0	SENT_123	[p9l241t3373r322b3437],
31	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	32	SENT_123	[p9l351t3373r959b3437],
32	drugs	NNS	O	drug	prep_of	29	SENT_123	[p9l1000t3373r1188b3455],
33	and	CC	O	and	_	0	SENT_123	[p9l1232t3373r1356b3437],
34	shorter	JJR	O	shorter	amod	36	SENT_123	[p9l1398t3373r1635b3437],
35	survival	NN	O	survival	nn	36	SENT_123	[p9l1676t3373r1950b3437],
36	time	NN	O	time	prep_of	29	SENT_123	[p9l1989t3373r2141b3437],
37	after	IN	O	after	_	0	SENT_123	[p9l9t3484r165b3548],
38	start	NN	O	start	prep_after	25	SENT_123	[p9l192t3493r336b3548],
39	of	IN	O	of	_	0	SENT_123	[p9l362t3484r443b3548],
40	levodopa	NN	O	levodopa	nn	41	SENT_123	[p9l459t3484r778b3566],
41	therapy	NN	O	therapy	prep_of	38	SENT_123	[p9l802t3484r1072b3566],
42	.	.	O	.	_	0	SENT_123	[p9l802t3484r1072b3566],

1	A	DT	O	a	det	3	SENT_124	[p9l1103t3486r1166b3547],
2	possible	JJ	O	possible	amod	3	SENT_124	[p9l1190t3484r1475b3566],
3	explanation	NN	O	explanation	nsubj	4	SENT_124	[p9l1504t3484r1905b3566],
4	is	VBZ	O	be	_	0	SENT_124	[p9l1933t3484r1986b3548],
5	that	IN	O	that	complm	10	SENT_124	[p9l2013t3484r2144b3548],
6	this	DT	O	this	det	8	SENT_124	[p9l7t3595r129b3659],
7	Variant	JJ	O	variant	amod	8	SENT_124	[p9l164t3595r404b3659],
8	allele	NN	O	allele	nsubjpass	10	SENT_124	[p9l438t3595r620b3659],
9	is	VBZ	O	be	auxpass	10	SENT_124	[p9l655t3595r709b3659],
10	associated	VBN	O	associate	ccomp	4	SENT_124	[p9l745t3595r1099b3659],
11	with	IN	O	with	_	0	SENT_124	[p9l1130t3595r1285b3659],
12	a	DT	O	a	det	14	SENT_124	[p9l1320t3616r1357b3659],
13	decreased	VBN	O	decrease	amod	14	SENT_124	[p9l1390t3595r1730b3659],
14	eﬁicacy	NN	O	eﬁicacy	prep_with	10	SENT_124	[p9l1764t3595r2038b3677],
15	of	IN	O	of	_	0	SENT_124	[p9l2072t3595r2154b3659],
16	the	DT	O	the	det	17	SENT_124	[p9l7t3706r111b3770],
17	transportation	NN	O	transportation	prep_of	14	SENT_124	[p9l137t3706r617b3788],
18	of	IN	O	of	_	0	SENT_124	[p9l643t3706r723b3770],
19	anti-Parkinsonian	JJ	MISC	anti-parkinsonian	amod	20	SENT_124	[p9l739t3706r1347b3770],
20	drugs	NNS	O	drug	prep_of	17	SENT_124	[p9l1373t3706r1562b3788],
21	by	IN	O	by	_	0	SENT_124	[p9l1588t3706r1677b3788],
22	OCTl	NN	O	octl	prep_by	20	SENT_124	[p9l1703t3708r1911b3770],
23	to	TO	O	to	_	0	SENT_124	[p9l1945t3715r2010b3770],
24	the	DT	O	the	det	25	SENT_124	[p9l2037t3706r2141b3770],
25	brain	NN	O	brain	prep_to	22	SENT_124	[p10l6t21r201b85],
26	.	.	O	.	_	0	SENT_124	[p10l6t21r201b85],

1	The	DT	O	the	det	2	SENT_125	[p10l243t21r375b85],
2	results	NNS	O	result	nsubj	3	SENT_125	[p10l410t21r633b85],
3	suggest	VBP	O	suggest	_	0	SENT_125	[p10l673t29r931b102],
4	that	IN	O	that	complm	12	SENT_125	[p10l965t21r1096b84],
5	patients	NNS	O	patient	nsubj	12	SENT_125	[p10l1128t21r1395b102],
6	with	IN	O	with	_	0	SENT_125	[p10l1431t21r1586b85],
7	the	DT	O	the	det	11	SENT_125	[p10l1620t21r1724b85],
8	AC	NN	O	ac	nn	11	SENT_125	[p10l1760t22r1881b85],
9	or	CC	O	or	_	0	SENT_125	[p10l1920t41r1993b85],
10	CC	NN	O	cc	nn	11	SENT_125	[p10l2027t22r2140b85],
11	genotype	NN	O	genotype	prep_with	5	SENT_125	[p10l8t140r325b213],
12	have	VBP	O	have	ccomp	3	SENT_125	[p10l355t132r518b196],
13	less	JJR	O	less	amod	14	SENT_125	[p10l549t132r675b196],
14	response	NN	O	response	dobj	12	SENT_125	[p10l704t152r1007b213],
15	to	TO	O	to	_	0	SENT_125	[p10l1037t140r1102b196],
16	these	DT	O	these	det	17	SENT_125	[p10l1132t132r1308b196],
17	drugs	NNS	O	drug	prep_to	12	SENT_125	[p10l1341t132r1529b213],
18	and	CC	O	and	_	0	SENT_125	[p10l1563t132r1687b196],
19	more	RBR	O	more	advmod	20	SENT_125	[p10l1715t152r1893b196],
20	severe	JJ	O	severe	amod	21	SENT_125	[p10l1925t152r2141b196],
21	symptoms	NNS	O	symptom	conj_and	17	SENT_125	[p10l10t252r383b324],
22	,	,	O	,	_	0	SENT_125	[p10l10t252r383b324],
23	resulting	VBG	O	result	partmod	12	SENT_125	[p10l416t243r717b324],
24	in	IN	O	in	_	0	SENT_125	[p10l749t243r816b306],
25	a	DT	O	a	det	28	SENT_125	[p10l846t263r883b306],
26	shorter	JJR	O	shorter	amod	28	SENT_125	[p10l916t243r1153b307],
27	survival	NN	O	survival	nn	28	SENT_125	[p10l1184t243r1458b307],
28	period	NN	O	period	prep_in	23	SENT_125	[p10l1487t243r1725b324],
29	.	.	O	.	_	0	SENT_125	[p10l1487t243r1725b324],

1	Acknowledgements	NNS	O	acknowledgement	nsubjpass	5	SENT_126	[p10l6t454r626b522],
2	This	DT	O	this	det	3	SENT_126	[p10l707t453r836b507],
3	study	NN	O	study	dep	1	SENT_126	[p10l875t453r1035b522],
4	was	VBD	O	be	auxpass	5	SENT_126	[p10l1067t470r1182b507],
5	supported	VBN	O	support	_	0	SENT_126	[p10l1220t453r1514b522],
6	by	IN	O	by	_	0	SENT_126	[p10l1547t453r1622b522],
7	the	DT	O	the	det	11	SENT_126	[p10l1656t453r1745b507],
8	Netherlands	NNP	ORGANIZATION	Netherlands	nn	11	SENT_126	[p10l1778t453r2140b507],
9	Genomics	NNP	ORGANIZATION	Genomics	nn	11	SENT_126	[p10l8t541r309b595],
10	Initiative/Netherlands	NNPS	ORGANIZATION	Initiative/Netherlands	nn	11	SENT_126	[p10l341t541r990b595],
11	Organisation	NNP	ORGANIZATION	Organisation	agent	5	SENT_126	[p10l1024t541r1410b611],
12	for	IN	ORGANIZATION	for	_	0	SENT_126	[p10l1440t541r1526b595],
13	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	16	SENT_126	[p10l1557t541r1837b595],
14	Research	NNP	ORGANIZATION	Research	nn	16	SENT_126	[p10l1868t541r2142b595],
15	project	NN	O	project	nn	16	SENT_126	[p10l6t629r215b698],
16	nr	NN	O	nr	prep_for	5	SENT_126	[p10l240t646r312b683],
17	.	.	O	.	_	0	SENT_126	[p10l240t646r312b683],

1	050-060-810	CD	NUMBER	050-060-810	_	0	SENT_127	[p10l344t630r747b683],
2	.	.	O	.	_	0	SENT_127	[p10l344t630r747b683],

1	Conﬂict	NN	O	conﬂict	nsubj	6	SENT_128	[p10l9t808r264b861],
2	of	IN	O	of	_	0	SENT_128	[p10l294t808r360b861],
3	Interest	NN	O	interest	prep_of	1	SENT_128	[p10l383t809r631b861],
4	The	DT	O	the	det	5	SENT_128	[p10l708t807r821b861],
5	authors	NNS	O	author	dep	3	SENT_128	[p10l853t807r1070b861],
6	declare	VBP	O	declare	_	0	SENT_128	[p10l1102t807r1314b861],
7	that	IN	O	that	complm	9	SENT_128	[p10l1344t807r1456b861],
8	they	PRP	O	they	nsubj	9	SENT_128	[p10l1484t807r1613b876],
9	have	VBP	O	have	ccomp	6	SENT_128	[p10l1641t807r1781b861],
10	no	DT	O	no	det	11	SENT_128	[p10l1811t824r1884b861],
11	conﬂict	NN	O	conﬂict	dobj	9	SENT_128	[p10l1916t807r2142b861],
12	of	IN	O	of	_	0	SENT_128	[p10l8t896r77b950],
13	interest	NN	O	interest	prep_of	11	SENT_128	[p10l96t896r327b950],
14	.	.	O	.	_	0	SENT_128	[p10l96t896r327b950],

1	Open	NNP	O	Open	nn	2	SENT_129	[p10l9t1114r180b1182],
2	Access	NN	O	access	nsubj	31	SENT_129	[p10l226t1114r437b1167],
3	This	DT	O	this	det	4	SENT_129	[p10l517t1112r646b1167],
4	article	NN	O	article	nsubjpass	6	SENT_129	[p10l695t1112r877b1167],
5	is	VBZ	O	be	auxpass	6	SENT_129	[p10l925t1112r970b1167],
6	distributed	VBN	O	distribute	parataxis	31	SENT_129	[p10l1019t1112r1338b1167],
7	under	IN	O	under	_	0	SENT_129	[p10l1382t1112r1555b1167],
8	the	DT	O	the	det	9	SENT_129	[p10l1598t1112r1688b1167],
9	terms	NNS	O	term	prep_under	6	SENT_129	[p10l1735t1120r1898b1167],
10	of	IN	O	of	_	0	SENT_129	[p10l1946t1113r2015b1167],
11	the	DT	O	the	det	16	SENT_129	[p10l2051t1112r2141b1167],
12	Creative	NNP	O	Creative	nn	16	SENT_129	[p10l8t1201r258b1255],
13	Commons	NNPS	O	Commons	nn	16	SENT_129	[p10l299t1202r605b1255],
14	Attribution	NNP	O	Attribution	nn	16	SENT_129	[p10l643t1201r976b1255],
15	Noncommercial	NNP	O	Noncommercial	nn	16	SENT_129	[p10l1011t1201r1497b1255],
16	License	NNP	O	License	prep_of	9	SENT_129	[p10l1535t1201r1765b1255],
17	which	WDT	O	which	nsubj	18	SENT_129	[p10l1803t1201r1987b1255],
18	permits	VBZ	O	permit	rcmod	16	SENT_129	[p10l2022t1218r2141b1270, p10l7t1289r133b1343],
19	any	DT	O	any	det	21	SENT_129	[p10l173t1306r279b1358],
20	noncommercial	JJ	O	noncommercial	amod	21	SENT_129	[p10l316t1289r782b1343],
21	use	NN	O	use	dobj	18	SENT_129	[p10l818t1306r934b1354],
22	,	,	O	,	_	0	SENT_129	[p10l818t1306r934b1354],
23	distribution	NN	O	distribution	conj_and	21	SENT_129	[p10l976t1289r1335b1355],
24	,	,	O	,	_	0	SENT_129	[p10l976t1289r1335b1355],
25	and	CC	O	and	_	0	SENT_129	[p10l1377t1289r1484b1343],
26	reproduction	NN	O	reproduction	conj_and	21	SENT_129	[p10l1520t1289r1903b1358],
27	in	IN	O	in	_	0	SENT_129	[p10l1941t1289r1998b1342],
28	any	DT	O	any	det	29	SENT_129	[p10l2035t1306r2142b1358],
29	medium	NN	O	medium	prep_in	26	SENT_129	[p10l7t1376r268b1442],
30	,	,	O	,	_	0	SENT_129	[p10l7t1376r268b1442],
31	provided	VBD	O	provide	_	0	SENT_129	[p10l297t1376r565b1446],
32	the	DT	O	the	det	34	SENT_129	[p10l591t1376r681b1431],
33	original	JJ	O	original	amod	34	SENT_129	[p10l710t1376r940b1446],
34	author	NN	O	author	iobj	31	SENT_129	[p10l968t1376r1234b1446],
35	(	CD	NUMBER	(	num	36	SENT_129	[p10l968t1376r1234b1446],
36	s	NNS	O	s	dobj	31	SENT_129	[p10l968t1376r1234b1446],
37	)	CD	NUMBER	)	nsubjpass	41	SENT_129	[p10l968t1376r1234b1446],
38	and	CC	O	and	_	0	SENT_129	[p10l1264t1376r1371b1431],
39	source	NN	O	source	nsubjpass	41	SENT_129	[p10l1399t1394r1591b1431],
40	are	VBP	O	be	auxpass	41	SENT_129	[p10l1620t1394r1707b1431],
41	credited	VBN	O	credit	rcmod	36	SENT_129	[p10l1736t1376r1988b1431],
42	.	.	O	.	_	0	SENT_129	[p10l1736t1376r1988b1431],

1	References	NNS	O	reference	nsubj	2	SENT_130	[p10l7t1608r415b1669],
2	l.	VBP	O	l.	_	0	SENT_130	[p10l54t1832r97b1885],
3	Koepsell	NNP	PERSON	Koepsell	nn	4	SENT_130	[p10l132t1831r398b1900],
4	H	NNP	O	H	dobj	2	SENT_130	[p10l432t1833r501b1896],
5	,	,	O	,	_	0	SENT_130	[p10l432t1833r501b1896],
6	Lips	NNP	ORGANIZATION	Lips	nn	7	SENT_130	[p10l539t1831r668b1900],
7	K	NNP	ORGANIZATION	K	appos	4	SENT_130	[p10l704t1833r773b1896],
8	,	,	O	,	_	0	SENT_130	[p10l704t1833r773b1896],
9	Volk	NNP	PERSON	Volk	nn	10	SENT_130	[p10l809t1831r951b1885],
10	C	NNP	O	C	appos	4	SENT_130	[p10l985t1832r1030b1885],
11	(	JJ	O	(	amod	10	SENT_130	[p10l1068t1831r1264b1900],
12	2007	CD	DATE	2007	tmod	11	SENT_130	[p10l1068t1831r1264b1900],
13	)	CD	NUMBER	)	num	14	SENT_130	[p10l1068t1831r1264b1900],
14	Polyspeciﬁc	NN	MISC	polyspeciﬁc	dep	2	SENT_130	[p10l1300t1831r1668b1900],
15	organic	JJ	O	organic	amod	17	SENT_130	[p10l1704t1831r1925b1900],
16	cation	NN	O	cation	nn	17	SENT_130	[p10l1961t1831r2142b1885],
17	transporters	NNS	O	transporter	dep	14	SENT_130	[p10l132t1926r500b1988],
18	:	:	O	:	_	0	SENT_130	[p10l132t1926r500b1988],
19	structure	NN	O	structure	dep	14	SENT_130	[p10l534t1926r808b1984],
20	,	,	O	,	_	0	SENT_130	[p10l534t1926r808b1984],
21	function	NN	O	function	conj_and	19	SENT_130	[p10l840t1918r1103b1984],
22	,	,	O	,	_	0	SENT_130	[p10l840t1918r1103b1984],
23	physiological	JJ	O	physiological	amod	24	SENT_130	[p10l1132t1918r1537b1988],
24	roles	NNS	O	role	conj_and	19	SENT_130	[p10l1565t1918r1725b1984],
25	,	,	O	,	_	0	SENT_130	[p10l1565t1918r1725b1984],
26	and	CC	O	and	_	0	SENT_130	[p10l1756t1918r1863b1973],
27	biopharmaceutical	JJ	O	biopharmaceutical	amod	28	SENT_130	[p10l1888t1918r2141b1988, p10l132t2006r454b2061],
28	implications	NNS	O	implication	dep	14	SENT_130	[p10l483t2006r865b2076],
29	.	.	O	.	_	0	SENT_130	[p10l483t2006r865b2076],

1	Pharm	NNP	O	Pharm	nn	2	SENT_131	[p10l897t2006r1093b2060],
2	Res	NNP	O	Res	_	0	SENT_131	[p10l1119t2009r1229b2061],
3	24	CD	NUMBER	24	num	5	SENT_131	[p10l1257t2008r1686b2061],
4	:	:	O	:	_	0	SENT_131	[p10l1257t2008r1686b2061],
5	l227	CD	NUMBER	l227	dep	2	SENT_131	[p10l1257t2008r1686b2061],
6	—	CD	NUMBER	—	num	7	SENT_131	[p10l1257t2008r1686b2061],
7	l25l	NN	O	l25l	dep	2	SENT_131	[p10l1257t2008r1686b2061],

1	Q	NNP	O	Q	nn	2	SENT_132	[p10l6t2238r78b2328],
2	Springer	NNP	O	Springer	_	0	SENT_132	[p10l104t2261r349b2331],
3	2	CD	NUMBER	2	dep	2	SENT_132	[p10l39t2345r90b2398],
4	.	.	O	.	_	0	SENT_132	[p10l39t2345r90b2398],

1	Jonker	NNP	PERSON	Jonker	nn	2	SENT_133	[p10l126t2344r334b2398],
2	JW	NNP	O	JW	_	0	SENT_133	[p10l368t2346r480b2409],
3	,	,	O	,	_	0	SENT_133	[p10l368t2346r480b2409],
4	Schinkel	NNP	PERSON	Schinkel	nn	5	SENT_133	[p10l522t2344r790b2398],
5	AH	NNP	O	AH	nsubj	6	SENT_133	[p10l825t2345r935b2397],
6	(	VBD	O	(	dep	2	SENT_133	[p10l973t2344r1176b2413],
7	2004	CD	DATE	2004	num	8	SENT_133	[p10l973t2344r1176b2413],
8	)	CD	NUMBER	)	dobj	6	SENT_133	[p10l973t2344r1176b2413],
9	Pharmacological	JJ	O	pharmacological	amod	12	SENT_133	[p10l1213t2344r1736b2413],
10	and	CC	O	and	_	0	SENT_133	[p10l1773t2344r1883b2398],
11	physiological	JJ	O	physiological	amod	12	SENT_133	[p10l1916t2344r2150b2413, p10l127t2432r336b2503],
12	functions	NNS	O	function	dep	2	SENT_133	[p10l394t2432r680b2488],
13	of	IN	O	of	_	0	SENT_133	[p10l739t2433r810b2488],
14	the	DT	O	the	det	18	SENT_133	[p10l856t2432r949b2488],
15	polyspeciﬁc	NN	O	polyspeciﬁc	nn	18	SENT_133	[p10l1004t2432r1385b2503],
16	organic	JJ	O	organic	amod	18	SENT_133	[p10l1444t2432r1673b2503],
17	cation	NN	O	cation	nn	18	SENT_133	[p10l1732t2432r1920b2488],
18	transporters	NNS	O	transporter	prep_of	12	SENT_133	[p10l1975t2440r2149b2488, p10l124t2529r357b2591],
19	:	:	O	:	_	0	SENT_133	[p10l1975t2440r2149b2488, p10l124t2529r357b2591],
20	OCTl	NN	O	octl	dep	2	SENT_133	[p10l396t2523r605b2587],
21	,	,	O	,	_	0	SENT_133	[p10l396t2523r605b2587],
22	2	CD	NUMBER	2	num	20	SENT_133	[p10l641t2523r694b2587],
23	,	,	O	,	_	0	SENT_133	[p10l641t2523r694b2587],
24	and	CC	NUMBER	and	_	0	SENT_133	[p10l731t2522r841b2576],
25	3	CD	NUMBER	3	conj_and	20	SENT_133	[p10l875t2523r904b2576],
26	(	NN	O	(	nn	28	SENT_133	[p10l944t2522r1389b2591],
27	SLC22A1-3	NN	O	slc22a1-3	nn	28	SENT_133	[p10l944t2522r1389b2591],
28	)	NN	O	)	dep	20	SENT_133	[p10l944t2522r1389b2591],
29	.	.	O	.	_	0	SENT_133	[p10l944t2522r1389b2591],

1	J	NNP	O	J	nn	4	SENT_134	[p10l1426t2524r1455b2576],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_134	[p10l1487t2522r1818b2576],
3	Exp	NNP	O	Exp	nn	4	SENT_134	[p10l1851t2524r1973b2591],
4	Ther	NNP	O	Ther	_	0	SENT_134	[p10l2008t2522r2153b2576],
5	30822-9	CD	NUMBER	30822-9	dep	4	SENT_134	[p10l127t2612r378b2665],

1	3	LS	NUMBER	3	_	0	SENT_135	[p10l40t2700r90b2753],
2	.	.	O	.	_	0	SENT_135	[p10l40t2700r90b2753],

1	Breidert	NNP	O	Breidert	nn	2	SENT_136	[p10l125t2699r372b2753],
2	T	NN	O	t	_	0	SENT_136	[p10l406t2701r460b2764],
3	,	,	O	,	_	0	SENT_136	[p10l406t2701r460b2764],
4	Spitzenberger	NN	O	spitzenberger	nn	5	SENT_136	[p10l499t2699r916b2768],
5	F	NN	O	f	appos	2	SENT_136	[p10l947t2701r999b2765],
6	,	,	O	,	_	0	SENT_136	[p10l947t2701r999b2765],
7	Grundemann	NN	ORGANIZATION	grundemann	nn	8	SENT_136	[p10l1036t2699r1431b2753],
8	D	NN	ORGANIZATION	d	appos	2	SENT_136	[p10l1464t2701r1534b2764],
9	,	,	O	,	_	0	SENT_136	[p10l1464t2701r1534b2764],
10	Schomig	NN	O	schomig	nn	11	SENT_136	[p10l1573t2699r1837b2768],
11	E	NN	O	e	appos	2	SENT_136	[p10l1872t2701r1916b2752],
12	(	CD	NUMBER	(	dep	11	SENT_136	[p10l1952t2699r2149b2768],
13	1998	CD	DATE	1998	num	16	SENT_136	[p10l1952t2699r2149b2768],
14	)	NNP	O	)	nn	16	SENT_136	[p10l1952t2699r2149b2768],
15	Catecholamine	NN	O	catecholamine	nn	16	SENT_136	[p10l127t2787r577b2843],
16	transport	NN	O	transport	dep	2	SENT_136	[p10l608t2795r877b2858],
17	by	IN	O	by	_	0	SENT_136	[p10l904t2787r981b2858],
18	the	DT	O	the	det	22	SENT_136	[p10l1010t2787r1101b2843],
19	organic	JJ	O	organic	amod	22	SENT_136	[p10l1132t2788r1355b2858],
20	cation	NN	O	cation	nn	22	SENT_136	[p10l1388t2788r1570b2843],
21	transporter	NN	O	transporter	nn	22	SENT_136	[p10l1599t2795r1926b2858],
22	type	NN	O	type	prep_by	16	SENT_136	[p10l1954t2795r2083b2858],
23	1	CD	NUMBER	1	number	24	SENT_136	[p10l2121t2789r2142b2842],
24	(	CD	NUMBER	(	dep	2	SENT_136	[p10l127t2877r378b2946],
25	OCTl	NN	O	octl	nn	26	SENT_136	[p10l127t2877r378b2946],
26	)	NN	O	)	dep	24	SENT_136	[p10l127t2877r378b2946],
27	.	.	O	.	_	0	SENT_136	[p10l127t2877r378b2946],

1	Br	NN	O	br	nn	3	SENT_137	[p10l410t2879r487b2930],
2	J	NN	O	j	nn	3	SENT_137	[p10l512t2879r540b2931],
3	Pharmacol	NN	O	pharmacol	_	0	SENT_137	[p10l566t2877r888b2931],
4	l25	CD	NUMBER	l25	num	6	SENT_137	[p10l924t2878r1315b2931],
5	:2	CD	NUMBER	:2	num	6	SENT_137	[p10l924t2878r1315b2931],
6	l8	NN	O	l8	dep	3	SENT_137	[p10l924t2878r1315b2931],
7	—	NN	O	—	dep	3	SENT_137	[p10l924t2878r1315b2931],
8	224	CD	NUMBER	224	num	7	SENT_137	[p10l924t2878r1315b2931],

1	4	LS	NUMBER	4	_	0	SENT_138	[p10l38t2966r90b3019],
2	.	.	O	.	_	0	SENT_138	[p10l38t2966r90b3019],

1	Okura	NNP	PERSON	Okura	nn	2	SENT_139	[p10l127t2965r315b3019],
2	T	NN	PERSON	t	_	0	SENT_139	[p10l347t2967r401b3031],
3	,	,	O	,	_	0	SENT_139	[p10l347t2967r401b3031],
4	Ito	NN	PERSON	ito	nn	5	SENT_139	[p10l437t2967r517b3019],
5	R	NN	PERSON	r	appos	2	SENT_139	[p10l551t2967r616b3031],
6	,	,	O	,	_	0	SENT_139	[p10l551t2967r616b3031],
7	lshiguro	NN	O	lshiguro	nn	8	SENT_139	[p10l652t2965r901b3034],
8	N	NN	O	n	appos	2	SENT_139	[p10l933t2967r1005b3031],
9	,	,	O	,	_	0	SENT_139	[p10l933t2967r1005b3031],
10	Tamai	NNP	O	Tamai	appos	2	SENT_139	[p10l1042t2965r1226b3019],
11	I	PRP	O	I	dep	10	SENT_139	[p10l1260t2967r1298b3031],
12	,	,	O	,	_	0	SENT_139	[p10l1260t2967r1298b3031],
13	Deguchi	NNP	PERSON	Deguchi	nn	14	SENT_139	[p10l1334t2965r1589b3034],
14	Y	NN	PERSON	y	appos	2	SENT_139	[p10l1621t2967r1675b3018],
15	(	CD	NUMBER	(	num	16	SENT_139	[p10l1710t2965r1907b3034],
16	2007	CD	DATE	2007	dep	14	SENT_139	[p10l1710t2965r1907b3034],
17	)	CD	NUMBER	)	num	20	SENT_139	[p10l1710t2965r1907b3034],
18	Bloodbrain	NN	O	bloodbrain	nn	20	SENT_139	[p10l1941t2965r2149b3019, p10l124t3055r280b3110],
19	barrier	NN	O	barrier	nn	20	SENT_139	[p10l314t3055r516b3110],
20	transport	NN	O	transport	dep	2	SENT_139	[p10l550t3063r819b3125],
21	of	IN	O	of	_	0	SENT_139	[p10l855t3055r925b3110],
22	pramipexole	NN	O	pramipexole	prep_of	20	SENT_139	[p10l950t3055r1344b3125],
23	,	,	O	,	_	0	SENT_139	[p10l950t3055r1344b3125],
24	a	DT	O	a	det	27	SENT_139	[p10l1385t3073r1416b3110],
25	dopamine	NN	O	dopamine	nn	27	SENT_139	[p10l1453t3055r1748b3125],
26	D2	NN	O	d2	nn	27	SENT_139	[p10l1786t3056r1875b3109],
27	agonist	NN	O	agonist	appos	2	SENT_139	[p10l1915t3055r2146b3126],
28	.	.	O	.	_	0	SENT_139	[p10l1915t3055r2146b3126],

1	Life	NNP	O	Life	nn	2	SENT_140	[p10l125t3144r248b3198],
2	Sci	NNP	O	Sci	_	0	SENT_140	[p10l280t3144r371b3198],
3	80	CD	NUMBER	80	num	5	SENT_140	[p10l402t3145r830b3198],
4	:	:	O	:	_	0	SENT_140	[p10l402t3145r830b3198],
5	l564	CD	NUMBER	l564	dep	2	SENT_140	[p10l402t3145r830b3198],
6	—	CD	NUMBER	—	num	7	SENT_140	[p10l402t3145r830b3198],
7	l571	NN	O	l571	dep	2	SENT_140	[p10l402t3145r830b3198],

1	5	CD	NUMBER	5	_	0	SENT_141	[p10l41t3234r90b3286],
2	.	.	O	.	_	0	SENT_141	[p10l41t3234r90b3286],

1	lshiguro	NN	O	lshiguro	nn	2	SENT_142	[p10l126t3232r375b3301],
2	N	NN	O	n	_	0	SENT_142	[p10l417t3234r489b3298],
3	,	,	O	,	_	0	SENT_142	[p10l417t3234r489b3298],
4	Saito	NNP	PERSON	Saito	nn	5	SENT_142	[p10l537t3232r686b3286],
5	A	NNP	O	A	dep	2	SENT_142	[p10l729t3233r800b3298],
6	,	,	O	,	_	0	SENT_142	[p10l729t3233r800b3298],
7	Yokoyama	NNP	PERSON	Yokoyama	nn	8	SENT_142	[p10l845t3232r1172b3301],
8	K	NNP	PERSON	K	appos	5	SENT_142	[p10l1213t3234r1283b3298],
9	,	,	O	,	_	0	SENT_142	[p10l1213t3234r1283b3298],
10	Morikawa	NNP	PERSON	Morikawa	nn	11	SENT_142	[p10l1328t3232r1639b3286],
11	M	NNP	O	M	appos	5	SENT_142	[p10l1681t3234r1763b3298],
12	,	,	O	,	_	0	SENT_142	[p10l1681t3234r1763b3298],
13	Igarashi	NNP	PERSON	Igarashi	nn	14	SENT_142	[p10l1809t3232r2049b3301],
14	T	NN	O	t	appos	5	SENT_142	[p10l2093t3234r2148b3297],
15	,	,	O	,	_	0	SENT_142	[p10l2093t3234r2148b3297],

1	ll	NN	O	ll	_	0	SENT_143	[p11l7t2240r89b2294],
2	.	.	O	.	_	0	SENT_143	[p11l7t2240r89b2294],

1	Tamai	NNP	O	Tamai	nsubj	3	SENT_144	[p11l126t17r312b72],
2	I	PRP	O	I	dep	1	SENT_144	[p11l341t19r364b71],
3	(	VBP	O	(	_	0	SENT_144	[p11l394t17r591b87],
4	2005	CD	DATE	2005	num	6	SENT_144	[p11l394t17r591b87],
5	)	CD	NUMBER	)	num	6	SENT_144	[p11l394t17r591b87],
6	Transport	NN	O	transport	dobj	3	SENT_144	[p11l622t19r913b87],
7	of	IN	O	of	_	0	SENT_144	[p11l941t17r1011b72],
8	the	DT	O	the	det	12	SENT_144	[p11l1029t17r1119b72],
9	dopamine	NN	O	dopamine	nn	12	SENT_144	[p11l1150t17r1446b87],
10	D2	NN	O	d2	nn	12	SENT_144	[p11l1475t18r1564b71],
11	agonist	NN	O	agonist	nn	12	SENT_144	[p11l1596t17r1814b88],
12	pramipex	NN	O	pramipex	prep_of	6	SENT_144	[p11l1839t17r2149b87],
13	—	CD	NUMBER	—	num	14	SENT_144	[p11l1839t17r2149b87],
14	ole	NN	O	ole	dep	20	SENT_144	[p11l127t105r215b159],
15	by	IN	O	by	_	0	SENT_144	[p11l241t105r317b174],
16	rat	NN	O	rat	prep_by	14	SENT_144	[p11l342t112r421b159],
17	organic	JJ	O	organic	amod	19	SENT_144	[p11l446t105r669b174],
18	cation	NN	O	cation	nn	19	SENT_144	[p11l697t105r879b159],
19	transporters	NNS	O	transporter	dep	20	SENT_144	[p11l904t112r1258b174],
20	OCT1	NN	O	oct1	dep	6	SENT_144	[p11l1286t106r1465b159],
21	and	CC	O	and	_	0	SENT_144	[p11l1501t105r1608b159],
22	OCT2	NN	O	oct2	dep	6	SENT_144	[p11l1634t106r1819b159],
23	in	IN	O	in	_	0	SENT_144	[p11l1849t105r1906b158],
24	kidney	NN	O	kidney	prep_in	20	SENT_144	[p11l1930t105r2146b174],
25	.	.	O	.	_	0	SENT_144	[p11l1930t105r2146b174],

1	Drug	NN	MISC	drug	nn	3	SENT_145	[p11l125t195r279b262],
2	Metab	NNP	MISC	Metab	nn	3	SENT_145	[p11l307t193r498b247],
3	Dispos	NNP	MISC	Dispos	_	0	SENT_145	[p11l526t193r734b262],
4	33:495	CD	NUMBER	33:495	num	3	SENT_145	[p11l765t194r1125b247],
5	—	CD	NUMBER	—	number	6	SENT_145	[p11l765t194r1125b247],
6	499	CD	NUMBER	499	num	3	SENT_145	[p11l765t194r1125b247],
7	.	.	O	.	_	0	SENT_145	[p11l81t326r90b335],

1	Goralski	NNP	O	Goralski	nn	2	SENT_146	[p11l127t281r384b335],
2	KB	NN	O	kb	nsubj	34	SENT_146	[p11l408t283r529b347],
3	,	,	O	,	_	0	SENT_146	[p11l408t283r529b347],
4	Lou	NNP	PERSON	Lou	nn	5	SENT_146	[p11l556t283r677b335],
5	G	NNP	PERSON	G	dep	22	SENT_146	[p11l702t282r770b347],
6	,	,	O	,	_	0	SENT_146	[p11l702t282r770b347],
7	Prowse	NNP	ORGANIZATION	Prowse	nn	8	SENT_146	[p11l797t283r1017b335],
8	MT	NNP	ORGANIZATION	MT	appos	5	SENT_146	[p11l1042t283r1165b347],
9	,	,	O	,	_	0	SENT_146	[p11l1042t283r1165b347],
10	Gorboulev	NNP	O	Gorboulev	nn	11	SENT_146	[p11l1193t281r1515b335],
11	V	NNP	O	V	appos	5	SENT_146	[p11l1539t283r1599b347],
12	,	,	O	,	_	0	SENT_146	[p11l1539t283r1599b347],
13	Volk	NNP	PERSON	Volk	nn	14	SENT_146	[p11l1625t281r1768b335],
14	C	NNP	O	C	appos	5	SENT_146	[p11l1792t282r1856b346],
15	,	,	O	,	_	0	SENT_146	[p11l1792t282r1856b346],
16	Koepsell	NNP	PERSON	Koepsell	nn	17	SENT_146	[p11l1883t281r2150b350],
17	H	NNP	O	H	appos	5	SENT_146	[p11l125t371r195b435],
18	,	,	O	,	_	0	SENT_146	[p11l125t371r195b435],
19	Sitar	NNP	O	Sitar	appos	5	SENT_146	[p11l238t369r376b423],
20	DS	NN	O	d	dep	22	SENT_146	[p11l411t370r504b423],
21	(	CD	NUMBER	(	num	20	SENT_146	[p11l545t369r742b438],
22	2002	CD	DATE	2002	dep	30	SENT_146	[p11l545t369r742b438],
23	)	CD	NUMBER	)	dep	22	SENT_146	[p11l545t369r742b438],
24	The	DT	O	the	det	27	SENT_146	[p11l780t369r895b423],
25	cation	NN	O	cation	nn	27	SENT_146	[p11l934t369r1116b423],
26	transporters	NNS	O	transporter	nn	27	SENT_146	[p11l1151t377r1504b438],
27	rOCTl	NN	O	roctl	nsubj	30	SENT_146	[p11l1542t370r1748b423],
28	and	CC	O	and	_	0	SENT_146	[p11l1794t369r1901b423],
29	rOCT2	NN	O	roct2	nsubj	30	SENT_146	[p11l1936t370r2148b423],
30	interact	VBP	O	interact	_	0	SENT_146	[p11l126t457r363b511],
31	with	IN	O	with	_	0	SENT_146	[p11l414t457r554b511],
32	bicarbonate	NN	O	bicarbonate	prep_with	30	SENT_146	[p11l605t457r974b511],
33	but	CC	O	but	_	0	SENT_146	[p11l1027t457r1129b511],
34	play	VBP	O	play	conj_but	30	SENT_146	[p11l1180t457r1316b526],
35	only	RB	O	only	advmod	38	SENT_146	[p11l1371t457r1509b526],
36	a	DT	O	a	det	38	SENT_146	[p11l1563t474r1594b511],
37	minor	JJ	O	minor	amod	38	SENT_146	[p11l1647t457r1835b511],
38	role	NN	O	role	dobj	34	SENT_146	[p11l1886t457r2007b511],
39	for	IN	O	for	_	0	SENT_146	[p11l2062t457r2152b511],
40	amantadine	NN	O	amantadine	nn	41	SENT_146	[p11l127t545r473b599],
41	uptake	NN	O	uptake	prep_for	38	SENT_146	[p11l507t545r708b614],
42	into	IN	O	into	_	0	SENT_146	[p11l744t545r858b599],
43	rat	NN	O	rat	prep_into	34	SENT_146	[p11l893t552r972b599],
44	renal	JJ	O	renal	amod	46	SENT_146	[p11l1005t545r1155b599],
45	proximal	JJ	O	proximal	amod	46	SENT_146	[p11l1187t545r1460b614],
46	tubules	NNS	O	tubule	dep	43	SENT_146	[p11l1494t545r1727b599],
47	.	.	O	.	_	0	SENT_146	[p11l1494t545r1727b599],

1	J	NNP	O	J	nn	4	SENT_147	[p11l1767t547r1795b599],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_147	[p11l1828t545r2150b599],
3	Exp	NNP	O	Exp	nn	4	SENT_147	[p11l125t635r245b702],
4	Ther	NNP	O	Ther	_	0	SENT_147	[p11l275t633r417b687],
5	303:959	CD	NUMBER	303:959	num	4	SENT_147	[p11l444t634r840b687],
6	—	CD	NUMBER	—	number	7	SENT_147	[p11l444t634r840b687],
7	968	CD	NUMBER	968	num	4	SENT_147	[p11l444t634r840b687],
8	.	.	O	.	_	0	SENT_147	[p11l81t766r90b774],

1	Gomes	NNP	PERSON	Gomes	nn	2	SENT_148	[p11l127t721r337b775],
2	P	NN	PERSON	p	nsubj	18	SENT_148	[p11l362t723r411b786],
3	,	,	O	,	_	0	SENT_148	[p11l362t723r411b786],
4	Serrao	NNP	PERSON	Serrao	nn	5	SENT_148	[p11l440t721r629b775],
5	MP	NNP	O	MP	appos	2	SENT_148	[p11l653t723r771b786],
6	,	,	O	,	_	0	SENT_148	[p11l653t723r771b786],
7	Viera-Coelho	NNP	O	Viera-Coelho	nn	8	SENT_148	[p11l795t720r1200b775],
8	MA	NNP	O	MA	appos	2	SENT_148	[p11l1224t722r1362b786],
9	,	,	O	,	_	0	SENT_148	[p11l1224t722r1362b786],
10	Soares-da-Silva	NNP	O	Soares-da-Silva	nn	11	SENT_148	[p11l1391t720r1865b775],
11	P	NN	O	p	appos	2	SENT_148	[p11l1887t723r1926b774],
12	(	CD	NUMBER	(	num	11	SENT_148	[p11l1952t720r2149b789],
13	1997	CD	DATE	1997	num	17	SENT_148	[p11l1952t720r2149b789],
14	)	CD	NUMBER	)	num	17	SENT_148	[p11l1952t720r2149b789],
15	Opossum	NN	O	opossum	nn	17	SENT_148	[p11l127t810r413b878],
16	kidney	NN	O	kidney	nn	17	SENT_148	[p11l435t809r642b878],
17	cells	NNS	O	cell	dep	11	SENT_148	[p11l667t809r800b863],
18	take	VBP	O	take	_	0	SENT_148	[p11l825t809r949b863],
19	up	RP	O	up	prt	18	SENT_148	[p11l972t826r1046b878],
20	L-DOPA	NN	O	l-dopa	nn	28	SENT_148	[p11l1072t810r1343b863],
21	through	IN	O	through	_	0	SENT_148	[p11l1365t809r1602b878],
22	an	DT	O	a	det	24	SENT_148	[p11l1626t826r1695b863],
23	organic	JJ	O	organic	amod	24	SENT_148	[p11l1720t809r1943b878],
24	cation	NN	O	cation	prep_through	20	SENT_148	[p11l1968t809r2151b863],
25	potential-dependent	JJ	O	potential-dependent	amod	28	SENT_148	[p11l124t897r728b966],
26	and	CC	O	and	_	0	SENT_148	[p11l753t897r861b951],
27	proton-independent	JJ	O	proton-independent	conj_and	25	SENT_148	[p11l884t897r1480b966],
28	transporter	NN	O	transporter	dobj	18	SENT_148	[p11l1505t904r1841b966],
29	.	.	O	.	_	0	SENT_148	[p11l1505t904r1841b966],

1	Cell	NN	O	cell	nn	3	SENT_149	[p11l1873t897r1996b951],
2	Biol	NNP	O	Biol	nn	3	SENT_149	[p11l2021t897r2151b951],
3	Int	NNP	O	Int	_	0	SENT_149	[p11l126t987r209b1039],
4	21	CD	NUMBER	21	number	5	SENT_149	[p11l235t987r301b1039],
5	:249	CD	NUMBER	:249	dep	3	SENT_149	[p11l316t987r594b1040],
6	—	NN	O	—	dep	5	SENT_149	[p11l316t987r594b1040],
7	255	CD	NUMBER	255	num	6	SENT_149	[p11l316t987r594b1040],
8	.	.	O	.	_	0	SENT_149	[p11l81t1121r90b1130],

1	Pinto-do	JJ	O	pinto-do	amod	2	SENT_150	[p11l125t1074r384b1130],
2	OP	NN	O	op	_	0	SENT_150	[p11l414t1076r516b1141],
3	,	,	O	,	_	0	SENT_150	[p11l414t1076r516b1141],
4	Soares-da-Silva	NN	O	soares-da-silva	nn	5	SENT_150	[p11l548t1074r1022b1130],
5	P	NN	O	p	appos	2	SENT_150	[p11l1048t1077r1087b1129],
6	(	CD	NUMBER	(	num	9	SENT_150	[p11l1117t1075r1314b1144],
7	1996	CD	DATE	1996	num	9	SENT_150	[p11l1117t1075r1314b1144],
8	)	CD	NUMBER	)	num	9	SENT_150	[p11l1117t1075r1314b1144],
9	Studies	NNS	O	study	dep	5	SENT_150	[p11l1345t1074r1562b1130],
10	on	IN	O	on	_	0	SENT_150	[p11l1591t1092r1665b1130],
11	the	DT	O	the	det	12	SENT_150	[p11l1690t1074r1780b1130],
12	pharmacology	NN	O	pharmacology	prep_on	9	SENT_150	[p11l1806t1074r2149b1145, p11l127t1184r239b1237],
13	of	IN	O	of	_	0	SENT_150	[p11l268t1166r337b1221],
14	the	DT	O	the	det	16	SENT_150	[p11l354t1166r445b1221],
15	inward	JJ	O	inward	amod	16	SENT_150	[p11l475t1166r683b1221],
16	transport	NN	O	transport	prep_of	12	SENT_150	[p11l709t1173r978b1236],
17	of	IN	O	of	_	0	SENT_150	[p11l1006t1166r1075b1221],
18	L-DOPA	NN	O	l-dopa	prep_of	16	SENT_150	[p11l1093t1167r1363b1221],
19	in	IN	O	in	_	0	SENT_150	[p11l1392t1166r1449b1220],
20	rat	NN	O	rat	nn	22	SENT_150	[p11l1475t1174r1554b1221],
21	renal	JJ	O	renal	amod	22	SENT_150	[p11l1579t1166r1729b1221],
22	tubules	NNS	O	tubule	prep_in	18	SENT_150	[p11l1756t1166r1989b1221],
23	.	.	O	.	_	0	SENT_150	[p11l1756t1166r1989b1221],

1	Br	NN	O	br	nn	4	SENT_151	[p11l2021t1168r2097b1220],
2	J	NN	O	j	nn	4	SENT_151	[p11l2123t1168r2151b1221],
3	Pharmacol	NN	O	pharmacol	nn	4	SENT_151	[p11l125t1254r447b1308],
4	ll8	NN	O	ll8	_	0	SENT_151	[p11l483t1256r872b1309],
5	:74	CD	NUMBER	:74	num	6	SENT_151	[p11l483t1256r872b1309],
6	l	NN	O	l	dep	4	SENT_151	[p11l483t1256r872b1309],
7	—	NN	O	—	dep	6	SENT_151	[p11l483t1256r872b1309],
8	747	CD	NUMBER	747	num	7	SENT_151	[p11l483t1256r872b1309],
9	.	.	O	.	_	0	SENT_151	[p11l81t1389r90b1397],

1	Becker	NNP	PERSON	Becker	nn	2	SENT_152	[p11l125t1343r345b1398],
2	ML	NNP	O	ML	nsubjpass	31	SENT_152	[p11l378t1345r508b1409],
3	,	,	O	,	_	0	SENT_152	[p11l378t1345r508b1409],
4	Visser	NNP	PERSON	Visser	nn	5	SENT_152	[p11l545t1343r740b1398],
5	LE	NNP	PERSON	LE	dep	23	SENT_152	[p11l773t1345r881b1409],
6	,	,	O	,	_	0	SENT_152	[p11l773t1345r881b1409],
7	van	NNP	PERSON	van	nn	9	SENT_152	[p11l918t1361r1030b1398],
8	Schaik	NNP	PERSON	Schaik	nn	9	SENT_152	[p11l1068t1343r1275b1398],
9	RH	NNP	O	RH	appos	5	SENT_152	[p11l1309t1345r1431b1409],
10	,	,	O	,	_	0	SENT_152	[p11l1309t1345r1431b1409],
11	Hofman	NNP	PERSON	Hofman	nn	12	SENT_152	[p11l1469t1343r1721b1398],
12	A	NNP	O	A	appos	5	SENT_152	[p11l1755t1344r1826b1409],
13	,	,	O	,	_	0	SENT_152	[p11l1755t1344r1826b1409],
14	Uitterlinden	NNP	ORGANIZATION	Uitterlinden	nn	15	SENT_152	[p11l1863t1343r2149b1398, p11l126t1434r236b1489],
15	AG	NNP	ORGANIZATION	AG	appos	5	SENT_152	[p11l273t1435r400b1501],
16	,	,	O	,	_	0	SENT_152	[p11l273t1435r400b1501],
17	Stricker	NNP	PERSON	Stricker	nn	18	SENT_152	[p11l443t1434r685b1489],
18	BH	NNP	O	BH	appos	5	SENT_152	[p11l720t1436r825b1488],
19	(	CD	NUMBER	(	dep	23	SENT_152	[p11l865t1434r1067b1504],
20	2009	CD	DATE	2009	num	23	SENT_152	[p11l865t1434r1067b1504],
21	)	NNP	O	)	nn	23	SENT_152	[p11l865t1434r1067b1504],
22	Genetic	NNP	O	Genetic	nn	23	SENT_152	[p11l1107t1434r1344b1489],
23	variation	NN	O	variation	dep	31	SENT_152	[p11l1382t1434r1657b1489],
24	in	IN	O	in	_	0	SENT_152	[p11l1695t1434r1753b1488],
25	the	DT	O	the	det	27	SENT_152	[p11l1789t1434r1881b1489],
26	organic	JJ	O	organic	amod	27	SENT_152	[p11l1921t1434r2149b1505],
27	cation	NN	O	cation	prep_in	23	SENT_152	[p11l127t1522r314b1577],
28	transporter	NN	O	transporter	nsubjpass	31	SENT_152	[p11l352t1530r689b1593],
29	1	CD	NUMBER	1	num	28	SENT_152	[p11l734t1524r754b1576],
30	is	VBZ	O	be	auxpass	31	SENT_152	[p11l802t1522r849b1577],
31	associated	VBN	O	associate	_	0	SENT_152	[p11l890t1522r1207b1577],
32	with	IN	O	with	_	0	SENT_152	[p11l1245t1522r1381b1577],
33	metformin	NN	O	metformin	nn	34	SENT_152	[p11l1419t1522r1744b1577],
34	response	NN	O	response	prep_with	31	SENT_152	[p11l1782t1540r2052b1593],
35	in	IN	O	in	_	0	SENT_152	[p11l2093t1522r2151b1576],
36	patients	NNS	O	patient	prep_in	31	SENT_152	[p11l124t1612r364b1683],
37	with	IN	O	with	_	0	SENT_152	[p11l411t1612r548b1667],
38	diabetes	NN	O	diabetes	nn	39	SENT_152	[p11l596t1612r846b1667],
39	mellitus	NN	O	mellitus	prep_with	36	SENT_152	[p11l893t1612r1157b1667],
40	.	.	O	.	_	0	SENT_152	[p11l893t1612r1157b1667],

1	Pharrnacogenomics	NNS	O	pharrnacogenomic	nsubj	48	SENT_153	[p11l1208t1612r1813b1683],
2	J	NNP	O	J	dep	1	SENT_153	[p11l1861t1615r1890b1667],
3	9:242247	CD	NUMBER	9:242247	num	2	SENT_153	[p11l1937t1614r2152b1667, p11l126t1704r238b1757],
4	Hofman	NNP	O	Hofman	nn	5	SENT_153	[p11l125t1793r377b1848],
5	A	NNP	O	A	dep	1	SENT_153	[p11l409t1794r480b1860],
6	,	,	O	,	_	0	SENT_153	[p11l409t1794r480b1860],
7	Breteler	NNP	PERSON	Breteler	nn	8	SENT_153	[p11l516t1793r765b1848],
8	MM	NN	O	mm	conj_and	5	SENT_153	[p11l795t1795r947b1860],
9	,	,	O	,	_	0	SENT_153	[p11l795t1795r947b1860],
10	van	NN	PERSON	van	nn	12	SENT_153	[p11l981t1811r1092b1848],
11	Duijn	NNP	PERSON	Duijn	nn	12	SENT_153	[p11l1125t1793r1300b1863],
12	CM	NN	O	cm	conj_and	5	SENT_153	[p11l1334t1794r1467b1860],
13	,	,	O	,	_	0	SENT_153	[p11l1334t1794r1467b1860],
14	Janssen	NNP	PERSON	Janssen	nn	15	SENT_153	[p11l1503t1795r1739b1848],
15	HL	NNS	O	hl	dep	1	SENT_153	[p11l1771t1795r1889b1860],
16	,	,	O	,	_	0	SENT_153	[p11l1771t1795r1889b1860],
17	Krestin	NNP	O	Krestin	nn	18	SENT_153	[p11l1924t1793r2151b1848],
18	GP	NNP	O	GP	dep	1	SENT_153	[p11l127t1882r231b1948],
19	,	,	O	,	_	0	SENT_153	[p11l127t1882r231b1948],
20	Kuipers	NNP	ORGANIZATION	Kuipers	nn	21	SENT_153	[p11l279t1881r521b1952],
21	EJ	NNP	ORGANIZATION	EJ	dep	1	SENT_153	[p11l568t1883r659b1948],
22	,	,	O	,	_	0	SENT_153	[p11l568t1883r659b1948],
23	Stricker	NNP	PERSON	Stricker	nn	24	SENT_153	[p11l710t1881r952b1937],
24	BH	NNP	O	BH	dep	1	SENT_153	[p11l995t1884r1117b1948],
25	,	,	O	,	_	0	SENT_153	[p11l995t1884r1117b1948],
26	Tiemeier	NNP	O	Tiemeier	nn	27	SENT_153	[p11l1167t1881r1442b1936],
27	H	NNP	O	H	dep	1	SENT_153	[p11l1484t1884r1555b1948],
28	,	,	O	,	_	0	SENT_153	[p11l1484t1884r1555b1948],
29	Uitterlinden	NNP	ORGANIZATION	Uitterlinden	nn	30	SENT_153	[p11l1602t1881r1976b1937],
30	AG	NNP	ORGANIZATION	AG	dep	1	SENT_153	[p11l2020t1882r2148b1948],
31	,	,	O	,	_	0	SENT_153	[p11l2020t1882r2148b1948],
32	Vingerling	NNP	O	Vingerling	nn	33	SENT_153	[p11l125t1971r456b2042],
33	JR	NNP	O	JR	dep	1	SENT_153	[p11l508t1974r605b2038],
34	,	,	O	,	_	0	SENT_153	[p11l508t1974r605b2038],
35	Witteman	NNP	PERSON	Witteman	nn	37	SENT_153	[p11l660t1972r961b2027],
36	JC	NNP	PERSON	JC	nn	37	SENT_153	[p11l1013t1973r1090b2027],
37	(	NNP	O	(	dep	1	SENT_153	[p11l1146t1972r1348b2042],
38	2009	CD	DATE	2009	num	39	SENT_153	[p11l1146t1972r1348b2042],
39	)	CD	NUMBER	)	dep	37	SENT_153	[p11l1146t1972r1348b2042],
40	The	DT	O	the	det	42	SENT_153	[p11l1402t1971r1519b2027],
41	Rotterdam	NNP	LOCATION	Rotterdam	nn	42	SENT_153	[p11l1572t1971r1897b2027],
42	Study	NNP	O	Study	dep	37	SENT_153	[p11l1952t1971r2145b2042],
43	:	:	O	:	_	0	SENT_153	[p11l1952t1971r2145b2042],
44	2010	CD	DATE	2010	num	45	SENT_153	[p11l126t2062r278b2115],
45	objectives	NNS	O	objective	conj_and	5	SENT_153	[p11l319t2061r630b2130],
46	and	CC	O	and	_	0	SENT_153	[p11l671t2061r781b2115],
47	design	NN	O	design	conj_and	5	SENT_153	[p11l819t2061r1020b2130],
48	update	VBP	O	update	_	0	SENT_153	[p11l1057t2061r1279b2130],
49	.	.	O	.	_	0	SENT_153	[p11l1057t2061r1279b2130],

1	Eur	NNP	O	Eur	nn	5	SENT_154	[p11l1322t2063r1433b2115],
2	J	NNP	O	J	nn	5	SENT_154	[p11l1470t2063r1499b2115],
3	Epidemiol	NNP	O	Epidemiol	nn	5	SENT_154	[p11l1537t2061r1857b2130],
4	24:553572	CD	NUMBER	24:553572	num	5	SENT_154	[p11l1897t2062r2152b2115, p11l128t2151r238b2204],
5	International	NNP	MISC	International	_	0	SENT_154	[p11l127t2238r525b2294],
6	HapMap	NNP	MISC	HapMap	nn	7	SENT_154	[p11l577t2241r846b2309],
7	Consortium	NNP	MISC	Consortium	dep	5	SENT_154	[p11l902t2238r1270b2294],
8	(	CD	NUMBER	(	dep	7	SENT_154	[p11l1323t2239r1527b2308],
9	2003	CD	DATE	2003	num	10	SENT_154	[p11l1323t2239r1527b2308],
10	)	CD	NUMBER	)	dep	5	SENT_154	[p11l1323t2239r1527b2308],
11	The	DT	O	the	det	14	SENT_154	[p11l1581t2238r1698b2294],
12	International	NNP	O	International	nn	14	SENT_154	[p11l1752t2238r2150b2294],
13	HapMap	NNP	O	HapMap	nn	14	SENT_154	[p11l126t2330r389b2397],
14	Project	NNP	O	Project	dep	10	SENT_154	[p11l418t2328r645b2397],
15	.	.	O	.	_	0	SENT_154	[p11l418t2328r645b2397],

1	Nature	NNP	O	Nature	_	0	SENT_155	[p11l674t2330r880b2382],
2	426:789	CD	NUMBER	426:789	num	1	SENT_155	[p11l907t2329r1307b2382],
3	—	CD	NUMBER	—	number	4	SENT_155	[p11l907t2329r1307b2382],
4	796	CD	NUMBER	796	dep	1	SENT_155	[p11l907t2329r1307b2382],
5	Martel	NNP	PERSON	Martel	dep	4	SENT_155	[p11l125t2416r324b2471],
6	F	NN	O	f	dep	1	SENT_155	[p11l358t2419r410b2483],
7	,	,	O	,	_	0	SENT_155	[p11l358t2419r410b2483],
8	Grundemann	NN	PERSON	grundemann	nn	9	SENT_155	[p11l448t2416r842b2472],
9	D	NN	O	d	appos	6	SENT_155	[p11l877t2418r947b2483],
10	,	,	O	,	_	0	SENT_155	[p11l877t2418r947b2483],
11	Calhau	FW	O	calhau	dep	6	SENT_155	[p11l985t2416r1197b2471],
12	C	NN	O	c	dep	6	SENT_155	[p11l1233t2417r1297b2483],
13	,	,	O	,	_	0	SENT_155	[p11l1233t2417r1297b2483],
14	Schomig	NN	O	schomig	nn	15	SENT_155	[p11l1337t2416r1602b2487],
15	E	NN	O	e	appos	1	SENT_155	[p11l1637t2419r1680b2470],
16	(	CD	NUMBER	(	num	17	SENT_155	[p11l1717t2417r1915b2486],
17	2001	CD	DATE	2001	dep	15	SENT_155	[p11l1717t2417r1915b2486],
18	)	CD	NUMBER	)	num	20	SENT_155	[p11l1717t2417r1915b2486],
19	Apical	JJ	O	apical	amod	20	SENT_155	[p11l1950t2416r2150b2487],
20	uptake	NN	O	uptake	dep	1	SENT_155	[p11l124t2506r325b2577],
21	of	IN	O	of	_	0	SENT_155	[p11l377t2507r446b2562],
22	organic	JJ	O	organic	amod	23	SENT_155	[p11l487t2506r710b2577],
23	cations	NNS	O	cation	prep_of	20	SENT_155	[p11l762t2507r972b2562],
24	by	IN	O	by	_	0	SENT_155	[p11l1021t2506r1098b2577],
25	human	JJ	O	human	amod	28	SENT_155	[p11l1146t2506r1353b2562],
26	intestinal	JJ	O	intestinal	amod	28	SENT_155	[p11l1403t2506r1676b2562],
27	Caco-2	NN	O	caco-2	nn	28	SENT_155	[p11l1728t2508r1941b2562],
28	cells	NNS	O	cell	prep_by	23	SENT_155	[p11l1994t2506r2145b2562],
29	:	:	O	:	_	0	SENT_155	[p11l1994t2506r2145b2562],
30	putative	JJ	O	putative	amod	31	SENT_155	[p11l124t2596r367b2665],
31	involvement	NN	O	involvement	dep	20	SENT_155	[p11l391t2596r768b2650],
32	of	IN	O	of	_	0	SENT_155	[p11l790t2596r860b2650],
33	ASF	NN	ORGANIZATION	asf	nn	34	SENT_155	[p11l872t2597r1008b2650],
34	transporters	NNS	O	transporter	prep_of	31	SENT_155	[p11l1032t2603r1401b2665],
35	.	.	O	.	_	0	SENT_155	[p11l1032t2603r1401b2665],

1	Naunyn	NNP	O	Naunyn	nn	4	SENT_156	[p11l1426t2598r1668b2665],
2	Schmiedebergs	NNP	O	Schmiedebergs	nn	4	SENT_156	[p11l1693t2596r2149b2665],
3	Arch	NNP	O	Arch	nn	4	SENT_156	[p11l125t2685r276b2739],
4	Phannacol	NNP	O	Phannacol	_	0	SENT_156	[p11l302t2685r624b2739],
5	363	CD	NUMBER	363	num	6	SENT_156	[p11l653t2686r759b2739],
6	240-49	CD	NUMBER	240-49	dep	4	SENT_156	[p11l772t2686r974b2739],

